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Mechanistic Studies of Vertebrate Hedgehog Signaling 
Abstract 
 Metazoans use Hedgehog signaling to direct many stages of embryonic development, and 
deregulation of this pathway is implicated in many types of cancer.  I investigated several steps 
of Hedgehog pathway transduction that were poorly understood in mechanistic terms. 
 The mature Hedgehog ligand is produced by a self-proteolysis reaction that covalently 
attaches a cholesterol molecule to the signaling half of the protein.  I showed that the catalytic 
cysteine forms a disulfide bridge that is essential for the folding and function of the C-terminal 
tail of Hedgehog, and identified two protein disulfide isomerases that remodel this bridge to free 
the catalytic thiol group after folding is complete.  Using pulse chase assays to follow Hedgehog 
processing, I demonstrated that the self-proteolysis reaction takes place in the endoplasmic 
reticulum, that the cleaved C-terminal tail of Hedgehog is degraded before moving to the Golgi, 
and that Hedgehog mutants defective in processing get degraded in their entirety by the same 
route. 
 Lipidated Hedgehog ligand requires the transmembrane protein Dispatched for secretion. 
I devised a system to test Dispatched function in cultured cells, and showed that some inactive 
Dispatched mutants fail to bind Hedgehog, while others bind more tightly than the wild type 
protein.  Scube2 was implicated as a Hedgehog pathway component in zebrafish genetic studies.  
I showed that Scube2 is a secreted protein that binds Hedgehog via its cholesterol adduct and 
solubilizes it in aqueous media.  Dispatched and Scube2 bind Hedgehog on opposing faces, and 
they function synergistically to release it from the membrane. 
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 Vertebrate Hedgehog signaling relies on intraflagellar transport through an antenna-like 
organelle called the primary cilium.  The Hedgehog receptor Patched and transducer protein 
Smoothened localize to primary cilia in a mutually exclusive pattern, depending on Hedgehog 
ligand presence.  I showed that cytoplasmic components of the pathway Suppressor of Fused 
(SuFu, a pathway inhibitor) and Glioma-associated oncogene transcription factors (the Gli 
family, the effectors of the pathway) localize to primary cilia and accumulate there when 
Smoothened is activated.  SuFu and Gli form a complex that dissociates when the pathway is 
turned on, and this dissociation depends on trafficking through the cilium. 
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Overview of Hedgehog Signaling Roles in Metazoans 
Higher metazoan development is a process in which a single starting cell becomes a 
complex organism possessing differentiated tissues that will not only carry out different tasks but 
also be organized in formations that will function as a coherent whole and sustain life.  Such a 
process requires cell-cell communication during embryogenesis, as each genetically identical cell 
must properly self-identify and carry out division, movement, and differentiation accordingly. 
 
The role of Hedgehog in Drosophila segmentation 
The body plans of higher animals are constructed from repeating segments, and the genes 
that establish and define these segments were first discovered in Drosophila melanogaster.  Fly 
embryos establish an anterior/posterior (A/P) and dorsal/ventral axes based on maternally 
deposited mRNA transcripts, and then proceed to subdivide segments along the A/P axis by a 
cascade of sequential activation of transcription factors.   The opposing gradients of four 
maternal factors turn on transcription of different gap genes which are translated in different 
latitudes on the A/P axis.  Nearly all gap genes encode transcription factors, which in turn drive 
the transcription of pair-rule genes.  It is the pair-rule genes that subdivide the embryo into seven 
segments, and turn on segment polarity genes.  Much of this process occurs without cell division, 
but the nuclei divide and eventually become separated into individual cells.   The segment 
polarity genes further divide the embryo into 14 segments, the final number, and maintain each 
segment identity and boundary.  Segment polarity genes can no longer all be transcription 
factors, because the cells of the embryo are now separated, and communication has to occur 
intercellularly.  In parallel, the homeotic genes activate and endow each equivalent segment with 
its own identity (Lewis, 1978). 
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In a classic screen for segmentation mutants, Nusslein-Volhard and Wieschaus used the 
development of the cuticle as an easy visual readout for mutations that affect embryonic 
patterning (Nusslein-Volhard and Wieschaus, 1980).  Mutants were grouped into the appropriate 
tier of segmentation genes by the phenotype of segments: mutation of segment polarity genes 
result in deletions in each segment, mutation of pair-rule genes shows deletions of alternating 
segments, and mutation of the gap genes shows stretches of segments disappearing.  The screen 
identified, among others, a segment polarity gene they named hedgehog, for the stubby 
appearance of the embryo that was densely covered with denticles instead of having them spaced 
out in a stripe pattern.   
Hedgehog functions as a segment polarity gene in the early stages (9-10) of 
embryogenesis.  It is an intercellular signaling molecule produced in cells that express segment 
polarity gene and transcription factor Engrailed.  The Engrailed stripes are established one step 
earlier by pair-rule genes.  Hedgehog signaling to adjacent anterior cells turns on the Wingless 
pathway.  Cells producing the Wingless signaling molecule in turn signal back and drive 
Engrailed expression in the adjacent cell.  This positive feedback loop maintains the boundary 
between Hedgehog and Wingless signaling cells, which straddle the parasegment boundary 
(DiNardo et al., 1988; Martizez Arias et al., 1988).  In later stages, Engrailed no longer relies on 
Wingless signal for expression and both the Wingless and Hedgehog pathways participate in 
patterning by interacting with homeobox gene expression. 
 
The role of Hedgehog in vertebrate embryogenesis 
Mammals and birds use three homologs of Drosophila Hedgehog.  Sonic hedgehog (Shh) 
has the broadest role in mammalian embryogenesis, and its mutation results in the most profound 
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birth defects.  Desert Hedgehog (Dhh) is most closely related to the Drosophila gene and is 
important to gonadal development.  Mutation of DHH results in Swyer syndrome, where genetic 
males develop as females.  Indian Hedgehog (Ihh) directs the growth of cartilage and bone, and 
its mutation results in brachydactyly.  Fish also use Tiggy-Winkle, Echidna, and Qiqihar 
hedgehog paralogs during embryonic patterning. 
The classic example of the prominent role Shh plays in early vertebrate embryogenesis is 
the patterning of the central nervous system.  The notochord is a spinelike organ which mostly 
serves to coordinate signaling, and is later lost, becoming a part of the intervertebral discs.  The 
notochord is responsible for patterning the neural tube that lies dorsally to it.  The ventral side of 
the neural tube must differentiate into motor neurons, while the dorsal side turns into sensory 
neurons.  During embryonic development, the notochord secretes Shh.  The ligand diffuses and 
establishes a morphogen gradient on the neural tube (Echelard et al., 1993; Krauss et al., 1993; 
Roelink et al., 1994).  The neurons closest to the notochord receive the highest dose and become 
the floor plate, which also starts secreting Shh ligand (Placzek et al., 1990).  Bone 
morphogenetic factor (Bmp) secreted from the ectoderm forms an opposing gradient.  Bmp and 
Shh establishe the dorsal/ventral axis of the neural tube and specify neurons into different fates 
depending on their position (Liem et al., 1995). 
The role of Shh in craniofacial development is well established.  In the absence of Shh 
signaling, the brain fails to form a ventral midline and separate into two hemispheres, resulting in 
a condition called holoprosencephaly.  Most holoprosencephaly is embryonic lethal.  Milder 
forms may result in the birth of organisms with facial abnormalities like cyclopia, anosmia, a 
single central incisor, and cleft palate (Chiang et al., 1996). 
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Shh signaling is also important to patterning of the limb bud, and only one digit forms on 
each limb in its absence.  During development, Hedgehog signal is produced by a region of 
mesenchyme known as the zone of polarizing activity, which is found on the posterior side of the 
limb bud.  High Shh concentrations specify posterior digits and low concentration specifies the 
thumb (Riddle et al., 1993; Lopez-Martinez et al., 1995). 
Segmentation is much less apparent in vertebrates, and is believed to rely on periodic 
oscillations of genes rather than transcription factor gradients, but many of the general principles 
remain.  In vertebrates, somites act analogously to arthropod segments.  Somites are groups of 
mesodermic cells that turn into segmented structures like the axial skeleton (sclerotome), skeletal 
muscles (myotome), and skin (dermomyotome).  Hedgehog signaling plays a less obvious role in 
segmentation of vertebrates, which relies on the pathways Notch and Wnt for boundary 
establishment.  Nevertheless, somitic cells express the Hedgehog receptor Patched, and Sonic 
hedgehog influences the differentiation of somites of the ventral part of the sclerotome by 
secretion from the nearby neural tube (Fan and Tessier-Lavigne, 1994; Marigo and Tabin, 1996).  
In further support of the role of Hedgehog in vertebrate segmentation, its mutation results in 
defects of the spine and ribs (Chiang et al., 1996). 
       Hedgehog signaling is also used throughout later stages of embryogenesis, and is 
involved in the formation of many other organs including the lungs, heart, pancreas, prostate, 
mammary glands, pituitary gland, and the visual system (reviewed in (McMahon et al., 2003)). 
 
The role of Hedgehog in adult organisms  
After the signaling-intensive period of embryogenesis is complete, the Hedgehog 
pathway is repurposed for directing functions that require cell division and differentiation.  
Chapter One 
 6!
Hedgehog participates in the growth of epithelial structures like hair, nails, scales, and feathers, 
as well as tooth formation.  It supports the function of organs with high turnover, such as the 
lining of the gastrointestinal tract, as well as differentiation processes like hematopoeisis.  
Hedgehog is also involved in skin, cartilage, and bone repair and drives differentiation of stem 
cells in response to trauma.  It has also recently been shown to play a role in axonal guidance 
(reviewed in (McMahon et al., 2003; Sanchez-Camacho and Bovolenta, 2009). 
There is intense pharmacological interest in the Hedgehog signaling pathway because of 
its role in cancer initiation and progression.  The types of carcinomas that utilize Hedgehog 
signaling for proliferation can be grouped into those that tend to be ligand dependent (even if 
autocrine) and those that are ligand independent, involving components downstream of the 
Patched receptor.  Gliomas (Dierks et al., 2007; Ehtesham et al., 2007), colorectal (Mazumdar et 
al., 2011), upper gastrointestinal tract cancers (Berman et al., 2003), prostate (Karhadkar et al., 
2004; Sanchez et al., 2004), and breast cancers (Kubo et al., 2004) tend to be ligand dependent.  
On the other hand, medulloblastomas (which involve mutations in PTCH1, SMO, or SUFU) tend 
to be ligand independent (Goodrich et al., 1997; Reifenberger et al., 1998; Taylor et al., 2002).  
Basal cell carcinomas often carry mutations in PTCH1 and SMO (Gailani et al., 1996; Hahn et 
al., 1996; Lam et al., 1999) whereas cancers of the pancreas carry mutations of GLI1 and GLI3 
(Thayer et al., 2003).  Rhabdomyosarcomas tend to be caused by mutations in PTCH1 and SUFU 
(Tostar et al., 2006), and in Ewing sarcoma transcription of GLI1 is directly activated by the 
Ews-Fli fused transcription factor (Beauchamp et al., 2009). 
       Ligand dependent tumors or those that result from a mutation in Patched can be 
treated with antagonists of the most drug-susceptible protein in the pathway, Smoothened.  In 
2012, Smoothened inhibitor vismodegib (GDC-0449) was approved by the Food and Drug 
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Administration as a treatment for basal cell carcinoma.  Those tumors with inactivating 
mutations of SUFU or activating mutations in SMO or GLI are more difficult to treat, and any 
targeted chemotherapeutic agent would have to be cell permeable and inhibit Gli.   
  
Overview of Hedgehog Signal Transduction   
Lipid modification of the Hedgehog protein  
Hedgehog is synthesized as a 45 kDa precursor protein.  After co-translational 
translocation in the endoplasmic reticulum (ER), the signal sequence is cleaved off (Lee et al., 
1992).  Hedgehog is palmitoylated on its N-terminus and undergoes a unique self-proteolysis 
reaction to attach a cholesterol adduct to the C-terminus of the cleaved N-terminal product.  The 
final ligand is a doubly lipidated 19 kDa protein.  It is the only protein known to undergo 
covalent modification with a cholesterol molecule.  
  
Sterolation of the Hedgehog protein 
The Hedgehog gene is believed to have evolved from a fusion of two disparate ancient 
genes.  Part of the C-terminal autoprocessing domain resembles an intein.  Inteins are defined as 
segments of proteins that can catalyze their own excision and join back the two pieces of the 
polypeptide in which they were embedded.  True inteins are self-propagating and include a 
bifunctional homing endonuclease domain inserted into a protein splicing domain (reviewed in 
(Chevalier and Stoddard, 2001)).  In a host that encodes the intein, entry of intein-less alleles can 
occur via conjugation, transduction, transformation, or sex.  The homing endonuclease creates 
double strand breaks in specific intein-less regions, and DNA repair then converts the wild type 
allele into the intein-containing allele using the host’s other copy of the gene (Gimble and 
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Thorner, 1992).  Intein segments begin with an obligate cysteine or serine residue.  In the first 
step of self-excision, the thiol or hydroxyl sidechain attacks the neighboring carbonyl in the 
peptide chain, generating a thioester intermediate.  The second step involves the same attack by a 
hydroxyl or thiol group of an amino acid further away, C-terminal to the intein domain.  This 
transesterification reaction produces a branched intermediate.  The next step is irreversible and 
involves the cyclization of the sidechain of an obligate asparagine residue at the end of the intein, 
resulting in excision of the intein with a five member aminosuccinimide ring on its end.  The last 
step is a spontaneous S-N or O-N shift of the ligated polypeptide to produce a stable protein with 
no trace of having had a segment inserted into it before (Figure 1.1, left side) (Xu et al., 1994; 
Shao and Paulus, 1997).  
Hedgehog’s autoprocessing domain is part of a large family of domains called Hint 
(Hedgehog intein) that are widespread in single celled organisms in the fungi, protist, eubacteria, 
and archaebacteria kingdoms.  Despite being a degenerate homolog, the Hedgehog C-terminal 
tail crystal structure aligns with those of self-propagating inteins (Hall et al., 1997).  The 
Hedgehog protein thus represents ancient metazoans harnessing the ability of an intein to ligate 
surrounding polypeptides, and redirecting its function to attach sterols to a protein. 
Hedgehog's self-proteolysis reaction proceeds very similarly.  The first step in cleavage is 
a nucleophilic attack by the sidechain of cysteine on the neighboring glycine carbonyl in a 
conserved GCF motif.  In the transesterification step, it is the 3! hydroxyl group of a cholesterol 
molecule that attacks the same carbonyl, breaking the thioester bond and generating an ester 
linkage of the N-terminal half of Hedgehog to cholesterol.  This is the active ligand (Figure 1.1, 




Figure 1.1  Comparison of intein excision and Hedgehog processing mechanism.   
Adapted from Xu, Paulus & Chong, 2000 ; Mann & Beachy, 2004. 
 
An important element of the Hedgehog C-terminus is the putative sterol recognition 
region (SRR) found in other Hog members.  The Hedgehog cleavage reaction does not 
absolutely require cholesterol as it can be carried out in vitro in the presence of reducing reagents 
such as dithiothreitol, hydroxylamine and glutathione-- resulting in a cleaved Hedgehog protein 
that is not sterolated.  Only the first 145 amino acids of the C-terminal tail are necessary for this 
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type of cleavage.  In contrast, cholesterol addition requires most of the tail (Lee et al., 1994; 
Porter et al., 1995). 
There are other genes in multicellular organisms that include a Hint domain fused to a 
different N-terminal domain.  This group of more closely related Hint domains has been named 
Hog (for the latter half of Hedgehog).  The most notable examples of non-Hedgehog Hog 
proteins are the Warthog, Ground, and Quahog found in C. elegans, an organism which lacks 
Hedgehog signaling, and uses these genes in unrelated ways for cuticle and extracellular matrix 
functions such as molting (Burglin, 1996; Aspock et al., 1999; Hao et al., 2006).  Although some 
of the warthog genes are reportedly processed (Porter et al., 1996b), there is no evidence of 
cholesterol incorporation by any protein other than Hedgehog, despite conservation of the SRR 
in C. elegans hog proteins (Aspock et al., 1999).  It is possible that there are other sterols or 
lipids being attached in the worm. 
  
Palmitoylation of the Hedgehog protein 
The common form of palmitoylation involves a cotranslational addition of a palmitate 
(C16:0) to a cysteine residue of a cytoplasmic protein by thioester linkage (S-palmitoylation).  
This is a dynamic lipid modification, and its addition and removal can be used to cyclically 
control a protein’s affinity for membranes.  Less common is the addition of the palmitate adduct 
to an N-terminal cysteine of a lumenal protein via a stable amide linkage.  This is the type of 
palmitoylation that Hedgehog undergoes.  It is performed in the endoplasmic reticulum by a 
membrane bound O-acyltransferase (MBOAT) family, discovered by four groups an 
alternatively named Rasp/Ski/Sit/Cmn in flies, or Hedgehog acetyltransferase (HHAT) in 
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vertebrates (Amanai and Jiang, 2001; Chamoun et al., 2001; Lee and Treisman, 2001; Micchelli 
et al., 2002). 
  
The effect of lipid modifications on signaling molecules  
It may seem surprising that signaling molecules destined for secretion and diffusion 
across multiple cells would be modified with hydrophobic adducts that increase their affinity to 
cell membranes.  This section will compare the effects of acylation and sterolation on Hedgehog, 
Spitz, Wnt, and the hormone ghrelin on diffusion rate, receptor affinity, and ligand potency.  
In Drosophila, there is another signaling molecule that is modified by the same 
palmitoyltransferase as Hedgehog: the EGFR ligand Spitz.  Spitz is synthesized as a membrane 
tethered lumenal protein that undergoes proteolytic cleavage by intramembrane protease 
Rhomboid (Urban et al., 2001) and is subsequently palmitoylated on its N-terminal cysteine by 
Rasp, the HHAT Drosophila homolog (Miura et al., 2006).  When Spitz is not palmitoylated, 
both its secretion rate and diffusion range increase, as might be expected with decreased overall 
hydrophobicity.  In whole animals, rasp mutation leads to dysfunctional attenuated Spitz 
signaling as assayed in retinal patterning.  Likewise, when the palmitoylated cysteine of Spitz is 
mutated to a serine, Spitz is unable to rescue the lethality of spitz mutant organisms (Miura et al., 
2006).  One possible explanation for this is that the palmitate adduct is essential for receptor 
binding or activation, but the palmitoylated and unpalmitoylated Spitz ligands have the same 
affinity for the EGF receptor and similar potency to activate it in vitro (Miura et al., 2006).  This 
highlights the notion that increasing the range and diffusion of a morphogen can lead to an 
inability to signal properly in a physiological context.  Spitz is designed as a relatively short-
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distance morphogen with a steep gradient, and requires high local concentrations to induce its 
targets.  
The Wnt family of proteins are ligands for the eponymously named pathway, and are 
homologs of the Drosophila segmentation polarity gene wingless mentioned earlier.  The Wnt 
proteins are S-palmitoylated on an internal cysteine by the acyltransferase Porcupine (Kadowaki 
et al., 1996; Tanaka et al., 2000)  One of the Wnts, Wnt3a, is also modified with palmitoleate 
(C16:1) on a serine residue (Takada et al., 2006).  It is worth noting that this palmitoylation of a 
lumenal protein differs from the S-palmitoylation of cytoplasmic proteins, and there is no 
evidence that the modification is dynamic.  Secretion of Wnt ligand is unaffected by mutation of 
the palmitoylated cysteine (Willert et al., 2003), while Wingless secretion is severely 
compromised by the protein’s resultant misfolding (van den Heuvel et al., 1993).  Mutation of 
the palmitoleated serine of Wnt3a also results in misfolding and retention of the protein in the 
ER (Takada et al., 2006). 
The secreted unpalmitoylated Wnt mutant is not active, however.  While it is possible 
that the palmitate adduct is required for proper folding of the protein, and the secreted Wnt is still 
slightly misfolded, wild type Wnt that is secreted after palmitoylation and subsequently treated 
with acyl protein thioesterase-1 is also inactive (Willert et al., 2003).  It has since been 
demonstrated that unpalmitoylated Wnts have reduced binding affinity to their receptors LRP5, 
LRP6, and Frizzled (Komekado et al., 2007; Kurayoshi et al., 2007). 
Ghrelin is a secreted hormone that stimulates growth hormone expression and the 
appetite in vertebrates.  Ghrelin is n-octanoylated on the third serine via an ester bond by an 
enzyme from the MBOAT family (Kojima et al., 1999; Gutierrez et al., 2008; Yang et al., 2008).  
Although the majority of circulating ghrelin is not octanoylated, only the octanoylated molecule 
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has affinity for the growth-hormone secretagogue receptor and activity (Kojima et al., 1999; 
Hosoda et al., 2000).  Perhaps because the hydrophobic chain is short, secretion and diffusion of 
ghrelin does not appear to be significantly reduced by lipid modifications, but there is some 
evidence that the octanoylated version requires a saturable transport system to cross the blood-
brain barrier, while ghrelin lacking lipid modification diffuses in and out freely (Banks et al., 
2002). 
Hedgehog secretion is not affected by mutation of HHAT or the cysteine residue that is 
palmitoylated, but the ligand is inactive in terms of signaling (Pepinsky et al., 1998; Chen et al., 
2004).  The binding of unpalmitoylated Hedgehog to Patched does not appear to be significantly 
reduced.  In one study, Hedgehog was tethered to the Patched receptor, and the constitutive 
signaling activity of this fusion was reduced in the absence of rasp, the Drosophila homolog of 
HHAT (Miura and Treisman, 2006).  Even more convincingly, expression of Hedgehog 
incapable of being palmitoylated has a slight dominant negative effect in vivo, presumably by 
competing with wild type Hedgehog for Patched binding (Lee et al., 2001b; Gallet et al., 2006).  
A direct comparison of binding in a cell culture assay showed that unpalmitoylated Hedgehog 
binds Patched and competes with palmitoylated Hedgehog binding (Williams et al., 1999).  The 
essential function of the palmitate adduct for signaling activity is not yet understood.  It is 
possible to rescue the signaling activity of Hedgehog lacking palmitate by substituting other lipid 
modifications at the N terminus, such as myristate, which fully rescues signaling capability, but 
substitution with a stretch of amino acids with hydrophobic side chains resulted in very little 
activity (Taylor et al., 2001).  Reception of the Hedgehog signal results in Patched internalization 
and turnover in the lysosome, and the ability of unpalmitoylated Hedgehog to induce this 
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internalization has not been measured.  It is possible that the palmitate adduct is essential for 
recognition by a factor responsible for internalizing Patched complexed with Hedgehog. 
The cholesterol moiety of Hedgehog is essential in that full length Hedgehog mutants that 
fail to self-proteolyse are inactive and cause holoprosencephaly (Nanni et al., 1999; Maity et al., 
2005).  In chapter 2 of this dissertation I outline the mechanism by which these mutants are 
degraded before ever reaching the plasma membrane. 
A signaling domain of Hedgehog lacking a cholesterol adduct can be easily generated by 
truncating the protein at the modified glycine residue.  The resultant Hedgehog protein is 
secreted freely from cells, unlike the wild type dually lipidated version or the palmitoylation site 
mutant which is still sterolated.   This argues that it is cholesterol and not palmitate that is mainly 
responsible for Hedgehog’s strong membrane affinity (Porter et al., 1995).  The potency of this 
truncated ligand is much stronger than that of the unpalmitoylated mutant, but is still 
significantly less than that of the dually lipidated Hedgehog, despite similar affinity for the 
Patched receptor, as directly measured in a cell culture assay (Williams et al., 1999).  One 
possible explanation for this reduced potency is that Hedgehog that does not get modified by 
cholesterol is also less efficiently palmitoylated, either because it migrates faster through the 
secretory pathway or because it has less affinity for the acyltransferase.  This would result in a 
mixture of Hedgehog ligands with increased numbers of inactive, unpalmitoylated proteins and 
reduced overall potency.  Supporting this explanation, the study that identified the HHAT 
detected only three species of Hedgehog after transfection into insect cells: unprocessed, 
sterolated, and dually lipidated (Pepinsky et al., 1998).  However, a different study measured 
[3H]palmitate incorporation into processed and truncated Hedgehog proteins, and found them to 
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be equal (Chen et al., 2004).  Thus, the cholesterol adduct does seem to have a role independent 
of the palmitate adduct in terms of ligand potency. 
  Enzyme Secretion Receptor Affinity Potency 
Ghrelin- Loss of octanoylation  
 
 
GOAT Similar Similar None 
Spitz- Loss of palmitoylation 
 
 
Rasp Greater Similar Similar 
Wingless -Loss of palmitoylation  
 
 
Porc None - - 
Wnt - Loss of palmitoylation  
 
 
Porc Similar Low Low 
Hedgehog- Loss of palmitoylation  
 
 
Rasp/HHAT Similar Similar None 




- Greater Similar Lower 
Hedgehog- Loss of cholesterol 




self-catalysis None - - 
Table 1.1.  A summary of the consequences of losing lipid adducts on signaling molecules 
 
Unlike the free diffusion of truncated Hedgehog, secretion of cholesterol modified 
Hedgehog depends on the actions of a twelve pass transmembrane protein called Dispatched, 
distantly related to the Hedgehog receptor Patched (Burke et al., 1999; Caspary et al., 2002; 
Kawakami et al., 2002; Ma et al., 2002).  The similarity between the proteins, and their 
relationship to other sterol interacting proteins will be discussed in a later section.  Dispatched is 
not required in the cells receiving the Hedgehog signal, does not affect Hedgehog lipid 
modification, and is not involved in trafficking cholesterol-modified Hedgehog to the plasma 
membrane.  In fact, disp-/- cells can still signal to immediately adjacent cells (Caspary et al., 
2002).  It is not known what function Dispatched is performing on a molecular level, but its 
homology to resistance-nodulation-division (RND) permeases in bacteria that form homotrimeric 
pumps suggests a transporting or flipping action that might drive the cholesterol adduct out of 
the plasma membrane. 
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The decreased membrane affinity and concomitant reduction in potency of the 
uncholesterated Hedgehog has resulted in a contradictory literature about the role of the 
cholesterol adduct in vivo and in terms of long range signaling.  In Drosophila, there are reports 
that Hedgehog without the cholesterol moiety has increased range (Burke et al., 1999; Dawber et 
al., 2005; Callejo et al., 2006), while in another study, cholesterol modification was required for 
activating long range targets (Gallet et al., 2006).  In the vertebrate limb bud, Hedgehog lacking 
cholesterol failed to activate long range targets in experiments by one group (Lewis et al., 2001), 
while a different group saw Hedgehog lacking cholesterol spread further and activate Hedgehog 
ectopically in the same system (Li et al., 2006).   
Models have also been proposed to explain the supposed requirement of cholesterol 
modification for long range signaling, such as the requirement for cholesterol adducts to form 
Hedgehog multimers or be incorporated into lipoprotein particles that can travel greater distances 
than the truncated Hedgehog proteins diffuse  (Zeng et al., 2001; Chen et al., 2004; Panakova et 
al., 2005; Goetz et al., 2006; Callejo et al., 2008).  A simpler explanation is that the effects of 
cholesterol on Hedgehog range may be comparable to the effects of palmitoylation on Spitz-- 
that is, that the lipid adduct is not increasing the range of Hedgehog, but rather allowing it to 
concentrate and activate targets at the appropriate distances from the secreting cells.  The 
differences between different groups might be attributable to different levels of overexpression 
of Hedgehog constructs, where experiments performed with higher levels of Hedgehog reveal 
the longer range of truncated Hedgehog while others do not detect tissue responses of diluted 
Hedgehog that has spread further. 
In the context of whole organisms, lipid modifications are essential for all of the 
signaling molecules discussed above.  Even when the lipid adduct does not contribute to ligand 
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potency in vitro, it is invariably essential for properly limiting ligand spreading and delivering 
appropriate dosages to the cells anticipating the signal.  It is interesting how fine-tuned these 
systems appear to be, given that the same type of ligand travels variable physical distances in 
different organisms, and in different locations within the same organism.  Lipid modifications 
may provide convenient “handles” that can interact with factors at the site of secretion, the site of 
reception, and anywhere along the intervening journey.  This allows for modulation of the 
steepness and distance of morphogen gradients.   
In chapter 3 of this dissertation, I present work on secreted protein Scube2 that interacts 
with the cholesterol adduct of Hedgehog and dramatically increases its diffusion from cells, 
providing a possible mechanism for long range movement of cholesterol modified Hedgehog. 
  
Hedgehog receptor Patched 
Patched, a twelve pass transmembrane protein, is the main Hedgehog receptor and binds 
the Hedgehog protein directly (Hooper and Scott, 1989; Ingham et al., 1991; Marigo et al., 1996; 
Stone et al., 1996).   In the absence of Hedgehog, Patched is active and inhibits 7-pass 
transmembrane protein Smoothened, which is an activator of the pathway.  When Hedgehog 
binds Patched, it is inhibited, and Smoothened is derepressed, activating downstream steps of the 
pathway (Ingham et al., 1991).  In the absence of Patched, the Hedgehog pathway is 
constitutively activated.  Hedgehog binding appears to inhibit Patched activity by triggering its 
internalization and destruction in the lysosome (Incardona et al., 2000; Gallet and Therond, 
2005). 
Patched inhibits Smoothened substoichiometrically, arguing that its action is catalytic 
(Taipale et al., 2002).  Like Dispatched, Patched bears resemblance to RND permeases, and is 
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believed to act as a pump or flippase to control the location of a small molecule that affects 
Smoothened activity.  There may be divergence between vertebrate and arthropod signaling at 
this step, as Drosophila Smoothened does not bind the same small molecules as vertebrate 
Smoothened.  Patched is also a target of the pathway, which acts as a negative feedback loop in 
which activation of the pathway also produces more of the pathway’s negative regulator.  In the 
context of Hedgehog migration across tissue, this negative feedback loop also functions to 
steepen the Hedgehog gradient, since the cells closest to the source are activated first and 
produce more receptor in response. (Chen and Struhl, 1996; Gallet and Therond, 2005). 
 
Figure 1.2  Proteins containing sterol sensing domains. 
Every protein is oriented with the cytoplasmic face of the membrane on the bottom and the extracellular face on top.  
Sterol sensing domains are highlighted in bold.  Created using UniProt annotations and TOPO2 Transmembrane 
protein display software.  http://www.sacs.ucsf.edu/TOPO2/ 
 
 
Sterol sensing domain proteins 
Sterol sensing domains (SSDs) are defined as spans of five consecutive transmembrane 
helices constituting ~180 amino acids.  These domains have no proven function but are 
conserved among several proteins involved in sterol homeostasis and trafficking, and certain 
point mutations in these domains dramatically affect the proteins’ function.  This section will 
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review the group of proteins that possess this domain before returning to Dispatched and Patched 
and examining what role the SSD might play in their function. 
An SSD is found in HMG-CoA reductase (HMGCR), an eight-pass transmembrane ER-
resident protein that converts HMG-CoA to mevalonate.  The SSD is not needed for its 
enzymatic activity but is required for sterol-level induced degradation (Gil et al., 1985; Sever et 
al., 2003).  Another enzyme in the cholesterol biosynthetic pathway that contains an SSD is 9- 
pass transmembrane protein 7-dehydrocholesterol reductase (DHCR7).   DHCR7 converts 7-
dehydrocholesterol into cholesterol, and cholest-5,7,34-trienol into desmosterol (which is then 
converted to cholesterol) in an alternative pathway.  Mutation of this enzyme blocks cholesterol 
production and precursors and their derivatives accumulate.   This defect in cholesterol 
biosynthesis results in Smith-Lemli-Opitz syndrome, which is characterized by many 
developmental abnormalities affecting virtually every organ system, because of cholesterol’s role 
as an integral component of cell membranes as well as a precursor for bile acids and steroidal 
hormones (reviewed in (Jira et al., 2003)). 
Besides biosynthetic enzymes, SSDs are found in a protein that regulates cholesterol 
homeostasis.  Transcription of cholesterol uptake receptors and cholesterol biosynthetic pathway 
genes is controlled by cis-acting sterol regulatory elements (SRE), which are activated by the 
binding of transcription factor SRE binding protein (SREBP).  SREBP is normally found in an 
inactive, membrane-bound state in the ER, and SREBP cleavage activating protein (SCAP) is 
bound to a resident ER protein Insulin induced gene 1 (Insig1) (Yang et al., 2002).  When 
cholesterol levels in the ER fall, Insig and SCAP dissociate and SCAP binds SREBP and 
transports it to the Golgi, where enzymes S1P and S2P cleave SREBP and release the 
transcription factor segment into the cytoplasm (Sato et al., 1994; Wang et al., 1994; Hua et al., 
Chapter One 
 20!
1996; Sakai et al., 1996).  SCAP is an eight pass transmembrane protein that contains an SSD 
and functions as the cholesterol sensor in the circuit.  Mutation of conserved aspartate 443 in the 
SSD to alanine renders SCAP unresponsive to sterols-- not binding to Insigs in the presence of 
high cholesterol, and driving transcription of SRE genes constitutively (Yabe et al., 2002). 
The SSD is also found in a protein that is involved in intracellular cholesterol transport.  
Niemann-Pick protein C1 (NPC1) was identified as a locus for the recessive autosomal disease it 
is named after.  Niemann-Pick disease is characterized by aberrant cholesterol trafficking, where 
unesterified cholesterol that was taken in via LDL particles stays in late endosomes/lysosomes 
and fails to redistribute to other membranes (Blanchette-Mackie et al., 1988; Sokol et al., 1988). 
The three organs that are particularly affected are the spleen, the brain, and the liver, which takes 
up excess cholesterol from the blood.  NPC1 is a 13 pass transmembrane protein that resides in 
endosomes (Garver et al., 2000), and whose SSD is in transmembrane helices 3 through 7.  
NPC1 has been demonstrated to bind cholesterol directly using a photoactivatable cholesterol 
analog (Ohgami et al., 2004).  This binding activity was dependent on a functional SSD.  NPC1, 
like Patched and Dispatched, shows homology with the RND permease family in prokaryotes.  
Indeed, Escherichia coli made to express mammalian NPC1 transported acriflavine and oleic 
acid across membranes (Davies et al., 2000).  NPC1 acts together with a partner protein, NPC2, 
which is a luminal/extracellular small protein that also binds cholesterol directly (Friedland et al., 
2003; Ko et al., 2003).  NPC2 can shuttle cholesterol between NPC1 and membranes (Infante et 
al., 2008).  The current model for the action of these two proteins is that NPC2 grabs cholesterol 
freed from LDL particles in the lysosome and hands them off to NPC1, which inserts cholesterol 
molecules into the membrane, allowing for them to be transported out of the lysosomes to the 
plasma membrane or ER.  Unexpectedly, mutation of conserved SSD aspartate 787 to asparagine 
Chapter One 
 21!
(in a similar position to the aspartate 443 of SCAP mentioned before) results in a gain-of-
function mutant of NPC1, which reportedly increases cholesterol trafficking to the plasma 
membrane and ER (Millard et al., 2005).  Other mutations in the SSD do disrupt NPC1 function 
(Watari et al., 1999). 
The SSDs of Patched and Dispatched are clearly required for their function, as mutation 
of the conserved aspartates result in constitutive signaling in the case of Patched (Strutt et al., 
2001; Taipale et al., 2002) and an inability to secrete Hedgehog signal in the case of Dispatched 
(Ma et al., 2002).  Dispatched works to secrete only sterolated Hedgehog, and is thus likely to 
bind cholesterol directly.  Patched, on the other hand, can be easily activated with Hedgehog 
lacking a cholesterol adduct, and mutation of the SSD does not affect its ability to bind 
Hedgehog (Strutt et al., 2001).  Rather, the SSD of Patched must function in sterol interaction in 
its catalytic activity of inhibiting Smoothened.  The developmental defects in Smith-Lemli-Opitz 
syndrome resulting from DHCR7 mutation seem to include defects in Hedgehog signaling, and it 
is believed that the defect is not at the level of Hedgehog ligand sterolation, but rather a faulty 
response by Smoothened (Koide et al., 2006). 
Given the conservation of the SSD in proteins that are known or believed to bind sterols, 
it is tempting to ascribe direct cholesterol binding activity to this domain.  Contrary to 
expectations, a cholesterol binding site on SCAP was recently mapped to a lumenal loop, and 
mutating one tyrosine residue to alanine in this loop mimics cholesterol binding—resulting in a 
constitutively inactive protein that remains bound to Insig (Motamed et al., 2011).  This finding 
raises the possibility that a protein like Dispatched might bind the cholesterol adduct of 
Hedgehog not with the SSD but an extracellular loop, and thus act to lift lipidated Hedgehog out 
of the plasma membrane to encourage its secretion. 
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Accessory Hedgehog receptors 
Although Patched binding to Hedgehog is the signal transducing event, there are many 
cell surface proteins that act as accessory receptors, and in some cases as inhibitory binders that 
modulate the signal.  Identification of these coreceptors has lagged behind that of other pathway 
components because of functional redundancy, but taken together they play an essential role in 
Hedgehog signal reception.  Cdo and Boc are integral membrane proteins with immunoglobulin 
and fibronectin-like repeats, the latter of which bind Hedgehog (McLellan et al., 2006; Tenzen et 
al., 2006; Yao et al., 2006).  Gas1 is another Hedgehog binding protein that is GPI anchored in 
the membrane and binds Hedgehog (Lee et al., 2001a; Martinelli and Fan, 2007).  These 
components were shown to not only limit the range of Hedgehog by soaking it up, but also 
interact with Patched and form true coreceptors with increased affinity for Hedgehog than 
Patched alone (Zheng et al., 2010; Izzi et al., 2011).  Vertebrates also express a transmembrane 
protein called Hedgehog interacting protein (Hip) that competitively binds Hedgehog on the 
same face as Patched and acts as an inhibitor (Chuang and McMahon, 1999; Bishop et al., 2009; 
Bosanac et al., 2009)  Hip is a Hedgehog target and, like Patched, forms a negative feedback 
loop in the pathway. 
In addition to the true receptors listed above, there is evidence that Hedgehog ligand 
forms at least transient interactions with elements of the extracellular matrix, and these 
interactions affect its rate of spreading.  Heparan sulfate proteoglycans have been shown to have 
effects on Hedgehog ligand spreading and signaling.  The initial observation implicating 
proteoglycans was the phenotype of the tout-velu (ttv) mutant in Drosophila, where Hedgehog 
was unable to diffuse to long range targets (Bellaiche et al., 1998).   ttv encodes an enzyme 
involved in proteoglycan synthesis (The et al., 1999) and only affects movement of cholesterol-
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modified Hedgehog (Callejo et al., 2006).  Dally-like protein, a cell surface heparan sulfate 
proteoglycan, is essential for Hedgehog signaling in Drosophila (Lum et al., 2003a).  In 
vertebrates, the role of proteoglycans is more questionable.  In contrast to flies, deletion of 
vertebrate glypican proteins is reported to increase Hedgehog signaling in most cases (Capurro et 
al., 2008; Williams et al., 2010).  Mutations of these glypicans cause phenotypes that might be 
associated with increased Hedgehog signaling, such as enlarged body size, but there are no 
profound developmental consequences that would be expected of a core Hedgehog pathway 
component. 
Several other extracellular matrix proteins reportedly affect Hedgehog binding and 
spreading in vertebrates and flies, including basement membrane heparan sulfate proteoglycan 
perlecan (Park et al., 2003), secreted glycoprotein vitronectin (Pons and Marti, 2000), and 
transmembrane receptor of broad specificity LRP2/megalin (McCarthy et al., 2002).  Like 
glypicans, it is unclear if any of these play a crucial role.  It is possible that they have essential 
functions in specific tissue or particular stages of development. 
The complexity of the cell surface system that binds Hedgehog probably stems from the 
multiple roles Hedgehog has in both embryogenesis and later tissue maintenance, and represents 
tissue adaptations to modulate signals.   
  
Cytoplasmic signal transduction events in Drosophila  
In Drosophila, there is one transcription factor that acts as both repressor and activator of 
Hedgehog target genes, encoded by segment polarity gene cubitus interruptus (ci).  Ci in its full 
length form (Ci-155) includes a zinc finger DNA binding domain and a transcriptional activation 
domain.  Ci-155 is partially degraded by the proteasome into a shorter form (Ci-75) that still 
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includes the DNA binding domain and acts as a repressor for the same genes it activates in its 
full length form.  Activation of Smoothened shifts the balance from Ci-75 to Ci-155, leading to 
activation of Hedgehog targets.  Despite the parsimonious use of one transcription factor, a 
graded response to Hedgehog signal can be achieved because some target genes are transcribed 
unless Ci-75 is actively repressing them (hh), some are transcribed regardless of Ci-75 and 
enhanced by activator Ci-155 (ptc), and others require the binding of Ci-155 and absence of Ci-
75 for activation (dpp) (Aza-Blanc et al., 1997; Methot and Basler, 1999).  
Ci is generally found in a complex containing kinesin Costal-2 (Cos2), serine/threonine 
kinase Fused (Fu), and negative regulator of the pathway Suppressor of Fused (SuFu) (Robbins 
et al., 1997; Sisson et al., 1997).  The complex tethers to microtubules via Cos2 and keeps Ci out 
of the nucleus.  Cytoplasmic Ci is subject to a sequence of events that includes phosphorylation 
by PKA, then CK1, and finally GSK3 (Jiang and Struhl, 1995; Wang et al., 1999; Price and 
Kalderon, 2002).  Phosphorylated Ci is recognized by ubiquitin ligases and marked for 
degradation by the proteasome (Smelkinson et al., 2007).  The Ci-75 form no longer associates 
with the Cos2 complex and enters the nucleus to repress transcription of target genes.  Loss of 
Cos2 or any of the kinases that initiate the process of Ci degradation result in accumulation of 
Ci-155 and pathway activation (Wang and Holmgren, 1999; Zhang et al., 2005).  Interestingly, it 
was observed that accumulation of Ci-155 did not correspond with full activation of the pathway, 
leading to hypotheses that Ci stabilization and activation were separate events and involved 
posttranslational modifications (Ohlmeyer and Kalderon, 1998).  More recent models postulate 
that activation might simply entail nuclear entry, and that Ci-155 may be protected from partial 
degradation but still be kept out of the nucleus, perhaps by SuFu, which plays only a small role 
in Drosophila when other pathway components are intact. (reviewed in (Kalderon, 2004)). 
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Activation of Smoothened increases the rate of Ci entry into the nucleus before 
conversion to the Ci-75 form (Chen et al., 1999).  The mechanism by which this happens is not 
yet fully understood.  There is evidence that Smoothened directly binds the cytoplasmic Ci 
complex via Cos2, and that this association happens regardless of Hedgehog signal.  What 
changes upon signal activation is that Smoothened and the Ci complex become enriched in the 
plasma membrane instead of the internal vesicles they favor when the pathway is not active (Jia 
et al., 2003; Lum et al., 2003b; Ogden et al., 2003; Ruel et al., 2003).  Smoothened might induce 
the phosphorylation and activation of Fu kinase, which in turn phosphorylates Cos2 and SuFu.  
This leads to a dissociation of Ci from the complex (Liu et al., 2007; Ruel et al., 2007). 
  
Vertebrate cytoplasmic components of the pathway    
The function of Cubitus interruptus is split into three related proteins in vertebrates, Gli1, 
2, and 3-- named for Gli1’s identification as a gene amplified in glioblastomas (Kinzler et al., 
1987).  Unlike its homologs, Gli1 does not have the N-terminal repressor domain and functions 
exclusively as an activator of target genes (Sasaki et al., 1999).  It does not undergo partial 
degradation by the proteasome (Dai et al., 1999; Ruiz i Altaba, 1999).  Gli1 is only synthesized 
in response to pathway activation, and so represents a positive feedback mechanism to strengthen 
the signal.  Gli2 and Gli3 are more similar to Ci, in that they can act as both repressors and 
activators of target genes (Ruiz i Altaba, 1999; Shin et al., 1999).  Gli2 is believed to function 
primarily as an activator.  Like Gli1, it is a pathway target, and the partially degraded form is 
either nonexistent or rare in physiological contexts.  Gli3 is primarily a repressor, and is robustly 
converted by the proteasome into the shorter form (Dai et al., 1999). 
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Vertebrate Hedgehog signal transduction from Smoothened to the nucleus has diverged 
from that in Drosophila.  The homologs of negative regulators Cos2 and Fu do not produce 
Hedgehog phenotypes when deleted (Chen et al., 2005; Merchant et al., 2005).  Meanwhile, 
SuFu, which is a minor player in Drosophila, turns out to be an essential negative regulator of 
the pathway in mammals (Cooper et al., 2005; Svard et al., 2006).  SuFu binds full length Gli 
proteins and prevents their entry into the nucleus (Pearse et al., 1999; Dunaeva et al., 2003).  
Interestingly, in the absence of SuFu, the pathway is fully activated, but full length Gli3 and Gli2 
are destabilized (Humke et al., 2010).  This is somewhat similar to what has been observed in 
Drosophila, with stabilization of Ci-155 not corresponding to full activation of the pathway.  It 
also suggests that full length Gli proteins are stable in the cytoplasm and destabilized after they 
enter the nucleus and carry out their transcriptional activating function.   
The most striking difference between flies and vertebrates is the organization of the 
vertebrate pathway inside a cell organelle that flies do not possess: the primary cilium. 
  
The primary cilium  
Primary cilia are present on most somatic cells in vertebrates.  The cilium shaft is 1 to 5 
microns long and comprised of nine microtubule doublets which are anchored in the basal body, 
a root of nine microtubule triplets that is formed from the older of the pair of centrioles since the 
cell’s last division.  Euploid cells will thus build only one cilium, and this cilium is resorbed 
every time the cell undergoes mitosis (Plotnikova et al., 2009).  The cilium is built and then 
dynamically maintained by intraflagellar transport (IFT).  Dedicated kinesin 2 motors perform 
anterograde transport (toward the tip), while retrograde transport back toward the basal body is 
performed by dynein 1b motors.  Disruption of anterograde transport by mutation of kinesins 
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results in a failure to generate cilia, or a retraction of already established cilia in the case of 
temperature sensitive mutations shifted after cilium formation (Kozminski et al., 1995; Pazour et 
al., 2000).  Disruption of retrograde transport has similar effects, with formation of a cilium that 
never reaches full length before retracting (Pazour et al., 1998; Piperno et al., 1998; Pazour et al., 
1999).  The motors and associated proteins essential for ciliogenesis have been divided into two 
complexes: IFT-A and IFT-B.  
The cilium is ensheathed in a lipid bilayer that is contiguous with the plasma membrane, 
but the lipid compositions of the cilium and an intermediate transition zone at its base are distinct 
(Montesano, 1979).  Membrane proteins cannot freely diffuse from the surrounding membrane, 
nor enter the cilium from internal vesicles without being actively allowed in by septins and basal 
body components (Craige et al., 2010; Hu et al., 2010).  Cytoplasmic proteins must likewise be 
shuttled in, and transition fibers at the base of the cilium are believed to form a flagellar pore 
complex analogous to the nuclear pore.  In fact, the same proteins might participate in nuclear 
and ciliary import-- importin-beta2 and small GTPase Ran are responsible for entry of KIF17 
into the cilium, and some nuclear localization sequences appear to also target cytoplasmic 
proteins into the cilium (Dishinger et al., 2010).  There are also loose consensus sequences for 
membrane protein import into primary cilia (Jenkins et al., 2006; Berbari et al., 2008; Mazelova 
et al., 2009).  The primary cilium is thus an organelle in every sense, with a distinct composition 
of proteins and lipids, and regulated entry and exit.  
Mutations in IFT components result in ciliopathies.  These diseases affect the organs 
most dependent on primary cilia for their function.  Polycystic kidney disease, retinal 
degenerative disease, and situs inversus are often caused by defects in ciliary transport.  Several 
syndromes that have symptoms clustered in these organs have now been found to be caused by 
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mutations that affect IFT: Bardet-Biedl syndrome, characterized by renal disease, obesity, 
diabetes, visual loss, ataxia, mental retardation, and brachydactyly, among many others, Meckel-
Gruber syndrome with similar organ systems affected, Joubert syndrome, affecting the balance 
apparatus, and Kartagener syndrome, affecting cilia in the respiratory tract as well as organ 
reversal. (reviewed in (Waters and Beales, 2011))  Cilia are also necessary for the function of at 
least two signaling pathways: Hedgehog and platelet derived growth factor (PDGF) signaling; 
more controversially, cilia have been implicated in Wnt and Notch signaling.  Some of the 
symptoms of ciliopathies may in fact be caused by perturbations of these signaling pathways.  
 
Hedgehog transduction in the primary cilium  
The essential role of ciliary transport in Hedgehog signaling was discovered in a screen 
for mouse mutants that have neural tube defects, which identified IFT complex B components 
Kif3a, Ift88, and Ift172 as essential for Hedgehog signaling downstream of Patched (Huangfu et 
al., 2003).  Other IFT-B components were subsequently shown to cause Hedgehog-related 
defects (Liu et al., 2005; Houde et al., 2006).  Mutation of retrograde transport components was 
also shown to impair Hedgehog signaling (Huangfu and Anderson, 2005; May et al., 2005).  The 
role of cilia in Hedgehog signaling is not restricted by tissue type, nor by organism, as the same 
dependence was demonstrated in zebrafish (Huang and Schier, 2009; Glazer et al., 2010; Tay et 
al., 2010), chick (Yin et al., 2009), and frogs (Park et al., 2006). 
Trafficking through the primary cilia is also necessary for negative regulation of the 
Hedgehog pathway.  Mutations of retrograde transport machinery Thm1 and Ift122, small 
GTPases Arl13b and Rab23, and ciliary protein Tulp3 cause ectopic activation of the pathway in 
at least some tissues (Eggenschwiler et al., 2001; Caspary et al., 2007; Tran et al., 2008; Norman 
et al., 2009; Patterson et al., 2009; Qin et al., 2011).  The severity of ectopic activation by the 
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above mutation varies, and in many cases, only a subset of Hedgehog target genes get activated, 
and not all tissues are equally affected.   The effect cannot be simplified into anterograde 
transport regulating the Hedgehog pathway positively and retrograde negatively, because 
mutation of some retrograde machinery such as the Dync2h1 motor results in loss of Hedgehog 
signaling, despite a short bulbous ciliary morphology indistinguishable from Thm1 and Ift122 
mutants (Ocbina et al., 2011).  These observations may explain why many ciliopathies produce 
symptoms of ectopic Hedgehog activation such as polydactyly.  
As would be expected from the striking effects of IFT on signaling, many Hedgehog 
pathway components congregate at primary cilia in signal-dependent fashion.  Patched localizes 
to the cilium in the pathway’s off state, exits upon Hedgehog binding, and Smoothened 
subsequently accumulates in its place (Rohatgi et al., 2007).  This is vaguely analogous to what 
occurs in flies, where Patched and Smoothened switch localization to the plasma membrane 
depending on the presence of Hedgehog ligand.  Treatment of vertebrate Smoothened with 
Smoothened Agonist (SAG) sends it to the cilium regardless of the continued presence of 
Patched there.  Given the small size of the compartment and specialized lipids in the cilium, it is 
tempting to speculate that Patched might be manipulating small hydrophobic molecules to keep 
Smoothened from accumulating in the cilium.  Many other components of the Hedgehog 
signaling pathway have since been shown to concentrate at primary cilia, including PKA (Barzi 




Aims of this dissertation      
 Genetics work in flies, mice, fish, and chick has made great strides in identifying the core 
and accessory components of the Hedgehog signaling pathway, but a mechanistic understanding 
of many of its steps remains elusive.  Hedgehog is both fascinating and frustrating in how little it 
resembles other pathways and how many of its steps can only be described in logical circuit 
terms of inhibition and activation rather than concrete biochemical events.  In this dissertation, I 
describe experiments in the tissue culture system that were used to answer several mechanistic 
questions: (a) where does Hedgehog processing occur in the cell and why is processing 
absolutely essential for its function, (b) how does a hydrophobic Hedgehog ligand manage to 
diffuse from cells secreting it, and (c) how does activated Smoothened at the primary cilium 
communicate with cytoplasmic components and activate the transcription factor Gli.  
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 The Hedgehog signaling pathway has important functions during metazoan development. 
The Hedgehog ligand is generated from a precursor by self-cleavage, which requires a free 
cysteine in the C-terminal part of the protein and results in production  of the cholesterol-
modified ligand and a C-terminal fragment. Here we demonstrate that these reactions occur in 
the endoplasmic reticulum (ER). The catalytic cysteine needs to form a disulfide bridge with a 
conserved cysteine, which is subsequently reduced by protein disulfide isomerase. Generation of 
the C-terminal fragment is followed by its ER-associated degradation (ERAD), providing the 
first example of an endogenous luminal ERAD substrate that is constitutively degraded. This 
process requires the ubiquitin ligase Hrd1, its partner Sel1, the cytosolic ATPase p97, and 
degradation by the proteasome. Processing-defective mutants of Hedgehog are degraded by the 
same ERAD components. Thus, processing of the Hedgehog precursor competes with its rapid 
degradation, explaining the impaired Hedgehog signaling of processing-defective mutants, such 





 The Hedgehog (Hh) signaling pathway is initiated by the binding of the secreted Hh 
ligand to its cell surface receptor, Patched (Marigo et al., 1996; Stone et al., 1996). This binding 
event inactivates Patched, resulting ultimately in the activation of a specific transcriptional 
program, which is important in embryonic development, adult stem cell maintenance and 
carcinogenesis (Kalderon, 2005; Lum and Beachy, 2004; Ogden et al., 2004). The secreted Hh 
ligand is generated through a unique process. Hh is synthesized as a precursor that is translocated 
into the endoplasmic reticulum (ER). The precursor undergoes cholesterol-dependent self-
cleavage, resulting in N- and C-terminal fragments (Lee et al., 1994; Porter et al., 1996a; Porter 
et al., 1995; Porter et al., 1996b) (Supplemental Figure 2.S1). This process is driven by the 
intein-like activity of the C-terminal fragment in two steps (Hall et al., 1997). In the first step, a 
conserved catalytic cysteine in the C-terminus attacks the polypeptide backbone and forms a 
thioester intermediate. In the second step, the 3!-hydroxyl group of a cholesterol molecule 
displaces the C-terminal fragment, generating an ester linkage with the carboxyl group of the N-
terminal fragment. Hh processing and cholesterol modification are critical for normal Hh 
signaling, and mutations in human Sonic Hedgehog (HShh) that impair processing cause 
holoprosencephaly, one of the most common congenital malformations of the brain (Maity et al., 
2005; Roessler et al., 2009; Traiffort et al., 2004). The cholesterol-modified N-terminal 
fragment, further modified by pamitylation at its N-terminus (Chamoun et al., 2001), is 
ultimately released from cells and is responsible for all the signaling effects of the Hh pathway. 
It is currently unknown where in the secretory pathway the processing of the Hh precursor 
occurs. In addition, the fate of the C-terminal fragment generated during the processing of the 




 Here we demonstrate that the self-cleavage of the Hh precursor occurs in the ER, 
requiring the reduction of a disulfide bond between the catalytic cysteine and another conserved 
cysteine in the C-terminal fragment by protein disulfide isomerase (PDI). After cleavage, the C-
terminal fragment is degraded by the ER-associated degradation (ERAD) pathway (Hirsch et al., 
2009; Xie and Ng), providing the first example of an endogenous luminal ERAD substrate that is 
constitutively degraded. Degradation requires key ERAD components previously implicated in 
the degradation of misfolded ER proteins, including the ubiquitin ligase Hrd1p (Bays et al., 
2001a; Bordallo et al., 1998), its interaction partner Sel1 (Gardner et al., 2000; Mueller et al., 
2008; Mueller et al., 2006), and the p97 ATPase (Bays et al., 2001b; Jarosch et al., 2002; 
Rabinovich et al., 2002; Ye et al., 2001). Our results indicate that the generation of the N-
terminal signaling domain of Hh in the ER is accompanied by the disposal of the C-terminal 
fragment by ERAD. We also show that processing-defective mutants of Hh, such as those 
causing human holoprosencephaly, are quickly degraded by the same ERAD pathway. Our 







Purified Hh precursor processing requires a conserved non-catalytic cysteine 
 We first investigated the in vitro processing of the purified Drosophila Hh precursor (Lee 
et al., 1994; Porter et al., 1996a). A fusion protein was generated that contains maltose binding 
protein (MBP), the last 15 amino acids of the N-terminal fragment, and the entire C-terminal 
fragment of Drosophila Hedgehog (MBP-DHh). The protein was expressed in E. coli and 
purified as a soluble protein on an amylose affinity column. When incubated with high 
concentrations of dithiothreitol (DTT) or with low concentration of DTT and cholesterol, MBP-
DHh underwent cleavage, generating an N-terminal fragment (MBP-DHh-N) and a C-terminal 
fragment (DHh-C) (Figure 2.1A), as described (Porter et al., 1996b). The N-terminal fragment 
was modified with cholesterol, as shown by the change in its electrophoretic mobility compared 
to the unmodified fragment (Figure 2.1A, lane 4 versus 3), and by the incorporation of 3H-
labeled cholesterol (Figure 2.1B).  
 We noticed that the precursor migrated slower on non-reducing SDS-PAGE gels when 
treated with even low concentrations of DTT (Figure 2.1A, lane 1 versus 2).  Because MBP-DHh 
contains only two cysteines, this suggests that the catalytically active cysteine (C258) is disulfide 
bonded with C400. Both cysteines are absolutely conserved among all Hh proteins, across phyla. 
In the crystal structure of the C-terminal fragment of Drosophila Hh (Hall et al., 1997), C258 is 
in close proximity to C400, suggesting the possibility of such a disulfide bond. Given that C258 
needs to be reduced to act as a nucleophile in Hh processing, this suggests that the disulfide-





Figure 2.1 Processing of purified Hh precursor. 
(A) A fusion was generated between maltose binding protein (MBP), the last 15 amino acids of the N-terminal 
fragment of Drosophila Hh, and the entire C-terminal fragment of Drosophila Hh (MBP-DHh). The purified protein 
was incubated for 5 hrs at room temperature with different concentrations of dithiothreitol (DTT) in the absence or 
presence of cholesterol (Cho).  The samples were analyzed by non-reducing SDS-PAGE and Coomassie staining. 
MBP-DHh-N and DHh-C are the N- and C-terminal fragments generated by Hh processing. 
(B) As in (A), but the reaction contained 3H-cholesterol. The samples were analyzed by reducing SDS-PAGE 
followed by either Coomassie staining (left) or fluorography (right).  
(C) In vitro translated, 35S-labeled wild type (WT) MBP-DHh or the indicated Cys mutants were incubated with 5 
KDa maleimide polyethylene glycol (Mal-PEG) as indicated, in the presence or absence of the reducing agent 
tris(2.carboxyethyl)phosphine (TCEP). The samples were analyzed by reducing SDS-PAGE and autoradiography. 
The positions of singly and doubly Mal-PEG modified species are indicated. The singly modified species have a 
different mobility, depending on which cysteine is modified. 
(D) As in (A), but comparing wildtype MBP-DHh with the two Cys mutants.  
 
 
inactive precursor; the known requirement of a reducing agent for Hh processing in vitro (Porter 
et al., 1996b) could be explained by the need to reduce this conserved disulfide bond.  
 To test whether the two cysteines indeed form a disulfide bridge in MBP-DHh, we 
expressed the same protein by in vitro translation in reticulocyte lysate and treated it with 
maleimide-polyethylenglycol (Mal-PEG), a reagent that adds ~5 kDa for each modified free 




lane 8), prior disulfide bond reduction with tris-carboxyethyl phosphine (TCEP) resulted in the 
appearance of significant levels of singly and doubly Mal-PEG-modified species (lane 9). When 
either of the two cysteines was mutated, only singly modified protein was detected, even without 
reduction (lanes 2,3 and 5,6). These data indicate the formation of a disulfide bond between 
C258 and C400. As expected, mutation of the catalytic C258 completely blocked cleavage of 
MBP-DHh (Figure 2.1D, lanes 5-8). Interestingly, mutation of the non-catalytic C400 also 
abolished cleavage, both in the presence of high concentrations of DTT and low concentrations 
of DTT and cholesterol (lanes 9-12). Thus, despite the presence of a reduced C258, the mutant is 
inactive, perhaps because a disulfide bond between C258 and C400 is required for the folding of 
the C-terminus into a catalytically active conformation. In all Hh proteins the non-catalytic 
cysteine is part of a conserved SCY sequence, and the mutation of the other two residues also 
abolishes cleavage of DHh (data not shown). Taken together, these experiments suggest that a 
disulfide bridge needs to form between the conserved cysteines, which subsequently would have 





Figure 2.2 Hh processing in Xenopus egg extracts. 
(A) In vitro translated, 35S-labeled Xenopus Sonic Hh (XShh) wild type precursor was incubated at room 
temperature with Xenopus egg extracts for the indicated times. Parallel experiments were performed with three point 





Figure 2.2 (Continued) 
(B) As in (A), but the extract was supplemented with the indicated concentrations of oxidized or reduced glutathione 
(GSSG or GSH).  
(C) In vitro translated, 35S-labeled Xenopus Sonic Hh, fused at its N-terminus to the maltose-binding protein (MBP-
XShh), was incubated at room temperature with Xenopus egg extracts for the indicated times, in the absence or 
presence of 0.5% of either the cholesterol-sequestering detergents digitonin or cholate or the control detergent Triton 
X-100 (TX-100). The samples were analyzed by SDS-PAGE and autoradiography. 
(D) In vitro translation was used to generate 35S-labeled fusions of MBP and either the N-terminal fragment of XShh 
(N), the C-terminal fragment of XShh (C), full-length XShh (FL), full-length XShh with a Cys mutation in the active 
site (C199A), or XShh lacking the last 93 amino acids (!C). The fusions were incubated for 1 hr with Xenopus egg 
extracts and subjected to Triton X-114 partitioning. Aliquots of the input (T), of the aqueous phase (A), or of the 
detergent phase (D) were analyzed by SDS-PAGE and autoradiography. 




Hh processing in extracts and intact cells also requires the conserved, non-catalytic 
cysteine. 
 To test whether the conserved, non-catalytic cysteine is essential for the processing of 
full-length, vertebrate Hh precursor, we established a novel cell-free assay based on Xenopus 
egg extracts. Radioactively labeled Xenopus Sonic Hedgehog (Lai et al., 1995) (XShh) 
precursor, generated by in vitro translation in reticulocyte lysate, was efficiently processed when 
incubated with Xenopus egg extracts (Figure 2.2A, lanes 1-3). As in the purified system, both the 
catalytic cysteine (C199) and the non-catalytic cysteine (C342) were required for cleavage (lanes 
4-6 and 10-12). Mutation of another conserved residue shown to be important for cleavage in 
DHh (T266) also abolished processing (lanes 7-9). Identical results were obtained with the 
corresponding DHh constructs, generated by in vitro translation and incubated with Xenopus egg 
extracts (data not shown). Consistent with our assumption that reduction of the disulfide bridge 
in the Hh precursor is required for processing, addition of increasing concentrations of oxidized 
glutathione (GSSG) inhibited XShh precursor cleavage (Figure 2.2B, lanes 1-12).  
 We next tested whether the N-terminal fragment generated in Xenopus extracts is 




detergents (Figure 2.2C, lanes 4-6 and 10-12 versus lane 1-3 and 7-9). Furthermore, the N-
terminal fragment generated in extracts partitioned into the Triton X-114 phase (Figure 2.2D, 
lanes 7-9), in contrast to the N-terminal fragment generated directly by in vitro translation (lanes 
1-3). The C-terminal fragment is also hydrophobic, as it partitioned into the detergent phase, 
whether alone or contained in the full-length protein (lanes 4-6 and 7-12). Deletion of the last 93 
amino acids from full-length XShh (XShh!C) rendered the protein hydrophilic (lanes 13-15). 
The deleted region indeed contains a number of hydrophobic amino acids and might interact with 
cholesterol during the intein reaction (Hall et al., 1997). This deletion greatly delayed, but did 
not completely abolish, processing of the precursor in Xenopus extracts (Figure 2.2E). Finally, 
when purified MBP-DHh precursor was added to Xenopus extracts, mass spectrometry identified 
cholesterol attached to the N-terminal fragment (data not shown). These data demonstrate that 
cholesterol is properly attached to Hh proteins in Xenopus egg extracts. 
 To test whether the conserved, non-catalytic cysteine is also essential for the processing 
of the Hh precursor in intact cells, we stably expressed wild type or cysteine mutants of human 
sonic Hh (HShh) C-terminally tagged with a hemagglutinin (HA) epitope (HShh-HA) in 293T 
cells. After inhibiting protein synthesis with cycloheximide, the wild type Hh precursor and the 
processed C-terminal fragment (HShh-C) were observed at early time points (Figure 2.3A). As in 
the in vitro system, no processing was observed when either the catalytic cysteine (C198) or the 
non-catalytic cysteine (C363) was mutated (Figures 2.3B and 2.3C, lanes 1). For both cysteine 
mutants, the block in processing correlated with a complete absence of active Hh ligand from 
293T cell supernatants, as assayed using Hh-responsive NIH-3T3 cells; in contrast, wild type 
HShh-HA expressed in 293T cells resulted in robust secretion of active Hh ligand (data not 




the ER more oxidizing (diamide) also inhibited Hh precursor processing in mammalian cells, 
while DTT had the opposite effect, as shown by pulse-chase experiments (Figure 2.3D). These 
data support the idea that Hh processing requires the formation and subsequent reduction of a 
disulfide bridge between the conserved cysteines. 
 We noted that after addition of cycloheximide both the Hh precursor and HShh-C 
disappeared in a time-dependent manner (Figure 2.3A-C). When the cycloheximide chase of 
wild type HShh-HA was performed in the presence of the proteasome inhibitor MG132, HShh-C 
accumulated, indicating that the precursor was efficiently processed and that HShh-C was 
normally degraded by the cytosolic proteasome (Figure 2.3A, lanes 5,6). Similar experiments 
with the processing-defective cysteine mutants showed that the Hh precursor is also degraded by 
the proteasome (Figure 2.3B, C, lanes 5, 6). When HShh-C was expressed by itself, it was also 
degraded, but at a slower rate (Supplemental Figure 2.S2), indicating that its degradation is most 
efficient when generated during normal processing. 
 
Hh processing does not require vesicular transport out of the ER 
 We reasoned that the remodeling of the conserved disulfide bridge in Hh occurs in the 
ER, the site of all known disulfide bond formation and reduction in the secretory pathway. To 
test this assumption, we performed pulse-chase experiments after blocking vesicular transport 
from the ER to the Golgi by brefeldin A (Figure 2.3E). No effect on Hh processing was observed 
at concentrations that caused the complete disappearance of the Golgi (Supplemental Figure 
2.S3), and regardless of whether or not a proteasome inhibitor was present (Figure 2.3E). These 
results strongly argue that both the processing of the Hh precursor and the degradation of HShh-





Figure 2.3 Processing of HShh is dependent on disulfide bridge formation and reduction. 
(A) HShh-HA was stably expressed in 293T cells. Protein synthesis was inhibited with cycloheximide (CHX), and 
the fate of the protein followed by SDS-PAGE and immunoblotting with anti-HA antibodies. Immunoblotting for 
p97 was used as a loading control. 
(B) As in (A), but with HShh-HA containing a mutation in the catalytic cysteine (C198S). 
(C) As in (A), but with HShh-HA containing a mutation in the conserved non-catalytic cysteine (C363A). 
(D) HA-tagged HShh was stably expressed in 293T cells. The cells were pulsed with 35S-methionine for 3 min and 
chase-incubated with unlabeled methionine for the indicated times. Diamide (200 uM) or DTT (0.5 mM) were added 
10 minutes before the pulse, and were present during the pulse and chase. The proteasome inhibitor epoxomicin (1 
uM) was present, added 1 hour before the pulse. The samples were analyzed by immunoprecipitation with HA-
antibodies followed by reducing SDS-PAGE and fluorography. Equal number of cells were processed for each 
condition.  
(E) As in (D), except that, where indicated, 10 uM brefeldin A and 1 uM epoxomicin were present, added 1 hr 






The Hh protein is a substrate for PDI 
It seemed likely that the remodeling of the conserved disulfide bridge in Hh is catalyzed by a 
member of the ER-localized thioredoxin (Trx)-like oxidoreductases, a class of enzymes generally 
responsible for such reactions. These enzymes contain at least one CXXC motif, the first 
cysteine of which forms a transient mixed disulfide bridge with the substrate; this mixed 
disulfide intermediate can be trapped by mutating the second cysteine in the CXXC motif 
(CXXA mutants). We therefore screened CXXA-mutants of ER-localized human Trx-like 
proteins for the formation of a mixed disulfide bridge with Hh. We co-expressed in 293T cells 
FLAG-tagged CXXA-mutants of 9 different Trx-like ER proteins together with HShh-HA. 
Because some of the proteins contain more than one CXXC motif, we tested a total of 17 
different constructs (Schulman et al., 2010). In each case, the formation of a mixed disulfide 
bridge was assayed by immunoprecipitation with HA- or FLAG- antibodies, followed by non-





Figure 2.4 PDI and PDIp are involved in remodeling of the conserved disulfide bridge in HShh 
(A) HShh-HA and FLAG-tagged thioredoxin-like ER proteins, in which one their CXXC motifs was changed to 
CXXA, were co-expressed in 293T cells. Cell extracts were subjected to immunoprecipitation with HA- or FLAG- 
antibodies, followed by SDS-PAGE and immunoblotting with FLAG- and HA- antibodies. Where indicated, the 




Figure 2.4 (Continued) 
(B) Wild type (WT) HShh-HA or the processing-defective C198A mutant were co-expressed with a FLAG-tagged 
CXXA mutant of PDI (C56A) in 293T cells. The cells were pulse-labeled with 35S-methionine for 3 min and chase-
incubated for different time periods. The proteasome inhibitor epoxomicin (1 uM) was added 1 hr before the pulse. 
All samples were subjected to immunoprecipitation with HA-antibodies followed by SDS-PAGE and fluorography. 
Where indicated, the samples were reduced with DTT before electrophoresis. 
 
 
 The strongest interactions were observed for PDI and the closely related PDIp protein 
(Figure 2.4A, first and third panel). As expected, both mixed disulfide adducts were sensitive to 
DTT treatment (second and fourth panels), and no adducts were seen when one of the two 
components was omitted (Supplemental Figure 2.S4). PDI and PDIp contain two CXXC motifs, 
but the reaction with Hh occurred overwhelmingly with the N-terminal motif. This data implies 
that the first CXXC motif of PDI is dedicated to substrate interaction, whereas the second CXXC 
motif interacts with the oxidase Ero1p (Tsai and Rapoport, 2002). 
 PDI and PDIp reacted with both the Hh precursor and HShh-C (Figure 2.4A, fourth 
panel), as expected from the fact that both contain the two conserved cysteines. Pulse-chase 
experiments in the presence of proteasome inhibitor demonstrated that the formation of the 
mixed disulfide between the Hh precursor and the CXXA-mutant of PDI occurs rapidly and 
precedes Hh processing, including the appearance of the mixed disulfide adduct between HShh-
C and the PDI mutant (Figure 2.4B). Interestingly, the mixed disulfide species can undergo the 
intein reaction with about the same kinetics as the Hh precursor itself. This also suggests that the 
non-catalytic cysteine of Hh is linked to PDI. Furthermore, when Hh processing was blocked by 
mutation of the catalytic cysteine, the Hh precursor formed a mixed disulfide bond with the PDI 
mutant.  
 These data are consistent with a model in which PDI function is linked and required for 




caused the accumulation of HShh-C (Figure 2.4A, bottom panel), likely because a mixed 
disulfide adduct with PDI is not susceptible to degradation.  
 
HShh-C is degraded in the ER 
 To study the fate of HShh-C, we first considered the possibility that it might be secreted 
together with the N-terminal fragment (HShh-N). HShh-HA was stably expressed in 293T cells, 
and HShh-N and HShh-C were analyzed by immunoblotting with Hh- and HA-antibodies, 
respectively, both in cells and in equivalent amounts of culture medium. Whereas HShh-N 
partitioned equally between cells and medium, HShh-C was present only in cells (Figure 2.5A, 
left panel). Even when HShh-C accumulated in cells after treatment with a proteasome inhibitor, 
only very small amounts of HShh-C were found in the medium (Figure 2.5A, right panel). These 
results show that HShh-C is not secreted, in contrast to HShh-N, the Hh ligand. Rather, the 
instability of HShh-C and its stabilization by proteasome inhibitors, even under conditions where 
vesicular transport out of the ER is blocked, suggests that HShh-C is degraded in the ER. 
Previous reports on the secretion of HShh-C can be explained by its massive overexpression and 
by the lack of quantification (Bumcrot et al., 1995). 
 To confirm that HShh-C is degraded in the ER, we tagged HShh with mCherry at its C-
terminus and visualized the protein by fluorescence microscopy. The protein showed the typical 
ER staining, co-localizing with calnexin (Figure 2.5B), in both 293T and in 3T3 cells stably 
expressing HShh-Cherry. When 3T3 cells stably expressing HShh-HA were treated with the 





Figure 2.5 HShh-C is not secreted and is degraded in the ER. 
(A) HShh-HA was stably expressed in 293T cells. The cells were washed and incubated for 12 hrs with DMEM 
containing 0.5% fetal bovine serum. The cell pellets and equivalent amounts of culture medium were analyzed for 
the presence of HShh-N and HShh-C by immunoblotting with HShh-N antibodies and HA-antibodies. Where 
indicated, the proteasome inhibitor epoxomicin was present during the last 3 hrs of incubation. The graph shows the 




Figure 2.5 (Continued) 
(B) HShh was tagged with mCherry at its C-terminus and stably expressed in 293T or in 3T3 cells. Its localization 
was determined by fluorescence microscopy. The ER was revealed by immunostaining with rabbit antibodies 
against calnexin. The bottom panels show merged images.  
(C) Wild type HShh-HA or the processing-defective mutant HShh-C198A-HA were stably expressed in 3T3 cells. 
Cells were immunostained with rat HA-and rabbit HShh-N- antibodies, followed by goat anti-rat Alexa488 (green) 
and goat anti-rabbit Alexa594 (red) secondary antibodies. The cells were incubated for 3 hrs with or without the 
proteasome inhibitor epoxomicin (1 uM). The third row shows merged images of the green and red channels. The 
bottom row shows DIC images.  
 
 
consistent with HShh-C being degraded in the ER (Figure 2.5C; second row; also Supplemental 
Figure 2.S5). Identical results were obtained with the proteasome inhibitors MG132 and 
bortezomib (not shown), and in 293T cells (Supplemental Figure 2.S5). The immunofluorescent 
staining observed under these conditions corresponds mostly to HShh-C (see immunoblot in 
Figure 2.5A). In contrast to HShh-C, HShh-N was not degraded, as demonstrated by staining 
with antibodies directed against the N-terminus of HShh (Figure 2.5C, first row). The subcellular 
localization of HShh-N was also different from that of HShh-C, with much of HShh-N localizing 
to the plasma membrane (see overlay in the third row of Figure 2.5C). The processing-defective 
HShh precursor mutant (HShh-C198A) was as unstable as HShh-C when analyzed by antibodies 
against either the N- or C-terminus, and it localized to the ER when stabilized by proteasome 
inhibitors (Figure 2.5C; the two right most panels). These data demonstrate that failure of 






Figure 2.6 ERAD components required for the degradation of HShh-C. 
(A) Cells were depleted of the ER-luminal lectin OS9 by siRNA and the fate of stably expressed HShh-HA was 
followed after cycloheximide (CHX) addition. The extent of OS9 depletion (in brackets) was determined by 
quantitative RT-PCR. Controls were treated with an unrelated siRNA. All samples were analyzed by SDS-PAGE 
and immunoblotting with HA-antibodies. The right panel shows quantification of HShh-C in the experiment. All 
samples were also analyzed by immunoblotting for p97 (loading control). 
(B) As in (A), but with depletion of the ER-luminal lectin XTP3 by two different siRNAs. 
(C) As in (A), but with depletion of the ubiquitin ligase Hrd1 by two different siRNAs 
(D) As in (A), but with depletion of the Hrd1-interacting protein Sel1 by two different siRNAs. 




Hh is degraded by ERAD 
 Next we examined if HShh-C generated in the ER lumen is degraded by the “ER-
associated degradation” (ERAD) pathway. Luminal, glycosylated ERAD substrates are generally 
processed by glycosidases in their carbohydrate moiety, which is subsequently recognized by 
lectins. The substrates are then translocated into the cytosol, poly-ubiquitinated by the ubiquitin 
ligase Hrd1, moved into the cytosol by the p97 ATPase, and finally degraded by the proteasome. 
Proteolysis is often preceded by deglycosylation (Wiertz et al., 1996). We tested which aspects 
of the ERAD pathway apply to the degradation of HShh-C. 
 We used RNAi to identify ERAD components required for the degradation of HShh-C. 
Depletion of the lectins implicated in recognizing glycosylated ERAD substrates, OS9 or XTP3 
(Bernasconi et al., 2010; Christianson et al., 2008; Hosokawa et al., 2009; Hosokawa et al., 
2008), caused a significant inhibition of degradation (Figures 2.6A, B; quantification in the right 
panels). No further inhibition was seen when both lectin were depleted at the same time 
(Supplemental Figure 2.S6). Depletion of the ubiquitin ligase Hrd1 (Bays et al., 2001a) and of its 
interacting partner Sel1, strongly stabilized HShh-C (Figures 2.6C, D). Finally, depletion of the 
ATPase p97 (Ye et al., 2001) also had a drastic inhibitory effect (Figure 2.6E); both the HShh 
precursor and HShh-C accumulated, indicating that they both undergo ERAD. The depletion by 
RNAi of other ERAD components (the Ring-finger ubiquitin ligases gp78 (Fang et al., 2001), 
TRC8 (Stagg et al., 2009), TEB4 (Hassink et al., 2005), as well as Derlin-1 (Lilley and Ploegh, 
2004; Ye et al., 2004), Herp (Carvalho et al., 2006; Kokame et al., 2000; Schulze et al., 2005), 
BiP (Denic et al., 2006), and ERdj5 (Ushioda et al., 2008) had no effect on HShh-C degradation 




1991) had no significant effect on the degradation of HShh-C (Supplemental Figure 2.S6), 
indicating that mannosidase I is not required for processing of the glycan on HShh-C.  
 The role of various ERAD components in the degradation of HShh was also tested by 
expression of dominant-negative constructs. A catalytically inactive mutant of the ubiquitin 
ligase Hrd1p, in which a cysteine in the Ring-finger domain is altered, strongly inhibited HShh-C 
degradation (Figure 2.7A). While overexpression of the wild type p97 ATPase only slightly 
delayed degradation of HShh-C, the catalytically inactive p97-QQ mutant was strongly 
inhibitory (Figure 2.7B). ERAD was similarly inhibited by overexpression of catalytically 
inactive Ubc6e (Ubc6e-C91S), or by overexpression of a GFP fusion of the SEL1L-interacting 
protein, UbxD8 (UbxD8-GFP (Lilley and Ploegh, 2004; Mueller et al., 2008)) (Figure 2.7C). 
 As with other ERAD substrates that are deglycosylated when arriving in the cytosol, we 
found that the major species of HShh-C accumulating in the presence of MG132 migrated 
slightly faster in SDS-gels than the glycosylated fragment (Figures 2.3A, 2.3E, 2.8A). This band 
is indeed deglycosylated as treatment of the glycosylated fragment with protein N-glycanase F 
generated a species of the same size (Figure 2.8A). As expected, depletion of ERAD components 
that block dislocation from the ER, led to the accumulation of glycosylated HShh-C (see, for 
example, Figure 2.6). 
 To test whether HShh-C was poly-ubiquitinated, we subjected cell extracts expressing 
HShh-HA to immunoprecipitation with HA-antibodies, followed by SDS-PAGE and 





Figure 2.7 Dominant-negative ERAD components inhibit HShh-C degradation.  
(A) Cells stably expressing HShh-HA precursor were transfected with a catalytically inactive Myc-tagged Hrd1 
(Hrd1-C291A) or with empty vector. The fate of HShh-HA was followed after addition of cycloheximide (CHX) by 
SDS-PAGE and immunoblotting with HA-antibodies. The right panel shows quantification of the HShh-C in the 
experiment. All samples were also analyzed by immunoblotting for p97 (loading control) and myc (Hrd1-C291A). 
(B) As in (A), but with transfection of either wild type p97, a catalytically inactive p97 mutant (p97-QQ), or with 
empty vector. Immunoblotting for GAPDH served as loading control. 
(C) HShh-HA was transiently expressed in 293T cells, together with dominant-negative Ubc6e (Ubc6e-C91S), 
control vector, or UbxD8-GFP. Greater than 90% of the cells showed strong GFP signal, by live cell fluorescence 
microscopy (not shown). Protein synthesis was inhibited with CHX, and the fate of HShh-HA was followed by 
SDS-PAGE and immunoblotting with HA-antibodies. Ponceau S staining of the blot is shown to demonstrate 












Figure 2.8 (Continued) 
(A) To test for deglycosylation of HShh-C, HShh-HA was stably expressed in 293T cells. A cycloheximide chase 
was performed for 2 hrs in the presence or absence of the proteasome inhibitor MG132. Cell lysates were incubated 
in the absence or presence of the glycanase PNGase F, as indicated. Samples were analyzed by SDS-PAGE and 
immunoblotting with HA- antibodies. Immunoblotting with p97 antibodies served as loading control. 
(B) To test for poly-ubiquitination of HShh, cells stably expressing HShh-HA were incubated in the absence or 
presence of MG132 for 2 hrs. Extracts were subjected to immunoprecipitation (IP) with HA-antibodies and the 
proteins were analyzed by SDS-PAGE and immunoblotting (IB) with HA-antibodies (lanes 3,4) or ubiquitin (Ub)- 
antibodies (lanes 1,2). Lanes 5 and 6 show blots of the extract before IP. 
(C) To test if Hrd1 poly-ubiquitinates HShh, an experiment as in (B) was performed, except that, where indicated, 
cells were transfected with a myc-tagged dominant-negative Hrd1 mutant (myc-Hrd1-291A). To test for the 
presence of the Hrd1 mutant, the samples were also analyzed by blotting with myc antibodies. Immunoblotting for 
p97 served as loading control. 
(D) Cells stably expressing HShh-HA were transfected with Myc-tagged wild type Hrd1 or catalytically inactive 
Hrd1 mutants (Hrd1 C291A or Hrd1 C291A-C307A). As a control, a myc-tagged version of reticulon 4A was used. 
Cell extracts were either analyzed directly (lanes 1-4) or subjected to immunoprecipitation with HA-antibodies 
(lanes 5-8). All samples were analyzed by SDS-PAGE and immunoblotting with HA- or myc- antibodies. 
 
 
HShh-HA was detected in cells treated with the proteasome inhibitor MG132 (lane 2), but not in 
untreated cells, even though equal amounts of HA-tagged protein were precipitated (lanes 3 and 
4). The specificity of the immunoprecipitation was demonstrated by a control IgG pull-down 
(Supplemental Figure 2.S7). Poly-ubiquitination of HShh was dependent on Hrd1, as it was 
inhibited by the expression of a dominant-negative Hrd1 mutant (Figure 2.8C).  
 To further confirm the role of Hrd1, we tested whether it interacts with its HShh 
substrate. Myc-tagged, wild type or dominant-negative Hrd1p were introduced into cells stably 
expressing HShh-HA. Cell extracts were subjected to immunoprecipitation with HA antibodies 
and precipitated proteins were analyzed by SDS-PAGE and immunoblotting with Myc 
antibodies. These experiments showed that HShh-HA precipitated all versions of Hrd1p-Myc 
(Figure 2.8D, lanes 6-8); less precipitation was seen with wild type Hrd1-Myc (lane 6). An 
unrelated ER protein, Myc-tagged reticulon, did not interact with HShh-HA (lane 5). Together, 





 Finally, because the full-length Hh precursor is also degraded by ERAD (see Figures 
2.3B, 2.3C, 2.6E), we tested whether it requires the same components as HShh-C. Indeed, ERAD 
of the processing-defective HShh C198S mutant stably expressed in 293T cells was inhibited by 
depleting the same components, i.e. OS9, Hrd1, Sel1, and p97 (Supplemental Figure 2.S8). 
These results show that the Hh precursor undergoes two competing reactions in the ER, 
cholesterol-dependent processing and degradation by an ERAD pathway identical to that 
employed by HShh-C. 
 
DISCUSSION 
 The main result of the present study is that processing of the Hh precursor takes place in 
the ER. This conclusion is based on several observations: (1) the insensitivity of Hh processing 
to inhibition of vesicular transport out of the ER, (2) the requirement for disulfide bridge 
formation and reduction for Hh processing, (3) the involvement of the ER luminal PDI in 
disulfide remodeling of Hh, (4) the degradation of Hh precursor and its C-terminal fragment by 
ERAD, and (5) microscopic visualization of Hh degradation in the ER. Processing of the Hh 
precursor in the ER is somewhat unexpected given the relatively low concentration of cholesterol 
in the ER membrane. In fact, it was previously speculated that Hh processing might occur in 
another, cholesterol-rich compartment of the secretory pathway (Maity et al., 2005). How 
cholesterol modification can occur at the low cholesterol concentrations of the ER remains 
unclear, but one possibility is that an additional factor in the ER facilitates the reaction.   
 We show that a disulfide bond needs to form between the catalytic cysteine and the only 
other cysteine in the C-terminal domain, a disulfide bond that is conserved among all Hh 




cysteine needs to be reduced in order to initiate cleavage of the polypeptide backbone. Why then 
form a disulfide bridge in the first place? We speculate that the Hh precursor requires a disulfide 
bridge for proper folding, which in turn is required for the autocatalytic activity of the C-terminal 
domain. Both the formation and reduction of the essential disulfide bridge require the activity of 
a member of the PDI family. While the oxidation of cysteines to form disulfide bridges is a 
common protein modification in the ER, net disulfide bond reduction is less common. One 
example is provided by the reduction of a disulfide bond that links the A1 and A2 chains of 
cholera toxin by PDI itself; the A1 chain thus freed from the rest of the toxin is retro-translocated 
into the cytosol (Tsai et al., 2001).  
 Our results show that PDI and the closely related PDIp protein are involved in 
remodeling of the conserved disulfide bridge in Hh. The specificity of these enzymes is indicated 
by the fact that seven other tested ER-localized family members do not interact and that only one 
of the two catalytic CXXC motifs of PDI and PDIp forms a mixed disulfide intermediate with 
Hh. Whether these enzymes are involved in the formation of the disulfide bridge, its reduction, 
or both, is unclear. However, our observation that a mixed disulfide adduct between Hh and PDI 
forms rapidly and undergoes the intein reaction, suggests that PDI reduces the disulfide bridge in 
Hh and remains bound to the non-catalytic cysteine while the Hh precursor is processed. Thus, 
disulfide bridge reduction by PDI might be mechanistically coupled to Hh processing and 
attachment of cholesterol.   
 Consistent with our conclusion that Hh processing takes place in the ER, we find that the 
resulting C-terminal fragment is degraded by ERAD. The degradation of the C-terminal 
fragment generated in the ER lumen requires several of the previously identified ERAD 




fragment. The process probably begins with recognition of the single carbohydrate chain in the 
C-terminal fragment, as suggested by the requirement for either of the two lectins implicated in 
ERAD, OS9 and XTP-3B. The C-terminal fragment is also likely recognized by Sel1, similarly 
to substrate recognition by the yeast homolog Hrd3p (Denic et al., 2006; Gauss et al., 2006). The 
next step in the process involves the ubiquitin ligase Hrd1, which forms a complex with Sel1. 
Once the substrate is poly-ubiquitinated on the cytosolic side of the ER membrane, the p97 
ATPase complex moves the C-terminal fragment from the membrane into the cytosol. The 
protein is also deglycosylated, likely by the cytoplasmic glycanase (Hirsch et al., 2003). Finally, 
the protein is degraded by the proteasome. As a result of ERAD, the C-terminal fragment never 
leaves the ER and is not secreted, in contrast to the N-terminal fragment, the Hh ligand. Given 
that the C-terminal fragment is not secreted even when stabilized by proteasome inhibitors, it 
appears that it is actively retained in the ER, possibly by its association with PDI. 
 ERAD is normally used to degrade misfolded ER proteins. In addition, there are several 
native proteins, such as HMG CoA reductase (Chin et al., 1985; Gil et al., 1985; Hampton and 
Rine, 1994), that are degraded in a regulated manner by ERAD. However, to our knowledge, 
there is only one native protein, Ubc6p, that is a constitutive ERAD substrate (Walter et al., 
2001). This yeast membrane protein is exposed to the cytosol and is continuously ubiquitinated 
by the Doa10p ubiquitin ligase (Swanson et al., 2001). The C-terminal fragment of Hh is the first 
example of a native luminal ER protein that is constitutively degraded by ERAD. Whereas it is 
conceivable that HMG CoA reductase is induced to unfold by binding of cholesterol and that 
Ubc6p is not properly folded, the C-terminal fragment of Hh must be properly folded to allow 
the self-cleavage reaction to happen. This hypothesis is supported by the fact that non-cleavable 




fragment, and by the same ERAD components. Apparently, the rapid degradation of the full-
length Hh precursor by ERAD is competing with its proper processing. This can explain why 
human Shh mutants that are defective in precursor processing are causing holoprosencephaly, a 
frequent congenital brain malformation; these mutant proteins would be quickly degraded in the 
ER and no active ligand would be secreted. Thus, our results suggest that ERAD plays a critical 
role in birth defects caused by Hh precursor mutations. Even for the wild type Hh precursor, 
ERAD might play a role in determining how much active ligand is generated; perhaps the 
concentration of cholesterol in the ER determines the balance between degradation and 
processing of the full-length precursor. Interestingly, the C-terminal fragment expressed by itself 
is also degraded, but more slowly than the C-terminal fragment generated through processing. 
Perhaps, when the fragment is generated close to the ER membrane, there is a more efficient 
handover to the ERAD machinery. The signal that targets Hh to the ERAD pathway remains 
unclear, but it could be related to the hydrophobic properties of the C-terminus.  
 Why is the post-translational processing of Hh proteins so complicated? Much of the 
complexity of the processing mechanism seems to originate from the requirement for cholesterol 
modification of the Hh ligand. Cholesterol attachment necessitates the autocatalytic intein-like 
reaction, which in turn requires the C-terminal domain to be properly folded. The formation of a 
critical disulfide bond involving the catalytic cysteine ensures that proper folding precedes 
catalysis. Once the C-terminus has done its job, however, it becomes dispensable, explaining 
why it is cleared by ERAD. Despite the progress, it remains to be clarified why the Hh ligand is 
modified by cholesterol, how cholesterol attachment changes its membrane association, and how 




MATERIALS AND METHODS 
Materials 
 The following materials were used in this study: MG132 (Biomol), bortezomib (gift from 
Dr Alfred Goldberg), epoxomicin (Enzo Life Sciences), diamide (TCI), rat anti-HA antibody 
(3F10, Roche), mouse anti-Myc antibody (9E10, Roche), rabbit anti-ubiquitin antibody 
(Biomol), rabbit anti-calnexin antibody (Abcam), rabbit anti-gigantin antibody (Abcam), rabbit 
anti-Shh (Cell Signaling), protein G-agarose (GE Bioscience), mouse anti-FLAG M2 agarose 
(Sigma). Stealth siRNA duplexes were custom-synthesized by Invitrogen.  
 
Protein purification and in vitro Drosophila Hedgehog processing assays 
 A fragment of Drosophila Hedgehog comprising amino acids 244-471 was expressed in 
bacteria as a maltose-binding protein (MBP) fusion (MBP-DHh). The soluble MBP-DHh was 
purified on amylose beads (New England Biolabs), according to the manufacturer’s instructions. 
Point mutations in DHh were generated using the QuickChange kit (Stratagene), were confirmed 
by DNA sequencing, and expressed and purified as MBP fusions, as for the wild type protein. 
The purified proteins were concentrated to 2.5 mg/mL and were stored at –80C. 
 Processing reactions contained 0.2-0.5 mg/mL MBP-DHh in incubation buffer (20 mM 
Hepes, pH 7.5, 50 mM NaCl, 0.1% Triton-X100), with or without reducing agent (DTT or 
glutathione), and with or without cholesterol (250 microM final, added from a stock solution in 
DMSO). The reactions were incubated at room temperature and were stopped at the indicated 
times by addition of SDS-PAGE sample buffer (with or without DTT). The samples were boiled, 





 To assay cysteine modification by maleimide-polyethyleneglycol (MalPEG), 35S-labeled 
MBP-DHh proteins (wild type and mutants) were generated by in vitro translation in reticulocyte 
lysates, and were dialyzed overnight against PBS, to remove small molecule thiols. The proteins 
were incubated with or without 5 mM tris(2-carboxyethyl)phosphine (TCEP) for 10 min, 
followed by incubation with 7 mM Mal-PEG 5kDa (Laysan Bio. Inc) for 30 min, at room 
temperature. The reaction was terminated with 100 mM DTT, and the samples were separated by 
SDS-PAGE, followed by autoradiography. 
 To determine if MBP-DHh is modified with cholesterol, processing reactions were 
performed in the presence of 0.5 uCi/microL radioactive cholesterol (1,2,3,6,7-3H-cholesterol, 
100 mCi/mmol, American Radiolabeled Chemicals). The samples were separated by SDS-PAGE 
and radioactive proteins were visualized by fluorography (Bonner and Laskey, 1974). 
 
Hh processing in Xenopus egg extracts 
 Xenopus Sonic Hedgehog (XShh) was cloned into the pCS2+ vector (Rupp et al., 1994), 
and radioactive XShh was generated by in vitro translation (TNT SP6 Coupled Reticulocyte 
Lysate System, Promega), in the presence of 35S-methionine (New England Nuclear). Xenopus 
egg extracts were prepared as described (Salic et al., 2000). A typical XShh processing reaction 
contained 1 uL of in vitro translated protein in 14 uL of Xenopus egg extract, supplemented with 
cycloheximide (100 ug/mL). The processing reactions were incubated at room temperature, and 
aliquots were removed at the indicated times, and mixed with SDS-PAGE sample buffer. The 
samples were boiled, separated by SDS-PAGE, and radioactive proteins were visualized by 
autoradiography. Triton-X114 partitioning experiments were performed as described (Bordier, 




temperature. Point mutants of XShh were generated using the QuickChange kit (Stratagene), and 
were confirmed by DNA sequencing. 
 
Cell culture and generation of stable cell lines 
 Human 293T cells were grown in DMEM supplemented with 10% fetal bovine serum, 
penicillin and streptomycin. NIH-3T3 cells were grown in DMEM with 10% bovine calf serum, 
penicillin and streptomycin. To generate stable cell lines, constructs encoding full-length human 
Sonic Hedgehog (HShh), C-terminally tagged with an HA epitope (HShh-HA) or fused with 
mCherry (HShh-Cherry) were cloned into the retroviral vector pLHCX (Clontech), and 
retroviruses were produced in 293T cells. The retroviruses were used to infect NIH-3T3 or 293T 
cells, and cells stably expressing HShh-HA or HShh-Cherry were generated by hygromycin 




 Cultured cells were fixed in PBS with 4% formaldehyde, and were permeabilized with 
TBST (10 mM Tris pH 7.5, 150 mM NaCl, 0.2% Triton X-100). Antibodies against HA (3F10, 
rat monoclonal, Roche), calnexin (rabbit polyclonal, Abcam) and gigantin (rabbit polyclonal, 
Abcam) were used at a final concentration of 0.25 and 0.5 ug/mL, respectively. Alexa-594- and 
Alexa-488-conjugated secondary antibodies (Invitrogen) were used at a final concentration of 1 
ug/mL. The immunostained cells were imaged by epi-fluorescence microscopy on an inverted 




100x PlanApo 1.4NA oil objective (Nikon). Images were collected using Metamorph image 
acquisition software (Applied Precision). 
 293T and 3T3 cells stably expressing HShh-HA were incubated for 3 hrs in the presence 
of control media or the proteasome inhibitors MG132 (10 uM), bortezomib (1 uM) or 
epoxomicin (1 uM). The cells were fixed and processed for immunofluorescence, to detect the 
HA epitope and calnexin. 
 
DNA constructs for mammalian cell transfection 
 Full-length HShh, tagged at the C-terminus with one copy of the HA epitope (HShh-HA), 
was cloned into pIRES2-eGFP (Clontech). The C-terminal fragment of HShh (HShh-C, amino 
acids 198-462, HA-tagged at the C-terminus) was cloned into pIRES2-eGFP, behind a sequence 
encoding the signal sequence of CD5. Site-directed mutagenesis of HShh was carried out using 
the Quickchange kit (Stratagene). Wild type and catalytically inactive p97 (p97-WT and p97-
QQ) were provided by Dr. Yihong Ye; myc-tagged wild type and the two dominant negative 
mutants of Hrd1 (Hrd1-WT, Hrd1-C291A and Hrd1-C291A-C307A) were provided by Dr. 
Emmanuel Wiertz; myc-tagged reticulon 4A was from Dr. Stephan M. Strittmatter. The Ubc6e-
C91S and UbxD8-GFP expression constructs were described previously (Lilley and Ploegh, 
2004; Mueller et al., 2008). The expression constructs for the mutant ER-localized thioredoxin-
like proteins were described previously (Schulman et al., 2010). 
 
Transfection of plasmids and siRNAs into cultured cells 
 Plasmids were transfected using Lipofectamine 2000 (Invitrogen), according to the 




transfection reagent (Mirus), at a final concentration of 50 nM siRNA, according to the 
manufacturer’s instructions. SiRNA transfection was performed twice, on days 1 and 3 of the 
experiment. On day 5, the cells were treated with cycloheximide (CHX, 50 uM) or CHX plus 
MG132 (50 uM) for the indicated period of time, after which cells were harvested, and proteins 
were analyzed by SDS-PAGE and immunoblotting. SiRNA sequences are shown in Table 2.S1. 
 
Quantitative RT-PCR analysis 
 Total RNA was extracted with TRIzol reagent, and cDNA was synthesized with ImProm-
IITM reverse transcriptase (Promega). Quantitative PCR was performed on an ABI Prism 7900 
cycler, using SYBR Green PCR Master Mix (ABI). The degree of siRNA knockdown was 
calculated relative to HPRT1 mRNA levels. The primers used to quantify mRNA knockdown are 
shown in Table S2. 
 
Immunoblotting 
 Cells were lysed on ice for 20 min, in TBS (10 mM Tris, pH 7.5, 150 mM NaCl), 
supplemented with protease inhibitors and 1% Triton X-100. The lysate was centrifuged for 30 
min at 4C and 20,000g. The supernatant was collected, mixed with SDS-PAGE sample buffer 
with DTT (50 mM final), and separated by SDS-PAGE, followed by immunoblotting. 
 
Immunoprecipitation and ubiquitination of HShh-HA 
 293T cells expressing HShh-HA were treated with either DMSO or MG132 (50 uM) for 




(Mueller et al., 2008). The precipitated proteins were separated by SDS-PAGE and ubiquitin 
conjugates were detected by immunoblotting with anti-ubiquitin antibodies (Biomol).   
 
Pulse-chase assays 
 Pulse-chase experiments were performed as described (Mueller et al., 2006). 293T cells 
were detached from plates and were incubated in suspension in methionine- and cysteine-free 
DMEM for 1 hour at 37C. The cells were then labeled for 3 min at 37C with 300 uCi/mL 35S-
methionine and -cysteine (35S-Protein Express Labeling Mix, New England Nuclear). Cellular 
density during labeling was 1x107 cells/mL. The chase was started by adding cold methionine 
and cysteine, at a final concentration of 5 mM and 1 mM, respectively. Aliquots of the cell 
suspension were removed at different time points, and cellular pellets were frozen. Cellular 
lysates were subjected to denaturing immunoprecipitation with HA antibodies. The precipitated 
proteins were separated on SDS-PAGE, and were visualized by autoradiography. 
 
Cycloheximide chase assays 
 293T cells stably expressing HShh-HA were incubated with cycloheximide (50 ug/mL) 
in OptiMEM (Invitrogen), in agitated suspension, at 37C. At the indicated times, aliquots were 
removed, the cells were harvested and HShh-HA was detected by immunoblotting. 
 To determine the effect of various dominant-negative constructs on HShh processing, 
293T cells expressing HShh-HA were transfected with expression constructs for Derlin1-GFP, 
UbxD8-GFP or dominant-negative Ubc6e, as described (Mueller et al., 2008; Mueller et al., 
2006), followed by cycloheximide chase, 24 hours after transfection. 




 We used a collection of FLAG-tagged CXXA mutants representing 9 different human 
ER-localized thioredoxin-like proteins (Schulman et al., 2010). Each construct was co-expressed 
in 293T cells with HShh-HA, either wild type of the processing-defective C198A mutant. 
Twenty-four hours later the cells were harvested, lysed, and the lysate was subjected to 
denaturing immunoprecipitation with HA- and FLAG-antibodies, as described (Schulman et al., 
2010). The precipitated proteins were separated by SDS-PAGE, under either reducing or non-
reducing conditions, followed by immunoblotting with FLAG or HA antibodies. 
 
Analyzing Hh secretion 
 293T cells stably expressing HShh-HA were incubated for 12 hrs in DMEM containing 
0.5% fetal bovine serum, with or without epoxomicin added for the last 3 hrs of the incubation. 
The cells were harvested and lyzed, while the protein in the culture medium was precipitated 
with trichloracetic acid. HShh-N and HShh-C were analyzed by SDS-PAGE, followed by 
immunoblotting with Shh antibodies (Cell Signaling) and HA antibodies (Roche). 
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 The Hedgehog signaling pathway plays critical roles in metazoan development and in 
cancer. How the Hedgehog ligand is secreted and spreads to distant cells is unclear, given its 
covalent modification with a hydrophobic cholesterol molecule, which makes it stick to 
membranes. We demonstrate that Hedgehog ligand secretion from vertebrate cells is 
accomplished via two distinct and synergistic cholesterol-dependent binding events, mediated by 
two proteins essential for vertebrate Hedgehog signaling: the membrane protein Dispatched and 
a member of the Scube family of secreted proteins. Cholesterol modification is sufficient for a 
heterologous protein to interact with Scube, and to be secreted in a Scube-dependent manner. 
Dispatched and Scube recognize different structural aspects of cholesterol, similar to how 
Niemann-Pick disease proteins 1 and 2 interact with cholesterol, suggesting a hand-off 
mechanism for transferring Hedgehog from Dispatched to Scube. Thus, Dispatched and Scube 




 The Hedgehog (Hh) signaling pathway has fundamental roles in embryonic development, 
adult stem cell maintenance and carcinogenesis (Lum and Beachy, 2004). Hh signaling is 
triggered by binding of the secreted Hh ligand to its membrane receptor, Patched (Ptch), setting 
in motion signal transduction events that ultimately lead to the specific transcriptional output of 
the Hh pathway. The Hh ligand is generated from a precursor protein, which is translocated into 
the endoplasmic reticulum (ER), undergoes signal sequence cleavage and then is modified 
covalently with two lipids: 1) a palmityl residue is attached at the N-terminus by the palmityl 
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transferase Skinny hedgehog (Chamoun et al., 2001); and 2) a cholesteryl residue is attached at 
the C-terminus by autocatalytic modification (Porter et al., 1996). The cholesterol modification 
reaction relies on the intein activity of the C-terminal domain of the Hh precursor, and generates 
an N-terminal fragment (the cholesterol-modified Hh ligand) and a C-terminal fragment that is 
disposed of by ER-associated degradation (Chen et al., 2011). The two lipid modifications of the 
Hh ligand occur independently (Chamoun et al., 2001) and are both essential for normal Hh 
signaling (Chamoun et al., 2001; Traiffort et al., 2004). 
 The Hh ligand is strongly hydrophobic and hence membrane-associated, which raises the 
critical question of how it is secreted and how it reaches cells located at a distance from the 
signaling cell. Genetic analysis identified Dispatched (Disp) and the Scube family of proteins as 
essential for long-range Hh signaling. Disp is a multi-spanning membrane protein required for 
long-range Hh signaling in Drosophila (Burke et al., 1999), mouse (Ma et al., 2002) and 
zebrafish (Nakano et al., 2004). Disp belongs to the RND family of transporters (Tseng et al., 
1999) and contains a sterol-sensing domain (SSD), a sequence of 5 consecutive membrane-
spanning helices found in several membrane proteins involved in cholesterol homeostasis 
(Kuwabara and Labouesse, 2002). Disp is specifically required for secretion of cholesterol-
modified Hh, as the N-terminal fragment of Hh without the cholesterol modification can be 
released in the absence of Disp. The Scube family (Grimmond et al., 2000) consists of the 
secreted proteins Scube 1, 2 and 3, and is required for long-range Hh signaling in zebrafish 
(Johnson et al., 2012). Scube2 was first identified in zebrafish (Hollway et al., 2006; Kawakami 
et al., 2005; Woods and Talbot, 2005) as playing a non-cell autonomous role in long-range Hh 
signaling. Epistatic analysis led to the proposal that Scube2 is involved in the transport or 
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stability of Hh ligand in the extracellular space (Hollway et al., 2006; Kawakami et al., 2005; 
Woods and Talbot, 2005). 
 For both Disp and Scube proteins, the mechanism by which they promote long-range Hh 
signaling is unknown. Although Disp is required for Hh secretion, there is no direct evidence that 
Disp participates in Hh release from cells. Additionally, it is unclear how the Hh ligand is kept 
soluble in the extracellular space, and how it is delivered to responding cells. Regarding Scube 
proteins, it is unclear if they are involved in Hh biosynthesis, secretion or in another aspect of Hh 
function outside the producing cell. 
 Here we dissect the mechanism of Hh secretion in vertebrate cells. We show that the 
vertebrate homologue, Dispatched-A (DispA) interacts with human Sonic hedgehog (hShh) via 
its cholesterol anchor, and that this interaction is necessary for hShh secretion. Interestingly, an 
inactive DispA mutant binds hShh more strongly than wild-type DispA, suggesting that 
dissociation of hShh from DispA is important for efficient secretion. However, DispA alone is 
not sufficient to release hShh from cells, indicating that additional factors are required to 
overcome the insolubility conferred by cholesterol modification. We demonstrate that a Scube 
family member, Scube2, synergizes with DispA to cause a dramatic increase in hShh secretion. 
Scube2 binds the cholesterol anchor of hShh and this interaction is required for promoting hShh 
secretion. Cholesterol modification is sufficient for a heterologous protein to bind Scube2 and to 
be secreted in a Scube2-dependent manner. Importantly, DispA and Scube2 recognize different 
aspects of the cholesterol anchor of hShh. Our results support a model in which membrane-
associated hShh is secreted by being handed off from DispA to Scube2, in a manner reminiscent 
of the transport of free cholesterol by the Niemann-Pick disease proteins NPC1 and NPC2 
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(Infante et al., 2008b). Thus a relay mechanism involving DispA and Scube2 promotes the 
release of cholesterol-modified hShh from the plasma membrane of producing cells. 
 
RESULTS 
Dispatched-A interacts with hShh in a cholesterol-dependent manner 
 It was suggested that Dispatched (Disp) might bind cholesterol-modified Hh (Burke et 
al., 1999); however, such an interaction has not been demonstrated. We first tested if mouse 
Dispatched-A (DispA) binds cholesterol-modified human Sonic Hedgehog (hShh) by co-
immunoprecipitation. DispA and hShh were stably co-expressed in 293T cells, followed by 
detergent solubilization and immunoprecipitation. Under these conditions wild-type DispA 
showed modest but reproducible binding to cholesterol-modified hShh (Figure 1A), consistent 
with the expectation of a transient DispA-hShh interaction. To probe the cholesterol dependence 
of the interaction, we expressed a construct that encodes the N-terminal fragment of hShh 
(hShhN, amino acids 1-198), which generates a protein lacking cholesterol but which is still 
palmitylated (Chamoun et al., 2001; Chen et al., 2004). DispA did not bind hShhN (Figure 1A), 
indicating that binding to hShh is cholesterol-dependent. Interestingly, the inactive DispA 
mutant, DispA-NNN (Ma et al., 2002) showed significantly stronger hShh binding compared to 
wild-type DispA (Figure 3.1A); the same result was obtained with the inactive DispA-AAA 
mutant. DispA-NNN and DispA-AAA are triple point mutants in which 3 aspartate residues 
located in transmembrane helices 4 and 10 are mutated to asparagines or alanines; one of these 
aspartates is conserved in RND family proteins and is required for their transporter function. Our 
results suggest that DispA-NNN and DispA-AAA are defective in hShh secretion perhaps 




Figure 3.1 Cholesterol-dependent binding of hShh to DispA is required for hShh secretion 
(A) 293T cells stably co-expressing hShh or hShhN, and myc-tagged wild-type DispA (WT) or DispA-NNN (NNN) 
were lysed with detergent and analyzed by immunoprecipitation with anti-myc antibodies, followed by SDS-PAGE 
and immunoblotting with anti-hShh antibodies. 
(B) Structures of the photoreactive sterols, 6-azicholestanol (1) and 25-azicholesterol (2). Also shown are the 





Figure 3.1 (Continued) 
(C) HShh, HA-tagged at the C-terminus (hShh-HA) was stably expressed in 293T cells. The cells were sterol-
depleted with methyl-!-cyclodextrin (MCD), after which cholesterol (Chol), epicholesterol (epiChol), 6-
azicholestanol (6-azi) or 25-azicholesterol (25-azi) were added back as soluble MCD complexes, for 3 hours. 
Lysates were analyzed by SDS-PAGE and immunoblotting with HA antibodies (to detect the hShh precursor and the 
C-terminal fragment, hShhC) and hShh antibodies (to detect the hShh ligand). 
(D) 293T cells stably co-expressing myc-tagged DispA-WT and hShh or hShhN were labeled with the indicated 
sterols, as in (B). After incubation for 6 hours, the cells were UV-irradiated and DispA-hShh photocrosslinking was 
analyzed by denaturing immunoprecipitation with myc antibodies, followed by SDS-PAGE and immunoblotting for 
hShh. Immunoblotting for tubulin served as loading control. 
(E) Left panels: immunofluorescence microscopy of hShh stably co-expressed with myc-tagged DispA-WT or 
DispA-NNN in NIH-3T3 cells. Cells were stained with rabbit anti-hShh and mouse anti-myc antibodies, followed 
by goat anti-rabbit Alexa488 and goat anti-mouse Alexa594 secondary antibodies. Right panels: localization by 
immunofluorescence microscopy of hShh and hShhN expressed in DispA-/- MEFs. 
(F) As in (C) but with 293T cells stably co-expressing myc-tagged DispA or the mutant missing the first 
extracellular loop, DispA-"loop1 ("), together with hShh or hShhN. 
(G) DispA-/- MEFs stably expressing hShh or hShhN, rescued by lentiviral expression of mCherry-tagged DispA or 
not, were co-cultured with Hh-responsive Shh Light II cells at a 1:20 ratio. Luciferase measurements were 
normalized to reporter cells grown alone (control). All experiments were performed in triplicate. Error bars represent 
the standard deviation of the mean. 
(H) DispA-/- MEFs stably expressing hShh, transduced with lentiviruses expressing mCherry-tagged DispA-WT, 




 A potential problem with our binding assay is that detergent solubilization could have a 
negative effect on the native conformation of DispA and/or might disrupt the DispA-hShh 
interaction. We thus developed a strategy to examine the DispA-hShh interaction in intact cells, 
using two different photoreactive cholesterol derivatives: 1) 6-azicholestanol (compound 1 in 
Figure 3.1B), a photoreactive sterol that carries a diazirine group on the B ring of the molecule 
(Thiele et al., 2000), and 2) 25-azicholesterol (compound 2 in Figure 3.1B), a novel 
photoreactive sterol that we synthesized, which carries a diazirine group at the end of the isooctyl 
tail. We reasoned that having the photoreactive group in two locations of the sterol molecule 
would increase the chance of detecting a potential interaction with DispA. We first asked if the 
two photoreactive sterols modify hShh in cells. When cells stably expressing hShh (Chen et al., 
2011) were depleted of sterols by acute treatment with methyl-!-cyclodextrin (MCD), hShh 
processing was strongly inhibited, causing the accumulation of the unprocessed hShh precursor 
(Figure 3.1C). Processing was rescued by adding back cholesterol (compound 3 in Figure 3.1B) 
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but not the diastereomer epicholesterol (compound 4 in Figure 3.1B), which is inactive in 
modifying Hh proteins (Mann and Beachy, 2004). Adding back either of the two photoreactive 
sterols fully rescued hShh processing (Figure 3.1C). We next used this strategy to generate hShh 
modified with photoreactive sterols by labeling cells that stably express DispA and hShh. The 
cells were then UV-irradiated, and formation of a covalent DispA-hShh bond was tested by 
denaturing immunoprecipitation of DispA followed by immunoblotting for hShh. DispA showed 
crosslinking to hShh modified with photoreactive sterol (Figure 3.1D), but not to hShhN, 
demonstrating that DispA binds hShh in a cholesterol-dependent manner in intact cells. 
Interestingly, DispA was photocrosslinked much more efficiently when hShh was modified with 
25-azicholesterol than with 6-azicholestanol (Figure 3.1D and 3.1F), suggesting that the isooctyl 
tail of cholesterol is a feature recognized by DispA during its interaction with hShh. Consistent 
with a DispA-hShh interaction in cells, DispA (wild-type and the NNN mutant) and hShh are 
both present at the plasma membrane by immunofluorescence microscopy (Figure 3.1E). 
Importantly, not all hShh puncta co-localize with DispA at the membrane, as expected from a 
transient interaction between the two proteins. In contrast to hShh, hShhN is found 
predominantly in intracellular vesicles and not at the plasma membrane (Figure 3.1E), consistent 
with the efficient release of hShhN from the cell surface. 
 We next asked if binding of DispA to hShh is important for hShh secretion. To generate a 
DispA mutant that cannot bind hShh, we deleted the first extracellular loop of DispA. This 
choice was based on the role that the first extracellular loop plays in two Disp-related proteins: it 
is required in the SREBP cleavage-activating protein (SCAP) for binding cholesterol (Motamed 
et al., 2011), and in Ptch for binding hShh (Marigo et al., 1996). Indeed, DispA-!loop1 did not 
bind hShh in our in vivo photocrosslinking assay (Figure 3.1F). We turned to a cellular assay that 
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relies on the function of DispA in hShh secretion and long-range signaling. DispA-/- mouse 
embryonic fibroblasts (MEFs) (Ma et al., 2002) were co-cultured with the Hh reporter cells, Shh 
Light II (Taipale et al., 2000). Stable expression of hShh in DispA-/- MEFs caused a slight 
activation of the Hh pathway in reporter cells (Figure 3.1G) because short-range Hh signaling 
does not require DispA. Co-expression of mCherry-tagged DispA in DispA-/- MEFs strongly 
increased the response of reporter cells, indicating that DispA rescued hShh secretion  (Figure 
3.1G). As expected, DispA did not affect signaling by DispA-/- MEFs expressing hShhN (Figure 
3.1G), because DispA is only required for secretion of cholesterol-modified hShh. Similar results 
were obtained by overexpressing DispA in NIH 3T3 cells (Supplemental Figure 3.S1). In 
contrast to wild-type DispA, mCherry-tagged DispA-!loop1 or DispA-NNN did not rescue 
signaling by DispA-/- MEFs expressing hShh, a result more obvious at a lower ratio of signaling 
cells to reporter cells (Figure 3.1H). The fact that DispA-!loop1 is inactive suggests that 




Figure 3.2 DispA is not sufficient for release of cholesterol-modified hShh 
(A) 293T cells stably expressing hShh and myc-tagged DispA constructs were washed of serum and were incubated 
with serum-free media for 6 hours. Secreted proteins were precipitated with trichloroacetic acid (TCA). Pellet and 
supernatant fractions were analyzed by SDS-PAGE and immunoblotting with anti-myc and anti-hShh antibodies. 
Blotting for GSK3 served as loading control. 
(B) Supernatants collected as in (A) were diluted 1:2 with serum-free media and hShh activity was assayed using 
Shh Light II reporter cells. Measurements were performed in triplicate and error bars represent standard deviation of 
the mean. 
(C) 293T cells expressing hShhN or hShh were incubated with serum-free media, with or without methyl-!-
cyclodextrin (MCD, 100 µM), and supernatants were harvested after 1 or 3 hours. Secretion of hShh and hShhN was 
analyzed as in (A). 
(D) 293T cells transiently expressing hShh, hShhN, hShh with a palmitylation site mutation (hShhC24S), or hShhN 
with a palmitylation site mutation (hShhN-C24S) were incubated in serum-free media for 4 hours, and secreted 
proteins were TCA-precipitated. Pellet and supernatant fractions were analyzed as in (A). The samples in this panel 
were loaded in duplicate. 
(E) A secreted HA-tagged Halotag protein was fused to amino acids 190-462 of hShh (Halo-Chh); autocatalytic 
processing of Halo-Chh generates Halotag fused to amino acids 190-198 of hShh, modified with cholesterol. 
Secreted HA-Halotag fused to amino acids 190-198 of hShh (Halo) is not cholesterol-modified and serves as 
negative control. The Halotag constructs were expressed in 293T cells, and secreted proteins were collected into 
serum free media for 4 hours. Pellet and supernatant fractions were analyzed by SDS-PAGE and immunoblotting 




DispA is not sufficient to release cholesterol-modified hShh from cells 
 Although the co-culture system provides a good functional assay for DispA, it measures 
hShh secretion only indirectly. We next tested directly if DispA is sufficient for hShh release 
from membranes, by examining secretion of hShh from 293T cells that stably over-express 
DispA. Since we observed that serum releases hShh in a non-specific, DispA-independent 
manner, we took care to remove residual serum from the cells by repeated washes with serum-
free medium. Under serum-free conditions, no hShh was released into the medium, in the 
absence or presence of overexpressed DispA, as assayed by Western blotting (Figure 3.2A) or by 
Hh activity assays (Figure 3.2B). These cells expressed large amounts of hShh, which was 
properly processed (Figure 3.2A) and strongly localized to plasma membrane, as determined by 
immunofluorescence microscopy. In contrast, stably expressed hShhN was efficiently secreted 
into serum-free medium and was active; as expected, DispA had no effect on hShhN secretion 
(Figure 3.2A and B). These results indicate that DispA alone is not sufficient to release hShh, 
perhaps because another factor is required to solubilize it in the media; in the absence of such a 
factor, hShh remains membrane-associated. 
 
Cholesterol is the main determinant of hShh membrane association 
 Given that hShhN is efficiently secreted, we tested if the cholesterol anchor is responsible 
for the strong association of hShh with membranes. HShh was quickly released from cells when 
media were supplemented with methyl-!-cyclodextrin (MCD) (Figure 3.2C), which can be 
explained by MCD binding the cholesterol anchor and promoting hShh solubilization. In contrast 
to hShh, secretion of hShhN was not further enhanced by MCD (Figure 3.2C). 
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 We next asked if the other hydrophobic modification of hShh, palmitylation, plays a role 
in hShh association with membranes. Like wild-type hShh, hShh-C24S, a mutant of hShh that 
cannot be palmitylated but is still modified with cholesterol (Chamoun et al., 2001)) was 
membrane-associated and was not secreted into serum-free medium (Figure 3.2D). As expected, 
hShhN and a mutant that lacks both the cholesteryl and palmityl moieties (hShhN-C24S) were 
efficiently secreted (Figure 3.2D). 
 Finally, we asked if cholesterol modification of an unrelated soluble protein is sufficient 
to recapitulate the strong membrane attachment of hShh. We used a construct encoding a 
secreted version of the Halotag protein fused to the C-terminal domain of hShh (Halotag-Chh); 
in cells, this fusion undergoes autocatalytic processing to generate cholesterol-modified Halotag. 
HA-tagged Halotag-Chh was expressed in 293T cells and secretion into serum-free medium was 
measured by immunoblotting with HA antibodies. Under these conditions, cholesterol-modified 
Halotag was not secreted and remained membrane-associated (Figure 3.2E); in contrast, Halotag 
without the cholesterol modification was soluble (Figure 3.2E). 
 Together, these results indicate that the cholesterol anchor is necessary and sufficient for 
hShh membrane attachment, while the palmityl moiety plays a less important role, if any. Thus 





Figure 3.3 The extracellular protein Scube2 stimulates secretion of cholesterol-modified hShh 
(A) Scube2 or Scube2!CUB was transfected into 293T cells stably expressing hShh, and 24 hours later secreted 
proteins were collected into serum-free media for 4 hours. HShh activity in serial dilutions of the supernatant was 
measured by luciferase assay in Shh Light II reporter cells. All experiments were performed in triplicate. Error bars 
represent the standard deviation of the mean. 
(B) Scube2 or Scube2!CUB was added in serum-free media to 293T cells stably expressing hShh, for 4 hours. 
Activity of secreted hShh was measured as in (A).  
(C) As in (A) but with 293T cells stably expressing hShh or hShhN. Secreted hShh and hShhN were collected for 6 
hours, and were analyzed by reporter assay in Shh Light II cells and by immunoblotting with anti-hShh antibodies. 
Note the much higher amount of secreted hShhN compared to hShh. 
(D) Sequence of the conserved hydrophobic patch in the CUB domain of vertebrate Scube2 orthologs. Also shown 
is the sequence of the Scube2-8Ala mutant, in which 8 hydrophobic residues are mutated to alanines. 
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Figure 3.3 (Continued) 
(E) HA-tagged Scube2, Scube2-8Ala, or Scube2!CUB were transfected into 293T cells stably expressing hShh. 
Secreted proteins were collected 24 hours later, for 6 hours into serum-free media. Aliquots of the cell pellet and 
supernatants were analyzed by SDS-PAGE and immunoblotting for HA and hShh. 
(F) HShh activity in the supernatants collected in (E) was measured as in (A). 
(G) HShh or the palmitylation-defective mutant hShhC24S were co-expressed in 293T cells with HA-tagged Scube2 
or Scube2!CUB. HShh and hShhC24S secretion was analyzed as in (E). 
(H) HShh and hShhC24S activity in the supernatants collected in (G) was measured as in (A). 
(I) Scube2 or Scube2!CUB was added in serum-free medium to 293T cells stably expressing hShh, for 1 hour at 
370C or 40C. HShh activity in the supernatants was measured as in (A). 
 
 
Scube2 dramatically increases secretion of cholesterol-modified hShh 
 The experiments above suggest the existence of an extracellular protein that helps the 
secretion of hShh by overcoming its cholesterol-dependent insolubility. The Scube family of 
secreted proteins is required for long-range Hh signaling in zebrafish (Johnson et al., 2012), but 
its mechanism is unknown. We examined if the first Scube protein implicated in Hh signaling, 
Scube2 (Hollway et al., 2006; Kawakami et al., 2005; Woods and Talbot, 2005), is involved in 
releasing hShh from cells. When Scube2 was expressed in 293T cells stably expressing hShh, it 
caused a dramatic increase in secretion of active hShh (Figure 3.3A). As negative control we 
used Scube2!CUB, a truncation mutant of Scube2 that lacks a C-terminal portion of the protein, 
including a cysteine-rich domain and a CUB domain; this loss-of-function mutation was 
identified in the initial cloning of zebrafish Scube2 (Woods and Talbot, 2005). Scube2!CUB 
was efficiently secreted but failed to stimulate hShh secretion (Figure 3.3A). Scube2 supplied 
exogenously also released hShh into serum-free media, indicating that Scube2 and hShh do not 
have to be co-expressed (Figure 3.3B). Scube2 had no effect on the secretion of hShhN, 
indicating that it acts specifically to release cholesterol-modified hShh (Figure 3.3C). 
Interestingly, although the amount of released hShh was significantly smaller than that of 
hShhN, the signaling activity of hShh was much higher than that of hShhN (Figure 3.3C), 
suggesting that cholesterol modification greatly enhances the potency of the hShh ligand. 
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 It is known that hShh can be released from cells by serum (Chen et al., 2011) and by high 
levels of heparin. HShh released with either serum or heparin was inactive in signaling assays, in 
contrast to hShh released by Scube2 (Supplemental Figure 3.S2). Thus, unlike other factors that 
can release hShh, release by Scube2 is physiological. 
 All Scube2 orthologs contain a conserved hydrophobic stretch in the middle of the CUB 
domain (Figure 3.3D), while the rest of the protein shows little clustering of hydrophobic amino 
acids outside the signal sequence. We reasoned that this hydrophobic stretch might be important 
for release of hShh. Indeed, a Scube2 mutant in which 8 amino acid residues in the hydrophobic 
stretch are mutated to alanines (Scube2-8Ala) is secreted (Figure 3.3E) but is completely inactive 
in releasing hShh (Figure 3.3E, F). This indicates that the conserved hydrophobic sequence in the 
CUB domain is necessary for Scube2 activity. 
 We next asked if palmitylation of hShh is required for release by Scube2. Like wild-type 
hShh, the non-palmitylated mutant hShhC24S was released by Scube2 but not by Scube2!CUB 
(Figure 3.3G), indicating that the palmitylation is not required for Scube-mediated hShh 
secretion. The Scube2-released hShhC24S was inactive in Hh signaling assays (Figure 3.3H), 
consistent with the requirement of the palmityl modification for Hh activity (Chamoun et al., 
2001). 
 We also performed an experiment to determine the effect of temperature on the release of 
hShh from cells by Scube2. While added Scube2 released a significant amount of hShh during 1 
hour at 370C, no hShh was released at 40C (Figure 3.3I). This is consistent with Scube2 having to 
overcome the hydrophobic interaction between the cholesterol anchor of hShh and the 




Scube2 does not affect hShh processing in producing cells or signaling in responding cells 
 One possible explanation for the enhanced secretion of hShh is that Scube2 stimulates 
hShh processing in producing cells. Radioactive pulse-chase analysis of hShh processing showed 
that it proceeded with the same kinetics in the presence of co-expressed Scube2 or the inactive 
Scube2!CUB mutant (Figure 3.4A). This result indicates that Scube2 does not affect hShh 
processing. 
 To determine if Scube2 has an effect on Hh signal transduction, we performed two 
experiments. First, we asked if Scube2 affects signaling by hShhN. Increasing concentrations of 
Scube2 added to a fixed concentration of hShhN had no effect on Hh pathway stimulation 
(Figure 3.4B, left side of the graph). In a second experiment, we asked if excess Scube2 affects 
signaling by hShh. When increasing amounts of Scube2 were added to hShh released into 
Scube2-containing media, there was no effect on Hh pathway stimulation (Figure 3.4B, right side 
of the graph); furthermore, Scube2 had no effect on Hh signaling on its own. Although it was 
proposed that Scube2 promotes Hh signaling at the level of the responding cell, possibly via its 
interaction with Ptch (Tsai et al., 2009), our Scube2 titration experiment argues against such a 
model. Our data, however, cannot exclude the possibility that the hShh-Scube2 complex (see 




Figure 3.4 Cholesterol-dependent binding of Scube2 to hShh is required for hShh secretion 
(A) HA-tagged Scube2 or Scube2!CUB was expressed in 293T cells stably expressing hShh. The cells were pulsed 
with 35S-methionine for 3 min and were chased with media containing unlabeled methionine for the indicated times. 
HShh processing was analyzed by immunoprecipitation with the 5E1 antibody, which recognizes full-length and 
processed hShh. Scube2 and Scube2!CUB were immunoprecipitated with anti-HA antibodies. The precipitated 
protein was analyzed by SDS-PAGE and fluorography. The same number of cells was processed for each condition. 
(B) The two graphs on the left show that Scube2 does not affect hShhN activity. HShhN was mixed with HA-tagged 
Scube2 or Scube2!CUB, in the indicated ratios, and its activity was measured in Shh Light II reporter cells. The two 
graphs on the right show Scube2 does not affect the activity of hShh pre-released with Scube2. 293T cells co-
expressing hShh and HA-tagged Scube2 were used to generate serum-free hShh-Scube2 conditioned media. This 
media was mixed with HA-tagged Scube2 or Scube2!CUB, in the indicated ratios, and its activity was measured in 
Shh Light II reporter cells. All experiments were performed in triplicate. Error bars represent the standard deviation 
of the mean. 
(C) 293T cells co-expressing hShh or hShhN, and HA-tagged Scube2 or Scube2!CUB were incubated in serum-free 
media for 4 hours. HShh and hShhN were immunoprecipitated from the supernatant with 5E1 antibodies. A portion 
of the supernatant was TCA-precipitated to serve as input. All samples were analyzed by SDS-PAGE and 
immunoblotting with anti-HA and anti-hShh antibodies. 
(D) HShh or hShhN was stably co-expressed with HA-tagged Scube2 or Scube2!CUB in 293T cells. The cells were 
labeled with the indicated sterols, followed by UV irradiation. Photocrosslinked Scube2-hShh was analyzed by 




Scube2 binds hShh in a cholesterol-dependent manner 
 It seemed likely that Scube2 might stimulate hShh secretion by direct binding. We first 
tested this hypothesis by immunoprecipitation of hShh secreted into serum-free medium by cells 
co-expressing hShh and HA-tagged Scube2, followed by immunoblotting for HA. Under these 
conditions we detected binding of Scube2 to hShh (Figure 3.4C). Scube2 did not bind hShhN, 
indicating that Scube2 binds hShh in a cholesterol-dependent manner (Figure 3.4C). As 
expected, the inactive mutant Scube2!CUB did not release or bind hShh, suggesting that binding 
to Scube2 is required for hShh secretion. 
 In the experiment above, hShh was immunoprecipitated with the 5E1 monoclonal 
antibody, which blocks binding of hShh to Ptch and to the antagonist Hedgehog-interacting 
protein (HIP), due to the very similar binding interfaces between hShh and 5E1, HIP, and Ptch 
(Maun et al., 2010). In contrast, the 5E1 antibody did not block binding of hShh to Scube2, 
indicating that the hShh-Scube2 interface is distinct and thus hShh binding to Scube2 might 
allow hShh interaction with the downstream components Ptch and HIP. 
 Finally, we examined the interaction between Scube2 and hShh in cells by 
photocrosslinking. Cells stably expressing HA-tagged Scube2 and hShh were labeled with 
photoreactive sterols, and were then UV-irradiated. Lysates were subjected to denaturing 
immunoprecipitation with HA antibodies followed by immunoblotting for hShh. We detected 
crosslinking between hShh modified with 6-azicholestanol and Scube2; as expected, 
Scube2!CUB was not crosslinked to Scube2 (Figure 3.4D). Interestingly, hShh modified with 
25-azicholesterol showed much less crosslinking to Scube2 (Figure 3.4D), in contrast to DispA-
hShh crosslinking, which occurred preferentially with 25-azicholesterol. This differential 
crosslinking suggests that Scube2 and DispA recognize different structural aspects of the 
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cholesterol molecule, in a manner that might facilitate the hand-off of hShh from DispA to 
Scube2. 
 
DispA synergizes with Scube2 to promote hShh secretion 
 We next tested if DispA and Scube2 act synergistically to promote hShh secretion, first in 
the co-culture system of DispA-/- MEFs and Hh reporter cells. DispA-/- MEFs expressing hShh 
and DispA were plated at different ratios with Hh reporter cells, and the co-cultures were 
incubated with Scube2 in serum-free media, followed by Hh activity assays. Under these 
conditions, Scube2 strongly synergized with wild-type DispA to cause hShh secretion and Hh 
pathway activation (Figure 3.5A). As expected, Scube2 did not synergize with DispA-NNN and 
had no effect on signaling by hShhN; also, Scube2!CUB had no effect on hShh (Figure 3.5A). 
Interestingly, at a higher ratio of hShh-producing cells to reporter cells, Scube2 was able to 
release some hShh even in the absence of DispA (Figure 3.5A); this is consistent with a model in 
which hShh partitions between the membrane and Scube2 in the media. 
 Similar results were obtained when we measured hShh secretion in 293T cells, in the 
absence or presence of co-expressed myc-tagged DispA. Addition of Scube2 to the cells 
synergized with wild-type DispA to release hShh into the supernatant, as assayed by 
immunoblotting (Figure 3.5B). As expected, Scube2 did not synergize with DispA-NNN, and 
Scube2!CUB had no effect on hShh secretion, irrespective of the presence of DispA (Figure 
3.5B). Similarly, Scube2 added to 293T cells synergized with DispA but not with DispA-!loop1, 
to cause secretion of hShh, as measured by Hh reporter assays (Figure 3.5C). Together, these 




Figure 3.5 Scube2 synergizes with DispA to stimulate secretion of cholesterol-modified hShh 
(A) DispA-/- MEFs stably expressing hShh, transduced with lentiviruses expressing mCherry-tagged wild-type 
DispA or DispNNN, were plated with Shh Light II reporter cells at 1:40 and 1:80 ratios. After 12 hours, Scube2 or 
Scube2!CUB was added in serum-free media. Luciferase measurements were performed 30 hours later and were 
normalized to untreated reporter cells. All experiments were done in triplicate. Error bars represent the standard 
deviation of the mean. 
(B) HA-tagged Scube2 or Scube2!CUB was transfected into 293T cells that stably express hShh, hShh and myc-
tagged DispA-WT, or hShh and myc-tagged DispA-NNN. Secreted proteins were collected into serum-free media 
24 hours later, for 4 hours. Aliquots of the cellular pellets and supernatants were analyzed by SDS-PAGE and 
immunoblotting with HA, myc and hShh antibodies. Blotting for GSK3 served as loading control. 
(C) As in (B), but with 293T cells expressing DispA-!loop1 instead of DispA-NNN. Activity of secreted hShh was 






Figure 3.6 Cholesterol modification is sufficient for interaction with and secretion by Scube2 
(A) Purified maltose-binding protein (MBP) fused to amino acids 244-471 of Drosophila Hedgehog (MBP-DHh) 
was used in in vitro processing reactions to generate MBP modified with either cholesterol (control), 6-
azicholestanol or 25-azicholesterol. The samples were analyzed by SDS-PAGE and Coomassie staining. MBP-
DHhN and DHh-C are the two fragments generated by in vitro processing. 
(B) The processing reactions in (A) were incubated with HA-tagged Scube2 or Scube2!CUB, followed by UV 
irradiation to induce photocrosslinking. The samples were analyzed by reducing SDS-PAGE and immunoblotting 
with HA antibodies. The arrow indicates the position of the photocrosslinked Scube2-MBP species. 
(C) Constructs that generate Halotag protein modified with cholesterol (Halotag-Chh) or not (Halotag) were co-
expressed in 293T cells with myc-tagged Scube or Scube2!CUB. Secreted proteins were collected in serum-free 




Cholesterol modification is sufficient for interaction with Scube2 and Scube2-dependent 
secretion 
 We asked if cholesterol modification is sufficient for interaction with Scube2, by 
photocrosslinking in vitro. To this end, we used an unrelated protein, maltose-binding protein 
(MBP) that we modified with photoreactive sterols by in vitro processing (Chen et al., 2011) 
(Figure 3.6A). Sterol-modified MBP fusions were then incubated with HA-tagged Scube2, 
followed by UV irradiation and immunoblotting with HA antibodies, to detect an increase in 
Scube2 size due to photocrosslinking. Under these conditions, Scube2 was crosslinked to MBP 
modified with 6-azicholestanol (Figure 3.6B), and much less efficiently to MBP modified with 
25-azicholesterol. This is the same preference for 6-azicholestanol over 25-azicholesterol that we 
observed for hShh-Scube2 photocrosslinking in cells (Figure 3.4D). The size of the 
electrophoretic mobility shift in Scube2 crosslinked to MBP (Figure 3.6B) is consistent with the 
addition of one molecule of MBP (40 kDa), indicating a 1:1 binding ratio between Scube2 and 
sterol-modified MBP. As expected, Scube2!CUB was not crosslinked to any of the sterol-
modified MBP proteins. These results suggest that cholesterol modification is sufficient for 
binding to Scube2.  
 Finally, we asked if cholesterol modification is sufficient for Scube2-dependent secretion. 
For this purpose we used cholesterol-modified Halotag, which is membrane-associated (Figure 
3.2E). HA-tagged Halotag-Chh was co-expressed in 293T cells with myc-tagged Scube2, and 
secretion into serum-free medium was measured by immunoblotting. As shown in figure 3.6C, 
cholesterol-modified Halotag was secreted only in the presence of Scube2, while Halotag 
without a cholesterol anchor was secreted independently of Scube2. As expected, Scube2!CUB 
did not release cholesterol-modified Halotag. These data demonstrate that a cholesterol anchor is 
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sufficient for an unrelated soluble protein to become membrane-associated, to bind Scube2, and 
to be secreted in a Scube2-dependent manner. 
 
DISCUSSION 
 The present study suggests a mechanism for how hShh is released from cells, in spite of 
its strong association with membranes. HShh has two lipid modifications, a palmityl residue at 
the N-terminus and a cholesteryl residue at the C-terminus. The cholesteryl moiety is mainly 
responsible for the insolubility of hShh, which has to be overcome to allow hShh mobilization 
and long-range Hh signaling. We now show that the multi-spanning membrane protein 
Dispatched-A (DispA), and the secreted protein Scube2 cooperate to accomplish hShh secretion. 
We demonstrate that during secretion hShh uses its unique cholesterol modification to interact 
with DispA and Scube2 via two distinct and synergistic binding events, and that these two 
interactions are required for hShh secretion. Interestingly, DispA and Scube2 recognize different 
structural aspects of the cholesterol molecule (Figure 3.7A), suggesting a hand-off mechanism 
for transferring hShh from DispA to Scube2. The advantage of such a mechanism is that it 
ensures hShh is never free in the aqueous environment, thus preventing its precipitation. 
According to this model, DispA would act in the hShh-synthesizing cell, whereas Scube2 could 
be provided either by the producing cell or by another cell.  
 Our results are in agreement with previous genetic evidence that showed that long-range 
Hh signaling absolutely requires Disp in vertebrates (Ma et al., 2002; Nakano et al., 2004) and in 
insects (Burke et al., 1999), and the Scube family of secreted proteins in zebrafish (Hollway et 
al., 2006; Johnson et al., 2012; Kawakami et al., 2005; Woods and Talbot, 2005). Both Disp and 
Scube are not required for short-range Hh signaling, consistent with their demonstrated role in 
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hShh secretion, rather than signal transduction. In addition, consistent with our results, genetic 
analysis shows that Scube2 acts non-cell autonomously, in contrast to Disp. So far, an essential 
role for Scube proteins in Hh signaling has only been demonstrated in zebrafish (Johnson et al., 
2012), but sequence conservation suggests that the function of Scube is conserved in mammalian 
Hh signaling. 
 While this manuscript was under review, another study (Creanga et al., 2012) was 
published, showing that Scube2 mediates release of cholesterol- and palmityl-modified hShh. 
Both this study and ours agree that cholesterol but not palmitate is strictly required for hShh 
release by Scube2; however Creanga et al. show that palmitylation enhances release of hShh by 
Scube2, which we did not observe in our experiments. The reason for this discrepancy remains to 
be elucidated. It should be pointed out that Scube-released hShh that lacks the palmitate 
modification is completely inactive in signaling assays (Creanga et al., 2012, and this study). 
 Our data support the following sequence of events in hShh biosynthesis (Figure 7B). 
Following autocatalytic cholesterol modification in the endoplasmic reticulum and palmitylation, 
hShh reaches the plasma membrane, to which it remains strongly attached via its cholesterol 
anchor. HShh then binds DispA, a cholesterol-dependent interaction that lowers the activation 
energy required for hShh extraction from the bilayer. Alternatively, hShh could associate with 
DispA earlier in the secretory pathway, and the two proteins might travel together to the plasma 
membrane. Binding to DispA is necessary but not sufficient for hShh secretion, because an 
extracellular binding partner is needed for hShh solubility. Additionally, if DispA binding is too 
strong, hShh secretion is impaired, as seen with some inactive DispA mutants. In the next step, 
hShh is transferred from DispA to the secreted protein Scube2, which is required for long-range 
Hh signaling in zebrafish. Scube2 interacts with the cholesterol anchor of hShh and dramatically 
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enhances hShh secretion by promoting its solubility. Cholesterol modification is sufficient, as 
demonstrated by the fact that an unrelated protein can be secreted in a Scube2-dependent 
manner. Although it is possible that Scube and Shh associate before reaching the plasma 
membrane when synthesized in the same cell, it is clear that this is not required for hShh 
secretion, as exogenous Scube2 can release hShh displayed on the cell surface.  
 It should be emphasized that the steps in hShh secretion outlined above represent 
partitioning equilibria of cholesterol-modified hShh, so that high concentrations of Scube2 
solubilize hShh from membranes even without DispA (the equilibrium on the left of Figure 
3.7B). HShh secretion however is greatly enhanced by DispA, as demonstrated by the strong 
synergy we observed between DispA and Scube2. How DispA synergizes with Scube2 remains 
to be elucidated. One possibility is that the orientation of the cholesterol anchor of hShh in the 
membrane favors its transfer to DispA, and is less favorable for a direct transfer to Scube2. 
Alternatively, Scube2 might bind DispA, which could facilitate the transfer of hShh between the 
two proteins. Based on homology to RND transporters, it was postulated that DispA acts as a 
pump (Ma et al., 2002). We speculate that the pumping activity of DispA might be involved in 
the transfer of hShh to Scube2. It will be important to elucidate the source of energy that DispA 




Figure 3.7. Mechanism of hShh secretion by the DispA and Scube2 
(A) Summary of the results for photocrosslinking of hShh to DispA and to Scube2 in cells. DispA is crosslinked to 
hShh modified with 25-azicholesterol and Scube2 is crosslinked to hShh modified with 6-azicholestanol, suggesting 
that DispA and Scube2 recognize different aspects of the cholesterol molecule. 
(B) The hShh ligand associates with membranes due to its hydrophobic cholesterol anchor. HShh binds DispA in a 
cholesterol-dependent manner, and this interaction is required for hShh secretion, perhaps by lowering the activation 
energy for hShh extraction from the lipid bilayer. From DispA, hShh is transferred to the secreted protein Scube2. 
The fact that DispA and Scube2 recognize different features of the cholesterol molecule suggests a hand-off 
mechanism for this transfer, such that the cholesterol anchor of hShh never contacts directly the aqueous 
environment, and is thus kept soluble. This mechanism is reminiscent of the transfer of free cholesterol between the 




 The interaction between Scube2 and hShh is expected to be dynamic, to allow hShh 
release. Such a transient interaction raises the question of how Scube2 keeps hShh soluble. One 
model is that hShh is kept soluble by an excess of Scube2, similar to sterol solubilization by 
complexation with methyl-!-cyclodextrin (MCD), in which sterol-MCD binding is dynamic and 
a several-fold molar excess of MCD is usually required for keeping the sterol soluble in aqueous 
solution. In a more complicated model, Scube2 might chaperone hShh and help it form a soluble 
multimeric species in which the cholesterol anchors are shielded from the aqueous environment 
by interactions between hShh monomers. A more detailed biochemical and structural analysis of 
the hShh-Scube interaction will be needed to answer these questions.  
 Our results suggest that Scube2 is not simply a solubilizing factor. HShh can be released 
by other agents, such as heparin and serum, but this requires very high concentrations and the 
released hShh is inactive in signaling assays. Thus, Scube2 interacts with hShh in a specific and 
efficient manner that maintains hShh activity. This raises the possibility that the hShh-Scube 
complex is the active species that signals to responding cells. For example, Scube2 might interact 
with Ptch, a possibility suggested by our finding that the 5E1 antibody, which blocks hShh 
binding to Ptch does not block hShh binding to Scube2. Alternatively, Scube2 might interact 
with one of the hShh co-receptors Gas1, Cdo and Boc. Any such interaction could facilitate the 
delivery of hShh to responding cells.  
 While cholesterol modification of Hh and the role of Disp are conserved between 
invertebrates and vertebrates, Scube proteins are only present in vertebrates. How then do 
invertebrates secrete Hh? A likely possibility is that the role of Scube is fulfilled in invertebrates 
by another secreted protein or by lipoprotein particles. Lipoproteins have been implicated in 
systemic transport of Hh in Drosophila (Panakova et al., 2005). It is unclear, however, if 
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lipoproteins are present in the extracellular space of early embryonic tissues, and thus if they 
play a role in Hh signaling at that stage. A biochemical approach will be required to determine if 
a secreted protein and/or lipoproteins function in invertebrates in a manner similar to Scube in 
vertebrates. 
 The proposed mechanism of hShh secretion is reminiscent of cholesterol trafficking by 
the Niemann-Pick disease proteins NPC1 and NPC2 (Infante et al., 2008b), which are involved 
in the egress of cholesterol from late endosomes/lysosomes. Cholesteryl esters are hydrolyzed in 
the lumen of the lysosome, releasing free cholesterol that binds NPC2, a soluble luminal 
cholesterol-binding protein. NPC2 transfers cholesterol to NPC1, a multispanning membrane 
protein in the limiting membrane of the lysosome. Cholesterol is then released from NPC1 into 
the lysosomal membrane, followed by its transport to other cellular membranes, perhaps through 
the cytosolic face of the membrane. 
 A comparison of hShh secretion to cholesterol egress from lysosomes reveals similarities 
as well as some important differences. DispA and NPC1 are both members of the RND family of 
transporters, and DispA binds the cholesterol anchor of hShh as NPC1 binds cholesterol (Infante 
et al., 2008a). While there is no homology between Scube2 and NPC2, they localize to 
topologically equivalent spaces (the extracellular space for Scube2 and the lumen of the late 
endosome/lysosome for NPC2), and Scube2 binds the cholesterol anchor of hShh as NPC2 binds 
cholesterol (Infante et al., 2008b). Importantly, DispA and Scube2 recognize different aspects of 
the cholesterol molecule (Figure 3.7A), which parallels the two distinct binding modes of NPC1 
and NPC2 to cholesterol (Kwon et al., 2009). However, while DispA appears to recognize the 
isooctyl tail of cholesterol, NPC1 binds cholesterol with the 3!-hydroxy buried and the isooctyl 
tail exposed (Kwon et al., 2009). Also, Scube2 appears to not bind the isooctyl tail of cholesterol, 
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while NPC2 binds the isooctyl tail (Kwon et al., 2009). Finally, one important difference is the 
direction of transport: DispA and Scube2 move hShh from the membrane to the extracellular 
space, while NPC1 and NPC2 transport cholesterol in reverse, from the lumen of the lysosome 
into the limiting membrane.  
 In summary, our results demonstrate a mechanism for hShh secretion that is reminiscent 
of the egress of free cholesterol from late endosomes/lysosomes. Both processes rely on the 
recognition of unique aspects of the cholesterol molecule and in both cases a similar mechanism 
is used to achieve solubility of the hydrophobic ligand. As mutations in NPC proteins cause 
disease, it seems possible that Disp and Scube could be involved in the pathogenesis of Hh 








 Details of cell culture conditions, DNA constructs, immunofluorescence microscopy, 
pulse-chase assays, immunoprecipitation, and production of Scube2-conditioned media are 
provided in Supplemental Information. To determine if photoreactive sterols modify hShh in 
vivo, 293T cells stably expressing hShh-HA (Chen et al., 2011) were sterol-depleted with 1% 
methyl-!-cyclodextrin (MCD) in Dulbecco’s Modified Eagle’s Medium (DMEM) for 45 
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minutes. Sterols were then added back as soluble MCD complexes. After 3 hours, the cells were 
harvested and hShh processing was assayed by immunoblotting. 
 
Photocrosslinking in cells 
 Human 293T cells stably expressing myc-tagged DispA and hShh constructs were sterol-
depleted, followed by incubation with sterol-MCD complexes (75 µM for cholesterol and 25-
azicholesterol, and 25 µM for 6-azicholestanol) in OptiMEM (Invitrogen), for 2 hours. After 
washing with OptiMEM, cells were incubated for 6 hours, followed by UV irradiation for 10 
minutes on ice. The cells were harvested and DispA constructs were subjected to denaturing 
immunoprecipitation with anti-myc antibodies (9E10) followed by SDS-PAGE and 
immunoblotting with rabbit anti-hShhN antibodies (Cell Signaling). A similar protocol was used 
to detect interaction of hShh to HA-tagged Scube2 in cells. 
 
Photocrosslinking in vitro 
 A fragment of Drosophila Hedgehog comprising amino acids 244-471 was expressed and 
purified from bacteria as a soluble maltose-binding protein (MBP) fusion (Chen et al., 2011), and 
was used to generate photoreactive sterol-modified MBP by in vitro processing. Sterol-modified 
MBP was incubated for 1 hour with HA-tagged Scube2 or Scube2!CUB, followed by UV 
irradiation for 10 minutes on ice. The samples were analyzed by SDS-PAGE and 





 293T cells stably expressing hShh were washed several times with DMEM to remove 
serum, and were incubated in DMEM, with or without the indicated factors. At the indicated 
time, the culture medium was harvested and secreted protein was analyzed by either precipitation 
with trichloroacetic acid followed by SDS-PAGE and immunoblotting, or by Hh reporter assays. 
 
Reporter assays 
 Hh activity was assayed in Shh Light II cells (Taipale et al., 2000). After incubation for 
30 hours, firefly luciferase (expressed under control of a Hh-responsive promoter) and Renilla 
luciferase (expressed under control of a constitutive promoter) were measured using the Dual-
Glo kit (Promega). Hh pathway activity was calculated as the firefly/Renilla ratio, normalized to 
1 for unstimulated cells. Each experiment was performed in triplicate, and error bars represent 
standard deviation of the mean. For co-culture assays, 293T cells or DispA-/- MEFs expressing 
various hShh, DispA and Scube2 constructs were plated together with Shh Light II cells. After 
12 hours, serum was washed off and the cells were incubated for 30 hours in serum-free media, 
followed by luciferase reporter assays. 
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In vertebrates, Hedgehog (Hh) signaling initiated in primary cilia activates the 
membrane protein Smoothened (Smo) and leads to activation of Gli proteins, the 
transcriptional effectors of the pathway. In the absence of signaling, Gli proteins are 
inhibited by the cytoplasmic protein Suppressor of Fused (SuFu). It is unclear how Hh 
activates Gli and whether it directly regulates SuFu. We find that Hh stimulation quickly 
recruits endogenous SuFu-Gli complexes to cilia, suggesting a model in which Smo 
activates Gli by relieving inhibition by SuFu. In support of this model, we find that Hh 
causes rapid dissociation of the SuFu-Gli complex, thus allowing Gli to enter the nucleus 
and activate transcription. Activation of protein kinase A (PKA), an inhibitor of Hh 
signaling, blocks ciliary localization of SuFu-Gli complexes, which in turn prevents their 
dissociation by signaling. Our results support a simple mechanism in which Hh signals at 




The Hedgehog (Hh) cell-cell signaling pathway is conserved in animals and has 
critical roles in embryonic development, in the maintenance of adult stem cells and in 
cancer (Huangfu and Anderson, 2006; Kalderon, 2005; Lum and Beachy, 2004; Rohatgi 
and Scott, 2007). In the resting state of Hh signaling, the transcriptional output of the 
pathway is kept off by the membrane protein Patched (Ptc), which inhibits the seven-
spanner Smoothened (Smo) (Alcedo et al., 1996). The Hh pathway is activated when the 
secreted protein Hh binds and inactivates Ptc (Marigo et al., 1996; Stone et al., 1996), 
Chapter Four 
 126 
thus relieving the inhibition exerted on Smo, which becomes active. Active Smo signals 
to the cytoplasm, leading to the activation of the zinc finger transcription factors that 
control the output of the Hh pathway, Cubitus interruptus (Ci) in Drosophila (Aza-Blanc 
et al., 1997; Ohlmeyer and Kalderon, 1998) and the Gli proteins (Gli1, 2, and 3) in 
vertebrates. 
A unique feature of vertebrate Hh pathway is that primary cilia are essential for 
signal transduction (Huangfu and Anderson, 2005), and the initial membrane events 
occur at cilia. Ptc is located at the base of the primary cilium (Rohatgi et al., 2007), and 
binding of Hh to Ptc leads to activation and recruitment of Smo to the cilium (Corbit et 
al., 2005; Rohatgi et al., 2007). Through an unknown mechanism, active Smo at the 
cilium relays Hh signals to the cytoplasm, resulting in the activation of Gli2 and Gli3 
(Lipinski et al., 2006; Ohlmeyer and Kalderon, 1998; Wang et al., 2000), which control 
transcription of Hh target genes (Alexandre et al., 1996; Dai et al., 1999; Ruiz i Altaba, 
1998). Since the discovery that Ptc and Smo function at the vertebrate primary cilium, an 
important question has been to understand how signaling through these upstream 
components of the Hh pathway couples to activation of the downstream Gli proteins. 
An early study showed that Gli proteins localize to cilia in vertebrate limb bud 
cells (Haycraft et al., 2005); however, the relationship between ciliary localization and 
the state of Hh signaling was not investigated. Recently, Gli2 and Gli3 were shown to be 
recruited to the tip of primary cilia upon Hh stimulation (Chen et al., 2009; Kim et al., 
2009; Wen et al., 2010), consistent with the idea that activation of Gli2 and Gli3 by Hh 
signaling occurs at cilia; however, the mechanism by which Gli proteins are activated at 
cilia has not been clarified. 
Chapter Four 
 127 
In the cytoplasm of unstimulated cells, two major negative regulators ensure that 
the vertebrate Hh pathway is kept off. The first negative regulator is the Gli-binding 
protein Suppressor of Fused (SuFu), which in vertebrates is essential for repressing Hh 
signaling: in cells lacking SuFu, the Hh pathway is maximally activated in a ligand-
independent manner (Cooper et al., 2005; Svard et al., 2006). SuFu is thought to inhibit 
Gli proteins by preventing their nuclear translocation (Ding et al., 1999; Kogerman et al., 
1999; Methot and Basler, 2000). Interestingly, constitutive activation of the Hh pathway 
in the absence of SuFu is independent of cilia (Jia et al., 2009), suggesting that Hh 
signaling at cilia may activate Gli proteins by inhibiting SuFu. 
The second major negative regulator of Hh signaling is protein kinase A (PKA). 
In Drosophila, PKA phosphorylates Ci and loss of PKA leads to Hh pathway activation 
(Jiang and Struhl, 1995; Lepage et al., 1995; Li et al., 1995; Price and Kalderon, 1999), 
while overexpression of PKA inhibits Hh signaling (Li et al., 1995). The inhibitory effect 
of PKA is conserved in vertebrate Hh signaling (Concordet et al., 1996; Epstein et al., 
1996) and, interestingly, depends on SuFu (Chen et al., 2009; Svard et al., 2006), 
suggesting that PKA might inhibit Gli proteins by modulating their interaction with 
SuFu. 
Although SuFu is essential for inhibiting Gli in unstimulated cells, it is unclear if 
Hh signaling regulates SuFu. In one model, SuFu is a simple buffer for Gli, and is not 
regulated by Hh signaling. This model is consistent with a recent study (Chen et al., 
2009), which found that Hh stimulation does not affect the interaction between 
overexpressed Gli2 and Gli3, and SuFu; however, the relevance of this result for normal 
Hh signaling is unclear, given the non-physiological levels of Gli and SuFu proteins 
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produced by transient transfection. In another model, Hh signaling at cilia activates Gli 
proteins by relieving SuFu inhibition, resulting in Gli nuclear translocation and 
transcriptional activation. This simple model is consistent with at least two findings:  1) 
the Hh pathway is constitutively active in SuFu-/- cells independent of cilia (Chen et al., 
2009; Jia et al., 2009), suggesting that active Smo at cilia might signal by inhibiting 
SuFu; and 2) activation of PKA by forskolin inhibits signaling by active Smo in cells that 
have SuFu (Wu et al., 2004), but cannot block constitutive signaling caused by loss of 
SuFu (Chen et al., 2009; Svard et al., 2006), suggesting that Smo and PKA might exert 
their opposing effects on Hh signaling through SuFu. 
To begin deciphering how active Smo at the cilium activates Gli proteins, we 
examined the behavior of endogenous SuFu, Gli2, and full-length Gli3 (Gli3-FL) in Hh-
responsive mammalian cultured cells. Focusing on endogenous proteins avoided 
problems associated with misregulation of overexpressed proteins. Furthermore, we 
analyzed biochemically the effect of Hh signaling on endogenous SuFu-Gli protein 
complexes, after brief Hh pathway stimulation, to avoid any confounding secondary 
effects due to prolonged pathway stimulation. Our results complement and extend the 
findings of a recent study (Humke et al., 2010) that described how Hh signaling leads to 
the dissociation of SuFu from Gli. Specifically, our study demonstrates that Hh 
stimulation through active Smo leads to the recruitment of endogenous SuFu-Gli 
complexes to cilia, and causes the rapid dissociation of a defined SuFu-Gli complex. 
Activation of PKA blocks localization of SuFu-Gli complexes to cilia and inhibits their 
dissociation by Smo, providing an explanation for how PKA inhibits Hh signaling: by 
uncoupling Smo activation from dissociation of SuFu-Gli complexes. We propose that 
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vertebrate Hh signals are transduced by active Smo at the primary cilium by dissociating 
inhibitory SuFu from Gli, and that a protein complex that likely contains only SuFu and 
Gli forms the core of vertebrate Hh signal transduction downstream of Smo. 
 
RESULTS 
Hedgehog stimulation quickly recruits endogenous SuFu and Gli proteins to the 
cilium 
Tagged SuFu and Gli proteins localize to primary cilia in vertebrate cells 
(Haycraft et al., 2005). To study the subcellular dynamics of SuFu and Gli during Hh 
signaling and to avoid expressing proteins at non-physiological levels, we raised 
polyclonal antibodies that specifically detect endogenous mouse SuFu, Gli2, and Gli3 in 
Hh-responsive cells (Supplemental Figure 4.S1). We first used these antibodies to 
examine how Sonic hedgehog (Shh) stimulation affects subcellular localization of 
endogenous SuFu, Gli2 and Gli3-FL (Figure 4.1A). Without Shh stimulation, low levels 
of SuFu, Gli2, and Gli3-FL were detected at cilia in NIH-3T3 cells and in MEFs; in 
contrast, Smo was absent from cilia in the absence of Shh stimulation (Figure 4.1A, B; 
see also Supplementary Table 4.1 for SuFu, Gli, and Smo behavior in all cell lines used 
in this study). Hh stimulation led to the dramatic increase in the localization of SuFu, 
Gli2, and Gli3-FL to cilia (Figure 4.1A), similar to that recently reported for endogenous 
or overexpressed Gli2 and Gli3 (Chen et al., 2009; Kim et al., 2009; Wen et al., 2010) 
and paralleling the recruitment of Smo to cilia (Rohatgi et al., 2007). Previous studies 
(Chen et al., 2009) failed to detect a signal-dependent recruitment of SuFu to cilia; one 
reason for this discrepancy might be that our antibodies are more sensitive than the 
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commercial antibodies used for SuFu detection. Our other findings (that SuFu and Gli 
form a complex and that SuFu localization to cilia is strictly dependent on Gli – see 
below) are consistent with the Hh-stimulated recruitment of SuFu to cilia that we 
observed. 
Recruitment of SuFu, Gli2, Gli3-FL and Smo was very rapid: strong ciliary 
localization of all these proteins was seen in as little as 30 minutes after addition of Shh 
to cells. The number of cilia positive for SuFu, Gli2, Gli3-FL and Smo continued to 
increase with time (Figure 4.1B). We conclude that, although low amounts of SuFu and 
Gli proteins are present at cilia in unstimulated cells, the ciliary levels of these proteins 
quickly rise upon Hh stimulation. 
SuFu, Gli2, and Gli3-FL show very similar “comet tail” patterns at the cilium, 
with the highest accumulation at the distal tip (Figure 4.1C). This pattern is different from 
that of Smo, which localizes along the entire length of the cilium, often at higher level 
towards its base (Figure 4.1A, C). Identical results were obtained when the Hh pathway 
was activated by the oxysterols 20-hydroxycholesterol (20-OHC) and 25-
hydroxycholesterol (25-OHC) (Corcoran and Scott, 2006; Dwyer et al., 2007) 
(Supplemental Figure 4.S2A), as well as by the synthetic Smo activator, SAG (Chen et 





Figure 4.1 Endogenous SuFu is rapidly recruited to primary cilia by Hh signaling, paralleling 




Figure 4.1 (Continued) 
A) Fluorescence micrographs of cilia from untreated cells or cells treated with Shh. Cilia were detected by 
staining against acetylated tubulin. Since the anti-GliC antibody detects both Gli2 and Gli3-FL, Gli2-/- and 
Gli3-/- mouse embryonic fibroblasts (MEFs) are shown to demonstrate ciliary recruitment of Gli2 and 
Gli3-FL separately. In all panels, the tip of the cilium points to the left. Scale bar is 2 µm. 
B) Cells were treated with Shh for varying amounts of time, and ciliary recruitment of SuFu, Smo, Gli2 and 
Gli3-FL was determined. Data shown are mean ± SD for three independent counts. Asterisks indicate P 
value for ciliary recruitment at one hour, compared to t=0 (one asterisk P<0.05, two asterisks P<0.01, three 
asterisks P<0.001). P<0.05 for all later time points. 
C) In NIH-3T3 cells stimulated with Shh for 1 hr, SuFu and Gli proteins localize at the tip, while Smo 
localizes along the length of cilia. Cilia were stained as in (A) and centrioles were stained with anti-!-
tubulin. 
D) Endogenous SuFu and Gli proteins co-localize at the tips of primary cilia in SAG-treated NIH-3T3 cells. 
Left panels: cilia co-stained for endogenous SuFu (rabbit antibody) and Gli (goat antibody). Right panels: 
cilia co-stained for Smo (rabbit antibody) and Gli (goat antibody). 
E) Cilia counts for the experiment in (D), left panels. Endogenous SuFu and Gli co-localize, both in the 
resting and the stimulated states of the Hh pathway. 
F) Recruitment of SuFu, Smo, and Gli to cilia in response to Hh stimulation does not require new protein 
synthesis. Ciliary localization was determined in NIH-3T3 cells treated or not with Shh, in the presence or 
absence of cycloheximide (CHX). 
G) Inhibition of protein synthesis does not block the transcriptional output of the Hh pathway. 
Transcription of the direct transcriptional targets, Gli1 and Ptch1 was assayed by Q-PCR after 3 and 6 
hours of stimulation with Shh, in the presence or absence of CHX.  
 
 
The similar localization pattern of SuFu and Gli at the tips of cilia, and the fact 
that SuFu binds Gli proteins (Pearse et al., 1999) suggests that SuFu and Gli likely 
localize to the cilium as a complex. Co-staining for endogenous SuFu and Gli (using a 
goat anti-Gli antibody, Supplemental figure 4.S1E) shows identical patterns at cilia 
(Figure 4.1D); furthermore, SuFu and Gli always appear together in cilia, both in the 
unstimulated and stimulated states of Hh signaling (Figure 4.1E). We thus propose that 
Hh stimulation quickly recruits SuFu-Gli complexes to cilia, suggesting that the 





Recruitment of endogenous SuFu and Gli proteins to the cilium does not require 
new protein synthesis 
Although the rapid recruitment of SuFu, Gli and Smo suggests that it represents 
an immediate response to Hh activation, results from Drosophila cultured cells showed 
that protein synthesis is required for certain aspects of Hh signal transduction (Lum et al., 
2003). In contrast to Drosophila cells, we find that in Shh-stimulated NIH-3T3 cells, 
inhibiting protein synthesis does not block the recruitment of endogenous SuFu, Gli, and 
Smo to cilia (Figure 4.1F and Supplemental Figure 4.S2B, C) or the transcriptional 
activation of Hh target genes (Figure 4.1G). Also in contrast to Drosophila cells, we did 
not observe any change in the electrophoretic mobility of SuFu or SuFu levels upon 
stimulation of the Hh pathway in NIH-3T3 cells or in MEFs (Supplemental Figure 
4.S4A, B). Recruitment of SuFu and Gli protein to cilia is thus an immediate response to 
Hh stimulation. 
 
Uncoupling ciliary recruitment of SuFu and Gli from the transcriptional response to 
Hh signaling: the role of dynamic microtubules 
Recruitment of SuFu, Gli and Smo to cilia upon Shh stimulation is not affected 
when microtubules (MTs) are depolymerized with nocodazole (Noc, Supplemental 
Figure 4.S2D, E), suggesting that these proteins do not need dynamic MTs to arrive at the 
ciliary base. Noc does not disrupt the stable MTs of primary cilia (Supplemental Figure 
4.S2F), suggesting that in the presence of Noc, motors such as Kif3a (Kovacs et al., 
2008) and Kif7 (Cheung et al., 2009; Endoh-Yamagami et al., 2009; Liem et al., 2009), 
which were implicated in Hh signaling, can still move along ciliary MTs, explaining the 
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proper SuFu, Gli and Smo localization to cilia. Interestingly, Noc inhibits Hh 
transcriptional responses in a dose-dependent manner (Supplemental Figure 4.S2G). Thus 
dynamic MTs are not required for recruitment of SuFu, Gli and Smo to cilia, but are 
required for the transcriptional output of the pathway. We speculate that dynamic MTs 
are required downstream of ciliary events, such as the transport of Gli from cilia to the 
nucleus (Humke et al., 2010; Kim et al., 2009). 
 
Active Smo is required for the recruitment and continued maintenance of SuFu and 
Gli to cilia 
Low levels of SuFu and Gli localize to cilia even in unstimulated cells, and do not 
require Smo, as seen in Smo-/- MEFs (Supplemental Figure 3-S3A). Shh stimulation of 
Smo-/- MEFs does not increase ciliary SuFu and Gli, indicating that signal-dependent 
recruitment of SuFu and Gli requires Smo. 
Active Smo translocates to cilia during normal Hh signaling, but inactive Smo can 
be pharmacologically forced to localize to cilia with the Smo inhibitor cyclopamine (Cyc) 
(Rohatgi et al., 2009; Wang et al., 2009; Wilson et al., 2009). Thus Smo might recruit 
SuFu and Gli to cilia irrespective of its activation state; alternatively, only active Smo 
recruits SuFu and Gli.  To distinguish between these two alternatives, we compared 
SuFu, Gli and Smo localization in cells treated with SAG (Chen et al., 2002; Frank-
Kamenetsky et al., 2002) or Cyc (Taipale et al., 2000). While both SAG and Cyc 
recruited Smo to cilia, SuFu and Gli were recruited only by SAG but not by Cyc (Figure 
4.2A-C), demonstrating that only active Smo recruits SuFu and Gli to cilia. 
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We next asked if maintaining high levels of SuFu and Gli in cilia is continuously 
dependent on active Smo. We first activated Hh signaling by addition of Shh, followed 
by Smo inhibition with Cyc; in this manner, Smo is inactivated without changing its 
ciliary localization. When Smo, SuFu, and Gli were recruited to cilia by Shh stimulation, 
addition of Cyc caused the levels of SuFu and Gli at the cilium to drop, while levels of 
Smo continued to rise (Figure 4.2D). Similar kinetics for the exit of SuFu and Gli from 
cilia were seen when cells were first stimulated with Shh, followed by Smo inhibition 
with the small molecule inhibitor, SANT-1 (Figure 4.2E). Smo inhibited by SANT-1 
exited cilia more rapidly than SuFu and Gli proteins. Taken together, these experiments 
demonstrate that active Smo at cilia is required for maintaining high levels of SuFu and 




Figure 4.2 Hh-dependent recruitment of SuFu and Gli proteins to cilia requires active Smo. 
A) NIH-3T3 cells were treated with the Smo agonist, SAG, or with the antagonist cyclopamine (Cyc). SuFu 
and Gli are recruited to cilia by SAG but not by Cyc, although both SAG and Cyc recruit Smo to cilia. In 
all panels, the tips of cilia point to the left. Scale bar is 2 µm. 
B) Cilia counts for the experiment in (A). 
C) Q-PCR assay of Hh pathway target genes for the experiment in (A).  
D) Maintaining increased levels of SuFu and Gli at cilia is continuously dependent on active Smo. Cyc was 
added in the presence of Shh to NIH-3T3 cells, pre-stimulated with Shh for 3 hours. Ciliary localization 
was determined before and after 3 hours of Shh stimulation, and after 1 and 3 hours following Cyc 
addition. 
E) NIH-3T3 cells were stimulated with Shh for 3 hrs, followed by incubation with the Smo antagonist, 
SANT-1 for 3 hrs. Ciliary localization of SuFu, Gli and Smo was measured at the indicated times. P values 
were all less than 0.002 for the recruitment of Smo, SuFu and Gli by Shh stimulation. P values for exit from 
the cilium were calculated relative to ciliary localization after 3 hrs of Hh stimulation. Asterisks indicate 






Figure 4.3  Localization of endogenous SuFu and Gli to cilia is antagonized by protein kinase A 
(PKA). 
A) Activation of PKA by forskolin (FSK) blocks localization of endogenous SuFu and Gli proteins to cilia. 
NIH-3T3 cells were treated with or without Shh and FSK.  Shh, FSK, or Shh and FSK recruit Smo to the 
cilium; in contrast, endogenous SuFu and Gli are removed from cilia by FSK, both in the presence and 
absence of Shh stimulation. Scale bar is 2 µm. 
B) Cilia counts for the experiment in (A).   
C) Q-PCR analysis of the experiment in (A). Inhibition of SuFu and Gli ciliary localization by FSK 
correlates with complete inhibition of the transcriptional output of the Hh pathway. 
D) FSK inhibits localization of SuFu and Gli to primary cilia in Smo-/- MEFs. The percentages under the 
bottom panels indicate corresponding ciliary counts. 
E) NIH-3T3 cells were incubated with or without Shh (the two left-most lanes), or with or without FSK 
(the two right-most lanes), followed by immunoblotting for SuFu, Gli3-FL, GSK3 and !-tubulin. The 
numbers above the top panel indicate levels of Gli3-FL in each lane, relative to !-tubulin. FSK treatment 
causes only a slight reduction in Gli3-FL, much smaller than the decrease caused by Shh. 
F) NIH-3T3 cells stably expressing a Gli1-SuFu fusion were incubated with control media, SAG, or FSK. 
The Gli1-SuFu fusion localizes to cilia in unstimulated cells and its localization is increased by SAG. FSK 
treatment completely blocks ciliary localization of the Gli1-SuFu fusion. Percentages below the lower 





Activation of protein kinase A (PKA) blocks ciliary trafficking of endogenous SuFu 
and Gli 
PKA is a negative regulator of the Hh pathway and forskolin (FSK), which 
activates PKA, is a potent inhibitor of Hh signaling. Recently, FSK was shown to recruit 
Smo to the cilium without activation of Hh signaling (Wilson et al., 2009). Interestingly, 
FSK treatment abolishes the ciliary localization of SuFu and Gli in both unstimulated and 
Shh-stimulated cells (Figure 4.3A and B), correlating with a complete inhibition of the 
transcriptional response to Hh stimulation (Figure 4.3C). We next asked if the effect of 
FSK on SuFu and Gli localization to cilia depends on Smo. SuFu and Gli localize to the 
tips of cilia in Smo-/- MEFs (Supplemental Figure 4.S3A), and FSK causes a strong 
decrease in ciliary SuFu and Gli (Figure 4.3D), demonstrating that FSK prevents SuFu-
Gli ciliary localization independently of Smo. 
One possible explanation for the dramatic inhibition of SuFu-Gli localization to 
cilia by FSK is an increased degradation of Gli proteins; indeed, FSK promotes partial 
proteolysis of overexpressed Gli2 and Gli3-FL (Pan et al., 2006; Wang and Li, 2006). In 
cells treated with FSK, endogenous SuFu levels do not change, and Gli3-FL levels 
decrease only modestly (much less than the decrease caused by Shh stimulation, figure 
3E), demonstrating that absence of SuFu-Gli from cilia in the presence of FSK is not due 
to degradation of SuFu or Gli proteins. Another explanation is that FSK blocks ciliary 
localization of the SuFu-Gli complex by promoting its dissociation. We excluded this 
possibility using 3T3 cells stably expressing a direct fusion between Gli1 and SuFu, in 
which FSK completely abolishes ciliary localization of the fusion (Figure 4.3F), without 
significantly affecting its expression level (Supplemental Figure 4.S3B). This effect of 
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FSK is mediated by PKA, as it is reversed by the small molecule inhibitor of PKA, H-89 
(Supplemental Figure 4.S3C). Furthermore, in FSK-treated cells, binding between 
endogenous SuFu and Gli3-FL is unaffected (Figure 4.5I). We conclude that activation of 
PKA by FSK blocks ciliary trafficking of the SuFu-Gli complex, providing a 




Figure 4.4  Gli proteins are required to localize SuFu to cilia but Gli proteins can localize to cilia in 
the absence of SuFu 
A) Wild-type and Gli2-/- Gli3-/- MEFs were incubated with or without Shh. SuFu does not localize to cilia, 
with or without Shh stimulation in Gli2-/- Gli3-/- MEFs, while Smo recruitment is normal. Scale bar is 2 
µm. 
B) Cilia counts for a time course of ciliary recruitment of Smo, SuFu, and Gli in Gli2-/- Gli3-/- MEFs 
stimulated with Shh. 
C) SuFu+/- and SuFu-/- MEFs were stimulated or not with Shh. Endogenous Gli proteins do not localize to 





Figure 4.4 (Continued) 
D) Immunoblot of SuFu-/- and SuFu+/- MEFs, stably expressing HA-tagged Gli1 (Gli1HA) and treated 
with the proteasome inhibitor bortezomib. Proteasome inhibition allows SuFu-/- cells to accumulate 
Gli1HA to levels similar to those in the control SuFu+/- cells.  
E) Stably expressed Gli1HA localizes to ciliary tips in SuFu-/- MEFs stimulated with SAG, in the presence 
of bortezomib. Percentages below the lower panels indicate corresponding ciliary counts. 
 
 
Gli proteins are required to recruit SuFu to cilia but Gli proteins can localize to cilia 
in the absence of SuFu 
Since SuFu and Gli interact, we asked if they require each other for ciliary 
localization, by examining localization of Gli and SuFu in MEFs lacking SuFu and Gli 
proteins, respectively. Gli proteins are necessary for SuFu localization to cilia: in Gli2-/- 
Gli3-/- MEFs (Lipinski et al., 2006), SuFu is completely absent from cilia, with or 
without Shh stimulation (Figure 4.4A and B), although SuFu levels are normal 
(Supplemental Figure 4.S4A); this excludes SuFu degradation as causing its absence 
from cilia in cells without Gli2 and 3. Importantly, Smo recruitment to cilia was normal 
in Gli2-/- Gli3-/- MEFs (Figure 4.4A and B), showing that ciliary transport and upstream 
Hh signaling were intact in these cells, and that localization of Smo to cilia does not 
depend on SuFu and Gli proteins. Either Gli2 or Gli3 is sufficient to localize SuFu to 
cilia, as seen in Gli2-/- and Gli3-/- MEFs (Figure 4.1A and B). Taken together, these 
findings argue in favor of the recruitment of SuFu-Gli2 and SuFu-Gli3 complexes to 
cilia. 
We next asked if, conversely, SuFu is required for localizing Gli proteins to cilia. 
In SuFu-/- MEFs, Gli proteins do not localize to cilia, with or without Shh stimulation, 
although Smo recruitment is normal (Figure 4.4C and Supplemental Figure 4.S3D). 
Localization of Gli to cilia was restored by stable expression of SuFu in SuFu-/- MEFs 
(Supplemental Figure 4.S3E).  One explanation for the absence of Gli proteins from cilia 
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in SuFu-/- cells is the dramatically reduced Gli levels in the absence of SuFu (Chen et al., 
2009; Ohlmeyer and Kalderon, 1998). Indeed, in SuFu-/- MEFs, Gli3-FL is dramatically 
decreased compared to SuFu+/- MEFs (Supplemental Figure 4.S3F), and 
pharmacological inhibition of the proteasome only partially rescues Gli3-FL levels. To 
overcome the instability of Gli proteins, we generated SuFu-/- cells stably overexpressing 
HA-tagged Gli1 (Gli1HA), which we stabilized by proteasomal inhibition with 
bortezomib. This treatment allowed Gli1HA to accumulate in SuFu-/- MEFs to levels 
similar to those in the SuFu+/- MEFs (Figure 4.4D). Under these conditions, some 
Gli1HA can be detected in cilia of SuFu-/- MEFs (Figure 4.4E), demonstrating that at 
least Gli1 can localize to cilia in the absence of SuFu, as demonstrated for transiently 
transfected Gli proteins (Chen et al., 2009). In SuFu-/- cells, Gli1HA was concentrated in 
the nucleus, while in SuFu+/- cells it was excluded from the nucleus (Supplemental 
Figure 4.S3G), consistent with the proposed mechanism of SuFu inhibition by 
sequestering Gli proteins in the cytoplasm (Ding et al., 1999; Kogerman et al., 1999; 
Methot and Basler, 2000). Nuclear accumulation of Gli1 in the absence of SuFu might 
also explain why ciliary levels of Gli1HA in SuFu-/- cells were lower than in SuFu+/- 
cells expressing comparable amounts of Gli1HA (Figure 4.4E).  
 
Hh stimulation causes the rapid disappearance of a defined SuFu-Gli complex  
Our cellular studies of endogenous SuFu and Gli proteins suggested that active 
Smo at cilia relays the signal to cytoplasmic SuFu-Gli complexes. As SuFu blocks 
nuclear import of Gli proteins, the major mechanistic question is how active Smo at the 
cilium modifies the SuFu-Gli complex to allow Gli activation and nuclear entry. Since 
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Hh signaling can occur in the absence of new protein synthesis (Figure 4.1F, G), we 
hypothesized that signaling must regulate SuFu-Gli complexes posttranslationally. To 
identify possible changes in endogenous SuFu-Gli complexes caused by Hh stimulation, 
we turned to measuring the size of native protein complexes by sucrose gradient 
centrifugation (Martin and Ames, 1961) of cellular lysates.  Since prolonged Hh signaling 
causes a decrease in the level of Gli proteins (Supplemental Figure 4.S4A-C), we 
examined the effect of brief Hh stimulation (1-1.5 hours). Given that SuFu and Gli 
proteins are recruited to cilia within 30 minutes or less, we reasoned that such a brief 
period of pathway activation should be sufficient to observe changes in SuFu-Gli 
complexes.  
NIH-3T3 cells were stimulated or not with Shh for 1 hour, after which they were 
lysed and SuFu was analyzed by sucrose gradient centrifugation. The majority of 
endogenous SuFu (MW=54 kDa) migrates as a small molecular weight peak (Figure 5A), 
similar in size and shape to the peak of glycogen synthase kinase 3 (GSK3, MW=47 
kDa). This hydrodynamic behavior indicates that most SuFu in cells is present as a 
monomer. In untreated cells, a small fraction of SuFu appears in fractions of higher 
Stokes radius (Figure 4.5A, top panel), consistent with SuFu associating with other 
proteins. Stimulating cells with Shh for 1 hour causes the dramatic decrease of the higher 
molecular weight SuFu (Figure 4.5A, middle panel), an effect that is completely reversed 
by the small molecule Smo inhibitor, SANT1 (Figure 4.5A, bottom panel). In another 
experiment, a 1.5-hour stimulation of NIH-3T3 cells with the Smo agonist, SAG, causes 




Figure 4.5  Biochemical evidence that Hh pathway activation causes rapid dissociation of endogenous 
SuFu-Gli complexes. 
Endogenous SuFu-Gli complexes were analyzed by sucrose gradient centrifugation (A-G) and by 
immunoprecipitation (H, I). 
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Figure 4.5 (Continued) 
A) In untreated NIH-3T3 cells, the majority of endogenous SuFu (MW=54 kDa) exists as a monomer, of 
similar size as the kinase GSK3! (MW=47 kDa). A small fraction of SuFu from untreated cells forms a 
higher molecular weight complex (top panel, overlined in black), the level of which quickly drops in cells 
treated with Shh for 1 hour (middle panel), an effect completely blocked if Smo is inhibited with SANT-1 
(200 nM, bottom panel). The position in the gradient of two size markers run in parallel is shown below the 
Western blots: aldolase, MW= 158 kDa, Stokes radius=48.1 Angstrom; and catalase, MW=232 kDa, Stokes 
radius=52.2 Angstrom. 
B) In Gli2-/- Gli3-/- MEFs, only the monomeric SuFu peak is seen by sucrose gradient centrifugation. Hh 
stimulation of Gli2-/- Gli3-/- MEFs does not change the size of the SuFu peak, although Smo is recruited to 
the cilia normally in these cells. 
C) As in (A) but cells were stimulated or not with SAG and sucrose gradient fractions were immunoblotted 
for endogenous SuFu, GSK3, and Gli3-FL. The higher molecular weight SuFu peak overlaps with 
endogenous Gli3-FL in unstimulated cells. Acute Hh pathway stimulation causes the simultaneous 
disappearance of the overlapping, higher molecular weight SuFu and Gli3-FL peaks. 
D) To prevent dissociation of SuFu from Gli, a direct fusion of Gli1 to SuFu was generated. NIH-3T3 cells 
stably expressing this Gli1-SuFu fusion were stimulated or not with SAG. The apparent size of the Gli1-
SuFu fusion peak does not change upon Hh pathway activation. 
E) Treatment of NIH-3T3 cells with SAG causes complete disappearance of the SuFu-Gli complex, which 
is not reversed by inhibition of the proteasome with bortezomib. In contrast, activation of PKA with 
forskolin (FSK) completely blocks SuFu-Gli dissociation induced by SAG stimulation. 
F) Quantification of the experiment in (E). The amount of SuFu in each fraction was measured relative to 
the amount of SuFu in the input lane. The first fraction represents the top of the sucrose gradient. 
G) Mouse SuFu expressed in Xenopus embryos shows the same size distribution as endogenous SuFu in 
mammalian cultured cells, suggesting that SuFu forms a similar complex with endogenous Gli proteins in 
Xenopus embryos. 
H) NIH-3T3 cells were incubated with or without SAG, followed by immunoprecipitation with anti-SuFu 
antibodies. The level of Gli3-FL is similar in SAG-treated and in untreated cells (left panels). Gli3-FL co-
immunoprecipitates with SuFu only in untreated cells but not in SAG-stimulated cells (right panels), 
indicating that acute Hh pathway activation dissociates endogenous Gli3-FL from SuFu. 
I) NIH-3T3 cells were incubated with control media, SAG, SAG and bortezomib, and SAG and FSK, 
followed by immunoprecipitation with anti-Gli3-FL antibodies. Gli2-/-Gli3-/- MEFs were used as negative 
control (lanes 1 and 6). Endogenous SuFu does not co-immunoprecipitate with Gli3-FL in cells stimulated 
with SAG, although levels of Gli3-FL decrease only slightly. Proteasome inhibition by bortezomib 
(sufficient to abolish any decrease in the level of Gli3-FL) does not block dissociation of endogenous SuFu 
from Gli3-FL. In contrast, SAG-induced dissociation of SuFu from Gli3-FL is completely blocked by FSK. 
 
 
Two lines of evidence demonstrate that the high molecular weight SuFu species is 
a SuFu-Gli complex: 1) The SuFu complex is absent from Gli2-/- Gli3-/- MEFs (Lipinski 
et al., 2006), in which only monomeric SuFu is seen on sucrose gradients (Figure 5B, top 
panel). This also indicates that SuFu is dedicated to binding Gli proteins and, in their 
absence, SuFu does not stably associate with other proteins. Additionally, the size of 
endogenous SuFu in Gli2-/- Gli3-/- cells does not change upon Hh pathway stimulation 
(Figure 4.5B, bottom panel), indicating that signaling specifically couples to SuFu-Gli 
complexes and not to monomeric SuFu. 2) The high molecular weight SuFu complex 
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overlaps with a Gli3-FL peak (Figure 5C, top panel), and Hh stimulation causes the 
simultaneous disappearance of the high molecular weight SuFu and Gli3-FL peaks 
(Figure 4.5C, bottom panel). Taken together, these data demonstrate that Hh stimulation 
causes the quick disappearance of the SuFu-Gli complex. 
Although we do not know the shape of the SuFu-Gli complex and thus cannot 
determine its exact size, its migration on sucrose gradients is consistent with the 
calculated size of a 1:1 complex (54+172=226 kDa for a mouse SuFu-Gli3-FL complex), 
suggesting that the complex might contain only one molecule of SuFu and Gli3-FL. To 
examine if SuFu behavior is conserved in other vertebrate systems, we determined the 
sucrose gradient profile of SuFu expressed in Xenopus embryos (Figure 4.5G), and found 
it very similar to that in NIH-3T3 cells, suggesting that SuFu forms complexes of a 
similar size with endogenous Gli proteins in Xenopus embryos. 
 
The SuFu-Gli complex dissociates in response to Hh signaling 
We considered two possibilities for the mechanism underlying the disappearance 
of the SuFu-Gli complex in response to Hh stimulation: 1) the SuFu-Gli complex 
disappears through proteolysis, either of SuFu or Gli; and 2) the SuFu-Gli complex 
disappears due to dissociation. Our results support the idea that Hh stimulation causes the 
dissociation of the SuFu-Gli complex. 
A recent study suggested that Hh signaling triggers the proteasomal degradation 
of SuFu in certain cancer cells (Yue et al., 2009). We find that in NIH-3T3 cells, neither 
the steady-state level nor the half-life of SuFu changes upon Shh stimulation 
(Supplemental Figure 4.S4A-E), suggesting that Hh signaling does not affect bulk SuFu 
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levels or stability. It is, however conceivable that Hh signaling might stimulate 
degradation of the small fraction of SuFu in SuFu-Gli complexes, but that the size of this 
pool is too small to detect. We excluded this possibility by blocking proteasomal 
degradation with the small molecule, bortezomib (see below). 
The levels of both Gli3-FL and Gli3-R (Supplemental Figure 4.S4A-C), and the 
half-life of Gli3-FL (Supplemental Figure 4.S4D, E) decrease following Hh pathway 
activation; it is thus possible that the disappearance of the SuFu-Gli complex reflects the 
increased turnover of Gli caused by Hh signaling. The following results show that SuFu-
Gli dissociation and not Gli degradation is responsible for the disappearance of the SuFu-
Gli complex: 1) the SuFu-Gli complex disappears after as little as 1.5 hours of SAG 
stimulation, which has little or no effect on Gli3-FL levels (Figure 4.5H and I); 2) the 
SuFu-Gli complex disappears even when the proteasome is blocked with high levels of 
bortezomib (Figure 4.5E, F and I), which are sufficient to completely block Gli3-FL 
degradation (see also Supplemental Figure 4.S4B); and 3) if dissociation is prevented by 
fusing SuFu and Gli1, the size of the stably expressed covalent SuFu-Gli1 complex no 
longer changes in response to Hh stimulation (Figure 4.5D). 
Finally, we used immunoprecipitation of endogenous SuFu and Gli3-FL from 3T3 
cells to demonstrate dissociation of SuFu-Gli3-FL by Hh stimulation. The amount of 
Gli3-FL immunoprecipitated with SuFu from stimulated cells is dramatically reduced 
compared to untreated cells, although total Gli3-FL levels do not change appreciably 
during the 1.5 hour stimulation time (Figure 4.5H). Conversely, the amount of SuFu 
immunoprecipitated with Gli3-FL is greatly decreased following acute Hh stimulation, an 
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effect that is not reversed if Gli3-FL levels are stabilized by inhibition of the proteasome 
(Figure 4.5I). 
In summary, Hh signaling causes the rapid dissociation of SuFu from Gli, 
suggesting a simple mechanism for relieving the inhibition of Gli by SuFu. We also 
conclude that Gli3-FL degradation during Hh signaling is not a cause but a consequence 
of dissociation from SuFu, consistent with the pronounced instability of Gli in cells 
lacking SuFu, in spite of maximal activation of Gli target genes. 
  
PKA inhibits SuFu-Gli complex dissociation: evidence that dissociation occurs at 
cilia 
Activation of PKA by FSK potently inhibits Hh signaling, and we found that FSK 
completely blocks the localization of the SuFu-Gli complex to cilia. Since FSK does not 
prevent recruitment of Smo to cilia by Hh stimulation, we used FSK to uncouple 
activation and recruitment of Smo to cilia, from ciliary recruitment of SuFu-Gli. We then 
asked if FSK affects dissociation of the SuFu-Gli complex caused by Hh stimulation. In 
cells treated with FSK, dissociation of endogenous SuFu-Gli3-FL by acute Hh 
stimulation is completely blocked (Figure 4.5E, F and I). This result is consistent with a 
model in which dissociation of SuFu-Gli complexes by active Smo occurs at cilia; 
alternatively, FSK might independently inhibit both SuFu-Gli ciliary localization and 
dissociation. We favor the first model because it is consistent with inhibition of SuFu-Gli 
dissociation in Kif3a-/- cells, in which ciliary localization of Smo is inhibited (Humke et 
al., 2010). Our findings also provide a new mechanism explaining the inhibition of Hh 
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A unique feature of the vertebrate Hh pathway is that primary cilia are critical for 
signal transduction (Huangfu and Anderson, 2005). The Hh ligand binds its receptor, 
Patched (Ptc), localized at the primary cilium (Rohatgi et al., 2007), leading to activation 
and recruitment of the seven-spanner Smo to the cilium (Corbit et al., 2005; Rohatgi et 
al., 2007), from where it signals to the cytoplasm to activate Gli proteins. In unstimulated 
cells, Gli proteins are kept inactive by the cytoplasmic protein SuFu. In vertebrate cells 
lacking SuFu, the Hh pathway is maximally active, independent of Smo (Cooper et al., 
2005; Svard et al., 2006) and independent of cilia (Jia et al., 2009). A simple model for 
vertebrate Hh signaling is that active Smo at the cilium inhibits SuFu, to allow Gli 
activation; however, a major unanswered question has been if and how SuFu is regulated 
by Hh signaling. 
We found that the endogenous complex formed by SuFu and Gli proteins 
localizes to cilia, and that this ciliary localization is strongly increased by Hh signaling 
through active Smo. This suggested that the Hh signal is transmitted from active Smo to 
the SuFu-Gli complex, leading to Gli activation. To determine the mechanism that 
activates Gli, we searched for biochemical changes of SuFu-Gli complexes caused by 
acute Hh stimulation. SuFu is an abundant protein (we estimated its concentration in 3T3 
cells at about 100 nM) and a small fraction of SuFu forms a complex with Gli in 
unstimulated cells, while most SuFu is monomeric. Hh stimulation leads to the rapid 
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dissociation of the SuFu-Gli complex (Humke et al., 2010), suggesting a simple 
mechanism in which Gli activation is the consequence of relieving its inhibition by SuFu, 
which allows Gli to enter the nucleus (Figure 4.6). We do not yet know if SuFu 
dissociation from Gli is sufficient to activate Gli or if posttranslational changes are also 
required (Ohlmeyer and Kalderon, 1998), such as Gli phosphorylation (Humke et al., 
2010). We also do not know if all dissociation of the SuFu-Gli complex takes place at 
cilia or if it also occurs in other parts of the cell. We propose that SuFu-Gli dissociation is 
the first step in a series of molecular events through which Gli proteins are activated by 
Hh signaling. This mechanism of vertebrate Hh signaling is reminiscent of Hh signal 
transduction in Drosophila, in which Hh stimulation causes the release of Ci complexes 
by decreasing the affinity of the atypical kinesin Costal-2 for microtubules (Robbins et 
al., 1997). 
 
Figure 4.6  A model for activation of Gli proteins during vertebrate Hh signaling. 
In the resting state of the Hh pathway (left panel), SuFu forms inactive complexes with Gli2 and Gli3-FL, 
which are sequestered in the cytoplasm. Without Hh stimulation, SuFu-Gli complexes traffic to the primary 
cilium at low level, independently of Smo; this basal ciliary trafficking is antagonized by PKA. Hh 
pathway stimulation (right panel) leads to the translocation of active Smo to the cilium, which, in turn, 
recruits SuFu-Gli complexes. Active Smo at cilia causes the dissociation of SuFu from Gli. Monomeric 
SuFu and Gli leave the cilium, followed by Gli nuclear translocation and activation of the transcriptional 
program of the Hh pathway. PKA antagonizes Hh signaling by blocking ciliary localization of SuFu-Gli 





Whether “active” Gli moves to the nucleus by itself or in complex with SuFu has 
been a matter of debate. We favor a model in which Gli enters the nucleus without SuFu, 
for the following reasons: 1) SuFu blocks nuclear localization of overexpressed Gli 
(Barnfield et al., 2005), while Gli proteins are nuclear in the absence of SuFu ((Humke et 
al., 2010) and the present study); 2) Hh stimulation causes the rapid dissociation of SuFu-
Gli complexes, indicating that a critical step in generating active Gli is the removal of 
bound SuFu; and 3) SuFu is not required in the nucleus, as the transcriptional output of 
the Hh pathway is maximal in SuFu-/- cells (Svard et al., 2006). 
Recently, the BTB domain protein SPOP was suggested to antagonize the 
interaction between SuFu and Gli (Chen et al., 2009). However, SPOP does not localize 
to cilia (Chen et al., 2009), and loss of SPOP causes only a modest increase in the 
unstimulated transcription of Hh target genes (Wen et al., 2010), suggesting that while 
SPOP might play a role in Gli turnover, it likely does not regulate the SuFu-Gli complex 
during the initial Hh signaling events at the ciliary membrane. 
The compartmentalization of vertebrate Hh signaling in primary cilia is 
accomplished through at least three, largely independent ciliary localization events: 1) 
localization of Ptc, which is independent of Smo (Rohatgi et al., 2007); 2) localization of 
Smo, which can be uncoupled from upstream components (Ptc and Hh), is independent of 
downstream components (SuFu and Gli), and is stimulated by PKA; and 3) localization 
of SuFu-Gli complexes, which is inhibited by PKA. We speculate that recruitment of 
SuFu-Gli complexes to cilia ensures that the signal from active Smo is channeled to Gli 
molecules inhibited by SuFu. If SuFu were recruited to cilia alone, it would compete with 
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SuFu-Gli complexes and inhibit signaling because monomeric SuFu is present in a large 
excess over SuFu-Gli. Gli-SuFu complexes thus serve not only to keep Gli proteins 
inactive and stable but also to make them activatable by Hh signaling at the cilium. 
 
Based on the size of the endogenous SuFu-Gli complex, we estimate it might 
consist of only these two proteins. Thus an unexpectedly simple protein complex lies at 
the core of vertebrate Hh signal transduction downstream of Smo. It will be important to 
understand how the integrity of the SuFu-Gli complex is maintained, how signaling 
stimulates its dissociation, and whether the posttranslational control of SuFu-Gli 
dissociation occurs at the levels of SuFu, Gli, or both. Additionally, it will be important 
to determine how SuFu-Gli complexes localize to cilia, and how active Smo increases 
their ciliary localization. 
The PKA activator, forskolin (FSK), blocks the transcriptional output of the Hh 
pathway, although only in the presence of SuFu. We found that FSK abolishes the 
localization of the SuFu-Gli complex to cilia, and its dissociation by Hh stimulation. We 
interpret these findings as follows: 1) dissociation of SuFu-Gli occurs at cilia during Hh 
signaling, and is inhibited if SuFu-Gli cannot travel to the cilium, similar to inhibition of 
SuFu-Gli dissociation observed in Kif3a-/- cells (Humke et al., 2010); and 2) PKA 
controls trafficking of SuFu-Gli complexes to cilia, independent of Smo, suggesting a 
novel mechanism for Hh inhibition by PKA. Although PKA localizes to the base of cilia 
(Barzi et al., 2010), whether Hh signaling regulates PKA remains unclear; one possibility 
is that local inhibition of PKA might allow coupling between active Smo and SuFu-Gli 
complexes at cilia. It is likely, however, that additional events are required to transmit the 
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signal from active Smo to the SuFu-Gli complex, since pharmacological inhibition of 
PKA blocks, rather than activates, Hh signaling (not shown). 
 
Of the three members of the Gli family of transcription factors, our study focused 
only on Gli2 and Gli3, which mediate the initial response to Hh stimulation. Gli1 is 
synthesized in response to Hh signaling (Dai et al., 1999; Ruiz i Altaba, 1998) and is part 
of a positive feedback loop that amplifies the output of the pathway. Gli1 binds to and is 
inhibited by SuFu (Chen et al., 2009; Merchant et al., 2004). We envision that another 
role of SuFu is to inhibit newly synthesized Gli1, and that the SuFu-Gli1 complex has to 
pass through the cilium in the presence of active Smo in order for Gli1 to become active. 
This would ensure that the Hh pathway remains signal-dependent even after prolonged 
stimulation and accumulation of Gli1 protein, avoiding runaway transcriptional 
activation. 
 
MATERIALS AND METHODS 
 
Cell culture and Hh pathway assays 
NIH-3T3 cells were grown in DMEM supplemented with 10% bovine calf serum, 
penicillin and streptomycin. Mouse embryonic fibroblasts (MEFs) were grown in DMEM 
supplemented with 10% fetal bovine serum, sodium pyruvate, non-essential amino acids, 
penicillin and streptomycin. To assay Hh signaling, confluent cell cultures were starved 
for 24-48 hours in starvation media (DMEM without serum for NIH-3T3 cells or with 
0.2% fetal bovine serum for MEFs). The media was then replaced with starvation media 
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supplemented with the appropriate Hh pathway agonist, antagonist or control vehicle. 
After incubation for the desired amount of time, the cultures were processed for 
immunofluorescence or were harvested for real-time PCR, Western blotting, 
immunoprecipitation or sucrose gradient centrifugation. 
 
Antibodies 
Polyclonal antibodies against mouse Smo, SuFu and Gli were generated in rabbits 
or goats (Cocalico Biologicals, Reamstown, PA), and were affinity-purified. The 
antibodies were tested for specificity by immunoblot (on either overexpressed or 
endogenous proteins) and by immunofluorescence on cells (against endogenous proteins) 
– see Supplemental Figure 4.S1. 
For the anti-Smo antibody, a fragment of the intracellular C-terminal domain of 
mouse Smo (amino acids 683-794) was expressed in bacteria as a soluble fusion with the 
maltose-binding protein (MBP). Serum from rabbits immunized with this recombinant 
protein was depleted of anti-MBP antibodies, after which anti-Smo antibodies were 
affinity purified against the antigen immobilized on Affigel 15 beads (BioRad). To 
generate anti-SuFu antibodies, full-length mouse SuFu (mSuFu) was expressed and 
purified from bacteria as an MBP fusion. The serum was affinity purified against a 6His-
tagged eGFP fusion of mSuFu covalently attached to Affigel 15. To generate anti-Gli 
antibodies, two fragments of the human Gli3 protein (an N-terminal fragment consisting 
of amino acids 1-799 and a C-terminal fragment consisting of amino acids 1061-1599) 
were expressed in bacteria as insoluble 6His-MBP-tagged fusions. Inclusion bodies were 
isolated, separated by SDS-PAGE and gel slices were used to immunize rabbits or goats 
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(Cocalico Biologicals, Reamstown, PA). The serum from rabbits immunized with the 
mixed recombinant Gli3 fragments was affinity purified successively against 6His-
hGli3(1-799) and 6His-hGli3(1061-1599), to generate the anti-GliN and anti-GliC 
antibodies. On immunoblots, anti-GliN detects both full-length and processed Gli3, while 
anti-GliC only detects full-length Gli3. By immunofluorescence, anti-GliC detects 
strongly both Gli2 and full-length Gli3, while anti-GliN detects Gli3 strongly and Gli2 
only weakly (Supplemental Figure 4.S1 and data not shown). Anti-GliN and anti-GliC do 
not detect human or mouse Gli1 by either immunoblotting or immunofluorescence. 
 
Real-time PCR assays of Hh pathway activity 
Total cellular RNA was treated with DNase (Promega), purified, and cDNA was 
generated from 1 microgram of total RNA using Transcriptor reverse transcriptase 
(Roche) and random hexamers. Gli1 and Ptch1 gene expression was assayed by 
Quantitative Real Time PCR using FastStart SYBR Green (Roche) on a Rotor-Gene 6000 
(Corbett Robotics). Relative gene expression was calculated using a Two Standard Curve 
method in which each gene-of-interest was normalized to the Ribosomal Protein L27 
gene. The sequences for gene-specific primers are: L27: 5’-
GTCGAGATGGGCAAGTTCAT-3’ and 5’-GCTTGGCGATCTTCTTCTTG-3’, Gli1: 
5’-GGCCAATCACAAGTCAAGGT-3’ and 5’-TTCAGGAGGAGGGTACAACG -3’, 
Ptch1: 5’-ACTGTCCAGCTACCCCAATG-3’ and 5’-CATCATGCCAAAGAGCTCAA-
3’. Error bars represent standard error of the mean for 3 independent experiments. 
 
Effect of protein synthesis inhibition on Hh signaling in NIH-3T3 cells 
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To determine if ciliary recruitment and transcription activation by the Hh pathway 
require new protein synthesis, NIH-3T3 cells were starved overnight and then were 
incubated for 30 minutes in starvation media supplemented or not with cycloheximide 
(CHX, 50 microgram/mL final). CHX-treated cells or controls were then incubated with 
Shh, in the presence or absence of CHX, respectively. Recruitment of Smo, SuFu and Gli 
to cilia was assayed by immunofluorescence following 3 hours of Shh stimulation. 
Expression of Gli1 and Ptch genes was assayed by Q-PCR after 0, 3 and 6 hours of 
stimulation. To determine the degree of protein synthesis inhibition by CHX, cell cultures 
were starved for methionine by incubation for 2 hours in Met-starvation media (DMEM 
without methionine). The cells were then incubated for 30 minutes in Met-starvation 
media with or without 50 microgram/mL CHX, followed by incubation with or without 
CHX for 3 hours in Met-starvation media supplemented with 35S-methionine (50 
microCi/mL final). The cells were harvested and 35S-labeled proteins were detected by 
SDS-PAGE and autoradiography. Protein synthesis was also measured by scintillation 
counting of 35S incorporated into TCA-insoluble material during the 3-hour incubation 
period. 
 
Requirement of active Smo for ciliary recruitment of SuFu and Gli proteins 
 Starved, confluent NIH-3T3 cells were incubated with or without 200 nM SAG or 
10 microM cyclopamine. After 3 hours, parallel cell cultures were either processed for 
immunofluorescence (to assay Smo, SuFu and Gli recruitment to cilia) or for Q-PCR (to 
assay Gli1 and Ptch1 transcription). To determine if continued localization of SuFu and 
Gli proteins to cilia requires active Smo, confluent NIH-3T3 cells were first incubated in 
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the absence or presence of Shh for 3 hours, to recruit Smo, SuFu and Gli to cilia. 
Cyclopamine (10 microM) was then added to Shh-stimulated cells, and ciliary 
localization of Smo, SuFu and Gli was determined, after the desired incubation time. To 
determine the effects of forskolin (FSK), starved, confluent NIH-3T3 cells were treated 
overnight with control vehicle, Shh, FSK (10 microM, from Sigma) or FSK (10microM) 
and Shh. Parallel cell cultures were processed for immunofluorescence or analyzed by Q-
PCR. To reverse the effects of FSK, the small molecule PKA inhibitor, H-89 





 Affinity-purified anti-Gli3 and anti-SuFu antibodies were covalently attached to 
AffiPrep Protein A beads (Bio-Rad), by crosslinking with dimethyl-pimelimidate 
(Pierce). Confluent cell cultures were starved for 48 hours, followed by treatment for 1.5 
hours with or without SAG (100 nM), bortezomib (2 microM) or FSK (20 microM). The 
cells were lysed on ice in lysis buffer (20 mM HEPES pH 7.5, 50 mM potassium 
chloride, 1 mM magnesium chloride) with 0.5% digitonin, in the presence of protease 
inhibitors (Complete, Roche). The lysate was clarified by centrifugation at 20,000g and 
the supernatant was incubated with antibody beads for 1.5 hours at 4C. The beads were 
washed in lysis buffer with 0.1% digitonin before elution in SDS-PAGE sample buffer 
and analysis by SDS-PAGE followed by immunoblotting. 
 




 Linear sucrose gradients (5-20% sucrose, 12.8 mLs) in XB buffer (10 mM 
HEPES pH 7.5, 100 mM potassium chloride, 1 mM magnesium chloride, 100 microM 
calcium chloride, supplemented with protease inhibitors) were prepared using a gradient 
maker (BioComp), and were cooled to 4C. Cells were treated and lysed as described for 
immunoprecipitation experiments and a volume of 150 microL of clarified lysate was 
layered on the top of the gradient. Gradients were centrifuged for 20 hours at 4 C at 
38,000 RPM in a SW-40 rotor (Beckman). The sucrose gradients were fractionated and 
each fraction was precipitated with trichloracetic acid (TCA). The TCA-precipitated 
proteins were analyzed by SDS-PAGE followed by immunobloting for endogenous 
SuFu, Gli3 and GSK3. The sucrose gradients were calibrated using the molecular weight 
markers ovalbumin (MW=44 kDa, Stokes radius=30.5A), aldolase (MW=158 kDa, 
Stokes radius=48.1A), catalase (MW=232 kDa, Stokes radius=52.2A), ferritin (MW=440 
kDa, Stokes radius=61A) and thyroglobulin (MW=669 kDa, Stokes radius=85A). 
 
Immunofluorescence 
Cells grown on glass coverslips were fixed for 30 minutes at room temperature in 
PBS with 4% formaldehyde. The coverslips were rinsed with TBST (10 mM Tris pH 7.5, 
150 mM NaCl, 0.2% Triton X-100) and then non-specific binding sites were blocked by 
incubation in TBST supplemented with 25 mg/mL bovine serum albumin (TBST-BSA). 
The coverslips were incubated with primary antibodies diluted in TBST-BSA, for one 
hour at room temperature. Coverslips were then washed with TBST, blocked again with 
TBST-BSA and incubated with the appropriate secondary antibodies in TBST-BSA. 
After washing, the coverslips were mounted on glass slides in mounting media (0.5% p-
phenylenediamine, 20 mM Tris pH 8.8, 90% glycerol). Affinity-purified primary 
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antibodies against Smo, Gli3 and SuFu were used at a final concentration of 1-2 
microgram/mL. Mouse anti-acetylated tubulin, mouse anti-gamma-tubulin, and mouse 
anti-FLAG antibodies were purchased from Sigma. Alexa dye-conjugated secondary 
antibodies (Invitrogen) were used at a final concentration of 1 microgram/mL. The 
immunostained cells were imaged by epi-fluorescence microscopy on an inverted Nikon 
TE2000U microscope equipped with an OrcaER digital camera (Hammamatsu) and a 
100x PlanApo 1.4NA oil objective (Nikon). Images were collected using Metamorph 
image acquisition software (Applied Precision). To measure ciliary localization of SuFu, 
Smo, and Gli, 150 cilia for each coverslip were identified by anti-acetylated tubulin 
staining and were scored visually for the presence or absence of SuFu, Smo, or Gli at the 
cilium. Error bars represent the standard deviation for groups of 50 cilia counted on 
different visual fields, on the same coverslip. P values for cilia counts were calculated 
using an unpaired two-tailed T test, comparing each time point to t=0. 
All experiments showing ciliary counts were repeated independently at least 
twice. Quantification of a representative experiment is shown in the panels where error 
bars are not provided. 
Immunoblotting 
Cells were resuspended in TBS with protease inhibitors, and were lysed with 1% 
Triton X-100 on ice for 20-30 minutes. The cell lysate was clarified by centrifugation for 
30 minutes in a refrigerated microfuge at 20,000g. The supernatant was collected, mixed 
with DTT (50 mM final) and 5x SDS-PAGE sample buffer, and separated by SDS-PAGE 
on 5-15% polyacrylamide gradient gels, followed by transfer to nitrocellulose 
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membranes. For immunoblotting, antibodies were used at a final concentration of 1 
microgram/mL in TBST with 5% non-fat dry milk. 
 
Measurement of the half-life of endogenous SuFu by CHX chase 
 To determine if activation of Hh signaling affects the half-life of endogenous 
SuFu, confluent, starved NIH-3T3 cells were pre-treated for 15 minutes in DMEM with 
CHX (50 microgram/mL). Parallel cultures were then incubated with CHX, in the 
presence or absence of 200 nM SAG in DMEM. At the indicated times, the cells were 
harvested and endogenous SuFu protein was detected by immunoblotting. 
 
Nocodazole treatment 
To test if microtubules (MTs) are required for recruitment of Smo, SuFu and Gli 
to cilia and for the transcriptional responses of Hh signaling, confluent, starved NIH-3T3 
cells were pre-incubated for 1 hour with 0.25-5 microM nocodazole (Noc) or with control 
vehicle. The cells were then stimulated or not with Shh or with 200 nM SAG, in the 
presence of the same Noc concentration as during pre-incubation. After 1 hour, the cells 
were processed for immunofluorescence against Smo, SuFu and Gli. Cilia were stained 
with the mouse anti-acetylated tubulin monoclonal antibody. To determine MT 
depolymerization, cells treated in parallel were stained with a mouse anti-!-tubulin 
antibody (DM1!, Sigma). For Q-PCR analysis, cells were harvested after 2 hours of 
incubation with or without Shh (or SAG), and in the absence or presence of the indicated 




Shh, chemical agonists and antagonists of the Hh pathway 
Shh was produced in 293T cells by transient transfection of an expression plasmid 
encoding amino acids 1-198 of human Sonic Hedgehog. Shh-conditioned media was 
harvested after 48 hours, pooled, filter sterilized and used in cellular assays, usually 
diluted 1:4 in starvation media. Media conditioned by mock-transfected 293T cells was 
used as control; it had no effect on ciliary recruitment of Smo, Gli or SuFu. The Smo 
agonist SAG was from Axxora, the Smo antagonists SANT-1 was from Calbiochem, 
cyclopamine was from LC Laboratories, 20-hydroxycholesterol (20-OHC) and 25-
hydroxycholesterol (25-OHC) were from Steraloids Inc. 
 
Pharmacological inhibition of the proteasome 
 To block ubiquitin-dependent proteolysis, confluent cells were starved for 24-48 
hours and were then pretreated with or without 2 microM bortezomib for 0.5-3 hours. 
The cells were then incubated with or without Hh pathway agonist, in the presence or 
absence of 2 microM bortezomib for the desired amount of time. Parallel cultures were 
processed for immunofluorescent detection, Western blotting, Q-PCR or sucrose gradient 
centrifugation. 
 
Generation of stable cell lines 
Constructs were generated in the retroviral vector pLHCX (Clontech), and 
retroviruses produced in 293T cells were used to infect NIH-3T3 cells or MEFs. Stably 
transduced lines were generated by hygromycin selection. Expression of the desired 
protein was confirmed by Western blotting and immunofluorescence. The retroviral 
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constructs used in this study were: 1) full-length mouse SuFu tagged at the C-terminus 
with 3 copies of the FLAG epitope; 2) full-length human Gli1 tagged at the C-terminus 
with one copy of the HA epitope; 3) a fusion between N-terminally Myc-tagged human 
Gli1 and mouse SuFu, which incorporates a flexible, 24 amino acid linker between Gli1 
and SuFu. 
 
Quantitation of endogenous SuFu levels in NIH-3T3 cells 
 The concentration of endogenous SuFu protein in NIH-3T3 cells was estimated 
by immunoblotting, against serial dilutions of recombinant mouse SuFu expressed and 
purified from baculovirus-infected Sf9 cells. 
 
Xenopus embryo injections 
 Capped messenger RNA for mouse SuFu was generated in vitro using the 
Message Machine kit (Ambion). One hundred picograms of SuFu mRNA in 10 nL of 
water were injected per blastomere, into both blastomeres of a two cell stage Xenopus 
embryo. Twenty-five injected embryos were harvested at stage 10-11 (staged according 
to Nieuwkoop and Faber) and were homogenized on ice in 150 microliters of XB buffer 
supplemented with 10 micrograms/mL cytochalasin B and protease inhibitors. The 
homogenate was clarified by centrifugation for 15 minutes at 20,000g, at 4 Celsius. The 
supernatant was harvested and subjected to sucrose gradient centrifugation, as described 
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Hedgehog ligand production and secretion 
In chapter 2, I presented work that placed the cellular location of Hedgehog processing in 
the endoplasmic reticulum.  This result was surprising because the endoplasmic reticulum 
membrane is cholesterol-poor compared to the plasma membrane.  The location of Hedgehog 
processing also led to an understanding of how the Hedgehog tail forms an essential disulfide 
bridge during folding that involves the catalytic cysteine.  I showed that after folding, the 
disulfide bond is undone by protein disulfide isomerases to free the thiol group and allow the 
auto-proteolysis reaction to take place.  This represents the first identification of a cellular factor 
that participates in the Hedgehog processing reaction.  I also demonstrated that the cleaved C-
terminal tail is degraded prior to reaching the Golgi, and a colleague’s work showed that the tail 
is retrotranslocated back into the cytoplasm to be destroyed by the proteasome by ER-associated 
degradation machinery (ERAD) usually dedicated to destruction of misfolded proteins.  The 
Hedgehog tail represents the first constitutive ERAD substrate identified in multicellular 
organisms.  Finally, we demonstrated that Hedgehog mutants that do not process themselves 
efficiently are degraded by ERAD in their entirety, suggesting that degradation and auto-
proteolysis are competing events. 
The work on Hedgehog secretion in chapter 3 started as a question raised by a final 
experiment I was attempting for the manuscript in chapter 2.  When I tried to demonstrate that 
wild type Hedgehog protein was secreted while processing mutants were not, I realized that 
detecting active, cholesterol-modified Hedgehog ligand in aqueous media was difficult.  I began 
working on Dispatched in hopes of being able to study Hedgehog secretion biochemically.  
While I showed that Dispatched bound Hedgehog in a cholesterol dependent manner, it was still 
almost impossible to measure Hedgehog secretion.  I devised a system where cells secreting 
Hedgehog were cocultured with responsive reporter cells, and in this way began to study 
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Dispatched functionally.  In a parallel endeavor, we tested the function of Scube2, a protein 
identified in a zebrafish screen as a Hedgehog component that acts at or upstream of Patched.  
When I coexpressed Scube2 and Hedgehog, I saw a dramatic increase of Hedgehog in the 
medium.  Although there were other proteins that increased Hedgehog solubility as observed by 
us and others, including heparin, suramin, and anything containing lipoproteins such as bovine 
serum, none of them resulted in an aqueous fraction with potent signaling.  In contrast, the 
Scube2-liberated Hedgehog was very active.  
I demonstrated that Scube2 acts non-cell autonomously and binds Hedgehog directly to 
stabilize it in aqueous solution.  Scube2 binding depended on the cholesterol adduct, and I went 
on to show that Scube2 was capable of binding and solubilizing a sterolated chimeric protein 
bearing almost no resemblance to Hedgehog.  I then demonstrated that Dispatched synergizes 
with Scube2 to release Hedgehog into the medium.  Finally, we managed to incorporate 
photocrosslinkable cholesterol analogs into Hedgehog to confirm cholesterol-specific binding to 
both Dispatched and Scube2.  Using two different analogs we demonstrated that Dispatched and 
Scube2 bind the cholesterol adduct on different faces, suggesting that they might synergize by a 
handoff mechanism.  This work represents a big step forward in understanding how cholesterol-
modified Hedgehog manages to diffuse long distances, and puts into question some of the 
models proposing Hedgehog multimerization or lipoprotein having a significant role in 
Hedgehog transport. 
One of the questions raised by the dramatic effect of Scube2 in vitro is whether it 
participates in Hedgehog signaling in every physiological setting, especially since mutation of 
Scube2 results in a less severe phenotype than mutations of Hedgehog or Smoothened.  One 
possibility is that Scube2 is required for long-range but not short-range Hedgehog signaling.  In 
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support of this, the you mutation was identified in a screen for altered myotome morphology, but 
the notochord was still able to induce the floor plate in these mutants (van Eeden et al., 1996).  
Floor plate induction is known to be contact-dependent, whereas signaling to somites requires 
Hedgehog to diffuse a much longer distance (Placzek et al., 1990; Placzek et al., 1993; Fan and 
Tessier-Lavigne, 1994; Johnson et al., 1994). 
Another possibility is that there is some functional redundancy of Scube2.  Scube2 is part 
of a family of three related proteins, all sharing the domain topology they are named after: signal 
sequence-EGF repeats- spacer- cysteine rich repeats-CUB domain.  Scube1 and Scube2 were 
first identified as embryonically expressed genes in mouse embryos (Grimmond et al., 2000; 
Grimmond et al., 2001) and also found as genes expressed by human vascular endothelium 
(Yang JBC 2002).  Scube3 bears 60% homology to the other two genes (Wu et al., 2004).  The 
most obvious question is whether the two other Scube proteins can also function to mobilize 
Hedgehog from the membrane.  The Scube proteins are expressed in somewhat different regions 
of the embryo that are known to be patterned using Hedgehog signaling, with Scube2 
concentrated along the neuroectoderm (Grimmond et al., 2001), Scube1 expressed more broadly 
in surface ectoderm, limb buds, and the gonads (Grimmond et al., 2000), and Scube3 expressed 
along the neural tube, branchial arches and fronto-nasal region, limb buds, and developing tooth 
and hair follicles (Haworth et al., 2007).  It is conceivable that Scube proteins might all 
participate in the Hedgehog pathway, but differentially expressed according to tissue type.  A 
recently published study examined the effects of morpholino knockdown of all three Scube 
proteins and found that although Scube2 was the major contributor to the phenotype, that all 
three genes overlapped in expression in some tissue and knockdown of Scube1 and Scube3 
enhanced the phenotype (Johnson et al., 2012). 
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As a protein necessary for Hedgehog secretion, Scube2 might provide a point of spatial 
and temporal regulation for the pathway.  It is not yet clear if Scube2 is secreted only by the cells 
that synthesize Hedgehog, by the cells expressing Patched and primed to receive the signal, or by 
some other population.  Evidence that Scube transcription might be regulated by other signaling 
pathways comes from the ordered patterns of expression and timing during embryogenesis in the 
mouse (Grimmond et al., 2000; Grimmond et al., 2001; Haworth et al., 2007), as well as some 
evidence that Scube proteins expression is downregulated by cytokine inflammatory signaling 
(Yang et al., 2002) and upregulated by insulin-mimetic compound vanadate (Tiago et al., 2011). 
The potency of the Hedgehog/Scube2 supernatant raises the question of whether Scube2 
plays any additional role besides stabilizing the hydrophobic adduct of Hedgehog in aqueous 
solution.  In the simplest scenario, Scube2 binds Hedgehog and diffuses through media or 
interstitial fluid before dropping it off on Patched or other coreceptors in Hedgehog responsive 
cells.  Another alternative is that Scube2 remains bound to Hedgehog and is endocytosed along 
with Patched.  This is possible because of the ability to immunoprecipitate a complex of Scube2 
and Hedgehog using 5E1, a monoclonal antibody raised against Hedgehog that binds the face 
that interacts with Patched and acts as an inhibitor of the Hedgehog ligand (Ericson et al., 1996; 
Pepinsky et al., 2000; Maun et al., 2010).  A third possibility is that Scube2 plays an active, 
positive role in targeting Hedgehog to its receptors.  Indeed, when the role of Scube2 in 
Hedgehog signaling was first reported, it was speculated that Scube2 might be acting as a 
peripheral protein coreceptor on the signal receiving cell, mediating Hedgehog ligand 
endocytosis (Hollway et al., 2006).  There is precedent for proteins containing CUB domains to 
act as endocytic receptors for cells, most notably the multipurpose cubilin receptor which is 
named after its 27 CUB domains, which was discovered as a receptor for intrinsic 
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factor/cobalamin complex, and later found to mediate endocytosis of many other molecules, such 
as hemoglobin, transferrin, vitamin D receptor, and apolipoproteins (reviewed in (Christensen 
and Birn, 2002)).  The N-terminal half of the Scube2 protein contains EGF repeats which might 
participate in a secondary targeting function separate from the CUB domain, given other 
examples of receptor/ligand interactions that depend on the EGF motif.  However, mutant 
analysis in a recent study showed little difference between Hedgehog activity after release by full 
length Scube2 versus Scube2 with the EGF repeats deleted (Creanga et al., 2012).  It remains to 
be determined if Scube2 binds Patched or any of the Hedgehog coreceptors. 
Drosophila do not have a clear homolog to Scube proteins, and the most closely related 
protein Tolloid is a BMP-1 homolog that binds Decapentaplegic, a member of the TGF-beta 
family (Finelli et al., 1994).  Tolloid has no known role in Hedgehog signaling, however.  A 
more likely candidate is Shifted, the Drosophila homolog of Wnt inhibitory factor-1 (WIF).  
Shifted is a secreted protein that promotes long range diffusion of cholesterol-modified 
Hedgehog, and does not act through the Wingless pathway to do so, suggesting there might be a 
direct interaction (Glise et al., 2005; Gorfinkiel et al., 2005).  It is possible that since the actual 
range of Hedgehog action in Drosophila is much smaller than in vertebrates, and there is no 
requirement for a soluble transporting protein like Scube2.  Hedgehog in flies might rely on other 
means, such as interactions with the extracellular matrix, to travel from cell to cell once it is 
secreted by the actions of Dispatched. 
Scube2 demonstrates some degree of flexibility in binding a cholesterol modified protein, 
as it can liberate not only Hedgehog but a chimera of HaloTag protein fused to the Hedgehog C-
terminus that shares only a few amino acids with the processed Hedgehog ligand.  It is possible 
that Scube proteins function to release other cholesterol modified proteins, if they exist.  The 
Chapter Five 
! 174!
existence of other sterolated proteins has been postulated by an experiment in which COS-7 cells 
were metabolically labeled with [3H]cholesterol and several bands were visible after SDS-
PAGE, but none of these have been identified to date (Porter et al., 1996).  Scube proteins could 
be used as a tool to fish out these proteins if, like Hedgehog, they are lumenal and peripheral. 
The ability of Hedgehog to covalently incorporate photocholesterol analogs opens up the 
possibility of identifying Hedgehog interactors in both secreting and receiving cells by 
photocrosslinking and Hedgehog immunoprecipitation.  My finding that protein disulfide 
isomerases participate in the reaction suggests there might be other ER factors involved in 
optimal Hedgehog processing (chapter 2).  Although the processing reaction carries out robustly 
in vitro, using purified protein, there is some evidence that Hedgehog processing in the ER of 
cells proceeds more efficiently than processing of chimeras that use the Hedgehog self-
proteolysis domain as a module (unpublished data).   Photocholesterol might be used to identify 
these factors, if they exist.  In the receptive cell, there is a growing list of Hedgehog interactors 
that exert positive and negative effects on Hedgehog signaling, and photocholesterol might be 
used to identify others, particularly coreceptors that might be interacting specifically with the 
cholesterol adduct. 
Photocholesterol can also potentially be used to map the regions of Dispatched that 
directly interact with the cholesterol adduct.  This can either be done by expressing pieces of the 
Dispatched protein, expressing Dispatched that is missing certain domains, or by using 
strategically inserted protease sites that can be cleaved after crosslinking.  Given the much 
stronger and more stable binding of Hedgehog to the Dispatched-NNN mutant, it can be 
exploited to identify the binding site. 
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The cell culture system I developed to quantitatively measure Dispatched activity can 
now be used for testing various Dispatched mutants and narrowing down the domains essential 
for Dispatched function.  It can also be used to quantitate Dispatched synergy with other 
proteins, as I have demonstrated for Scube2.  One of the drawbacks of the system as presented in 
this dissertation is the inability to distinguish strong short range signaling from weaker but 
broader signaling, and the addition of Dispatched-independent noise from activation of 
Hedgehog signaling in immediately adjacent cells (Burke et al., 1999; Caspary et al., 2002).  
This was circumvented by using low ratios of Hedgehog secreting cells to Hedgehog responsive 
cells, but the system could be adapted into one that better recapitulates physiological signaling.  
A more sophisticated plating scheme where Hedgehog secreting cells are plated together and 
subsequently inserted as a block into a lawn of Hedgehog responsive cells would reduce adjacent 
cell contact and emphasize the long range Hedgehog signal.  It might also allow for direct 
quantitation of Hedgehog activation at varying distances.  This system would combine the 
genetic and biochemical tractability of the tissue culture system with a better recapitulation of 
Hedgehog secretion and spreading in whole organisms. 
My discovery that mutation of the SSD aspartates in Dispatched results in stronger 
binding to Hedgehog is interesting, because it speaks to the existence of two distinct events in 
Dispatched-mediated Hedgehog secretion: binding, followed by a separate action that mediates 
the actual release.  It remains to be determined whether Dispatched function is an energy-driven 
process, or depends on any kind of gradient across the plasma membrane.  This result also brings 
up the possibility that the corresponding aspartate mutant of Patched might be locked tightly with 
its substrate.  Dispatched-NNN robustly immunoprecipitates with cholesterol-modified 
Chapter Five 
! 176!
Hedgehog still bound, so it might be possible to exploit the Patched-NNN mutant and use it to 
try to copurify its elusive lipid substrate—one of the holy grails of the Hedgehog field. 
 
Signal transduction at the cilium 
In chapter 4 of this dissertation, I presented evidence that SuFu and Gli localize to cilia in 
a manner that depends on activated Smoothened.  We showed that the proteins accumulate in 
cilia tips within minutes and this change did not depend on de novo protein synthesis.  We also 
showed that mere presence of Smoothened at the cilium was not sufficient for SuFu and Gli 
recruitment by using cyclopamine, which is a pathway inhibitor that paradoxically also prompts 
Smoothened to localize to the cilium.  We found that another pathway inhibitor, PKA activator 
forskolin, weakly recruited Smoothened to the cilium but completely abolished even basal levels 
of SuFu and Gli at the ciliary tip. 
We showed that in the absence of Gli, SuFu does not localize to cilia, hinting that it is the 
nuclear localization sequence of Gli that might be targeting the complex to the cilium.  In the 
absence of SuFu, Gli does not appreciably localize to cilia unless massively overexpressed.  
Bypassing the cilium, Gli readily enters the nucleus to drive transcription of target genes.  This 
result argues that the main function of the primary cilium is to relieve the inhibition of Gli by 
SuFu.   
I proceeded to examine the nature of Hedgehog signal activation in terms of biochemical 
changes of the Gli and SuFu complex, and demonstrated that the complex dissociates upon 
signal activation.  I exploited our finding that forskolin blocks ciliary transport of SuFu and Gli 
but not Smoothened to show that SuFu/Gli dissociation in response to pathway activation does 
not occur unless the two proteins enter the cilium.  This conclusion was also supported by work 
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from another group showing that IFT protein Kif3a was required for SuFu/Gli dissociation 
(Humke et al., 2010). 
The work presented in chapter 4 provided the first evidence that the signal is transduced 
from Smoothened to Gli at the primary cilium, and provided a mechanism for Gli activation, 
although how Smoothened triggers this mechanism remains unresolved. 
Study of the signal transduction events that occur inside the primary cilium is greatly 
hampered by the lack of a protocol to purify cilia away from the rest of the cell.  Although 
Hedgehog components concentrate at cilia, it is unlikely that a significant fraction of abundant 
cytoplasmic proteins like SuFu and Gli is inside the organelle at any one time.  Thus, it has been 
difficult to determine what Smoothened activation entails in physical terms, and how it might 
promote the dissociation of the SuFu-Gli complex. 
For example, it has been difficult to test whether all full length Gli species that enter the 
nucleus have traveled through the primary cilium first.  SuFu appears to be in significant excess 
of Gli2 and Gli3 in the cell, and appears to bind both efficiently before they can enter the 
nucleus.  SuFu is also capable of binding Gli1, and might be providing regulation to what would 
otherwise be a runaway positive feedback loop of Hedgehog driving transcription of Gli1, which 
then drives its own transcription in addition to other target genes.  Furthermore, despite a few 
reports of detecting SuFu in the nucleus (Kogerman et al., 1999; Stone et al., 1999), it has no 
evident nuclear localization sequence and most of the literature now agrees that SuFu sequesters 
Gli before its entry into the nucleus, rather than shuttling it out.  It is interesting to consider the 
differences between the nuclear pore and putative ciliary pore complex, and what might allow 
SuFu/Gli to shuttle in and out of the cilium while being kept out of the nucleus.  It also remains 
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possible that SuFu/Gli do shuttle in and out of the nucleus, but are simply much easier to detect 
in a small primary cilium than a cell nucleus. 
Another rather simple question that has been difficult to address is where in the cell Gli is 
degraded, and whether partial degradation versus full degradation occur in different locations.    
One of the first mechanistic explanations offered for the requirement of cilia for negative 
regulation of the Hedgehog signaling is that mutation of IFT components like Ift88, Ift172, 
Kif3a, and Dnchc2 decreases the processing of Gli3 into a repressor form (Huangfu and 
Anderson, 2005).  This suggests that partial degradation is either triggered or carried out by Gli 
passage through the primary cilium.  Although there has been no proteasomal machinery 
detected inside the ciliary shaft, there is a significant clustering of proteasomes around the basal 
body (Wigley et al., 1999).  Thus, it is possible that Gli3 passes through the cilium in complex 
with SuFu, obtains a posttranslational modification of some sort, is recognized and partially 
degraded by proteasomes at the cilium’s base, and, free of SuFu binding, translocates to the 
nucleus to carry out repressor functions.  Evidence of such a cilium-dependent posttranslational 
modification remains elusive.  Furthermore, although IFT and SuFu affect the ratio of full length 
and repressor forms of Gli3, they are not essential for Gli3 processing (unpublished data). 
One of the more interesting aspects of Gli proteins is that their activation is not 
synonymous with stabilization of a full-length form.  SuFu in fact functions to increase levels of 
full length Gli, while also keeping its activity in check.  This is most easily explained by a model 
in which SuFu binds the activator domain of Gli—borne out by a lack of binding between SuFu 
and Gli repressor forms—and directly blocks access by the proteasome or the kinases that mark 
Gli for degradation.  When the SuFu/Gli complex dissociates, Gli becomes destabilized, and it is 
far more difficult to detect its presence in the nucleus than the transcriptional consequences of its 
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entry.  The quick clearance of Gli3 is likely to occur inside the nucleus, and may represent a way 
for the cell to tightly control the length of transcriptional response to a pulse of Hedgehog 
pathway activation.  Thus, stabilization and activity of Gli3 are almost diametrically opposed.  In 
flies, Ci-155 does appear to get stabilized in response to Hedgehog activation.  This does not 
represent a contradiction, because vertebrates produce increased levels of Gli1 and Gli2 in 
response to Hedgehog signaling. 
Another question is where the dissociation of SuFu and Gli occurs in the cell.  The 
accumulation of the two proteins at the tip might be indicative of a delay in retrograde movement 
caused by dissociation inside the cilium.  We attempted to compare entry and exit rates of SuFu 
and Gli, to see if there was a difference between them in one direction but not the other, but these 
experiments did not yield statistically significant results.  This is a question for which a definitive 
answer can only be obtained by obtaining a purified ciliary fraction. 
The most interesting question about the events at the primary cilium is what activated 
Smoothened does to trigger Gli dissociation from SuFu.  The most obvious hypothesis is 
triggering a phosphorylation event on one or the other.  Gli has an enormous number of 
phosphorylation sites, at least some of which are important for partial degradation, but have no 
documented effect on its ability to activate genes.  I mapped three phosphorylation sites on SuFu 
in collaboration with Wilhelm Haas of the Gygi laboratory, and used stable isotope labeling by 
amino acids (SILAC) to see if Hedgehog activation triggers phosphorylation or 
dephosphorylation of any of these, but there was no significant difference.  Once again, the 
ability to purify cilia away from the rest of the cytoplasm would greatly help in identifying the 
biochemical changes that occur to SuFu or Gli to trigger their dissociation. 
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An understanding of Hedgehog signal transduction events downstream of Smoothened is 
especially important given the role Hedgehog plays in driving certain types of aggressive tumors.  
The emergence of Smoothened antagonists as chemotherapeutic agents for Hedgehog-reliant 
cancers is promising, and vismodegib was FDA-approved for treatment of basal cell carcinomas 
to great fanfare.  There are ongoing trials to test vismodegib's ability to treat other cancers, 
including tamoxifen-resistant breast cancer, pancreatic cancers, and medulloblastoma caused by 
mutations in PTCH.   However, in one of the early trials there was a report of a patient with 
metastatic medulloblastoma that initially responded well to vismodegib treatment, but the cancer 
rapidly became resistant to the drug via a point mutation in Smoothened (Rudin et al., 2009).  
Thus, multiple targeted therapies are probably needed to decrease a tumor's chances to evolve 
resistance.  Furthermore, tumors driven by inactivating mutations in tumor suppressors SUFU 
and GLI3, activating mutations in oncogenes GLI2 or GLI1, and those which acquire 
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SUPPLEMENTARY MATERIAL (CHAPTER 2) 
 
Supplemental Figure 2.S1 Schematic of the Hh proteins used in this study 
The domain structure of Drosophila Hedgehog (DHh), Xenopus Sonic Hedgehog (XShh) and human Sonic 
Hedgehog (HShh) is shown. The catalytic cysteine is part of a conserved GCF sequence, while the non-catalytic 
cysteine is part of a conserved SCY sequence. Auto-proteolytic cleavage of the Hh precursor is driven by the intein-
like C-terminal part of the molecule (C), and generates the N-terminal signaling fragment (N), attached to 






Supplemental Figure 2.S2 ERAD of HShh-C expressed in isolation. 
(A) HShh-C with a C-terminal HA tag was expressed directly in 293T cells. Protein synthesis was inhibited with 
cycloheximide (CHX), and the fate of the protein followed by SDS-PAGE and immunoblotting (IB) with HA-
antibodies. Where indicated, cells were incubated in the presence of the proteasome inhibitor MG132. The lower 
panel shows the quantification of the experiment in comparison with the degradation of HShh-C generated from the 
HShh precursor. 
(B) As in (A), but cells expressing either HShh-C or HShh precursor were labeled with 35S-methionine and -
cysteine, and chase- incubated with unlabeled amino acids for the indicated time periods. The samples were 
analyzed by SDS-PAGE and autoradiography. Arrows indicate the position of the C-terminal fragment (C) and that 
of the full length HShh (FL).  The C-terminal fragment generated by HShh processing is larger than the one 






Supplemental Figure 2.S3 Control showing dispersion of the Golgi by brefeldin A. 
Cells stably expressing HShh-HA were incubated in the absence or presence of 10 uM brefeldin A for 1 hr, in 
parallel to the experiment shown in Figure 3E. The cells were fixed and processed for immunofluorescence with 





Supplemental Figure 2.S4 Control showing specificity of the HShh-PDI mixed disulfide detection. 
Wild type (WT) HShh-HA, the processing-defective C198A mutant, or empty vector were co-transfected with a 
FLAG-tagged CXXA mutant of PDI (C56A) in 293T cells. Cell extracts were subjected to immunoprecipitation 
with HA- or FLAG- antibodies, followed by SDS-PAGE and immunoblotting with FLAG- and HA- antibodies. 




Supplemental Figure 2.S5 HShh-C is degraded by the proteasome 
(A) HShh-HA was stably expressed in 293T cells. Cells were immunostained with rat HA antibodies, following a 3-
hr treatment with or without the proteasome inhibitor epoxomicin (1 uM). The ER was stained with rabbit calnexin 
antibodies. 






Supplemental Figure 2.S6 Testing various factor for their effects on HShh-C ERAD. 
(A) Cells were simultaneously depleted of the ER-luminal lectins OS9 and XTP3 and the fate of stably expressed 
HShh-HA precursor was followed after cycloheximide (CHX) addition by SDS-PAGE and immunoblotting with 
HA-antibodies. The extent of depletion (in brackets) was determined by quantitative RT-PCR. Controls were treated 
with an unrelated siRNA. The right panel shows quantification of HShh-C in the experiment. All samples were also 
analyzed by immunoblotting for p97 (loading control). 
(B) As in (A), but cells were depleted of the ubiquitin ligase gp78 using two siRNAs. 
(C) As in (A), but cells were depleted of the ubiquitin ligase TRC8 using two siRNAs. 
(D) As in (A), but cells were depleted of the ubiquitin ligase TEB4 using two siRNAs. 
(E) As in (A), but cells were depleted of the ER membrane protein Derlin-1 (Der1) using two siRNAs. 
(F) As in (A), but cells were depleted of the human Usa1 homologue Herp using two siRNAs. 
(G) As in (A), but cells were depleted of the ER luminal chaperone BiP. 
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Supplemental Figure 2.S6 (Continued) 
(H) As in (A), but cells were depleted of the ER-localized oxidoreductase ERdj5 using two siRNAs. 
(I) Cells stably expressing HShh-HA were transiently transfected with FLAG-tagged ERdj5 (wild type) or with 
dominant-negative constructs (HQ and SS) (Ushioda et al., 2008). An empty vector served as control. A 
cycloheximide chase was performed as in (A).  
(J) Cells stably expressing HShh-HA were pulsed with 35S-methionine for 3 min and chase-incubated with unlabeled 
methionine for the indicated time periods. Both the pulse and the chase were performed in the presence or absence 
of 100 ug/mL 1-deoxymannojirimycin (DMJ) and 1 uM of the proteasome inhibitor epoxomicin. The samples were 
analyzed by immunoprecipitation with HA-antibodies followed by reducing SDS-PAGE and fluorography. Equal 
number of cells were processed for each condition.  






Supplemental Figure 2.S7 Control showing specificity of the immunoprecipitation of poly-ubiquitinated 
HShh. 
This experiment serves as a control for those shown in Figures 8B and C. Cells stably expressing HShh-HA were 
incubated in the absence or presence of MG132 for 2 hrs. Extracts were subjected to immunoprecipitation (IP) with 
HA-antibodies or with control IgG, and the proteins were analyzed by SDS-PAGE and immunoblotting (IB) with 






Supplemental Figure 2.S8 ERAD components required for the degradation of HShh precursor. 
(A) The processing defective mutant of HShh-HA with mutation of the catalytic cysteine (C198S) was stably 
expressed in 293T cells. Cells were depleted of the ER-luminal lectin OS9 by siRNA and the fate of HShh-HA 
precursor was followed after cycloheximide (CHX) addition. The extent of OS9 depletion (in brackets) was 
determined by quantitative RT-PCR. Controls were treated with an unrelated siRNA. All samples were analyzed by 
SDS-PAGE and immunoblotting with HA-antibodies. The right panel shows quantification of HShh-C298S in the 
experiment. All samples were also analyzed by immunoblotting for p97 (loading control). 





Supplemental Figure 2.S8 (Continued) 
(C) Cells stably expressing HShh-C198S-HA were transfected with a catalytically inactive Myc-tagged Hrd1 (Hrd1-
C291A) or with empty vector. The fate of HShh-HA was followed as in (A). All samples were also analyzed by 
immunoblotting for p97 (loading control) and myc (Hrd1-C291A).  
(D) As in (A), but with depletion of the Hrd1-interacting protein Sel1 by siRNAs. 
(E) As in (A), but with depletion of the ATPase p97 by siRNA. 
(F) As in (C), but with transfection of RGS-his-tagged wild type p97, a catalytically inactive p97 mutant (p97-QQ), 




Supplemental Table 2.S1: Sequences of SiRNA duplexes used in this study. 























































































Supplemental Table 2.S2: Primers for quantitative RT-PCR. 
Homo 
sapiens gene 





Hrd1 860-945 TGGACAATGTCTGCATCATCTG 
CAGCTGGTATGGAAAATGTGGTT 










































SUPPLEMENTARY MATERIAL (CHAPTER THREE) 
 
 
Supplemental Figure 3.S1 DispA Activity Measured in NIH 3T3 Cells, Related to Figure 3.1  
(A) NIH 3T3 cells stably expressing hShh or hShhN, transduced with a lentivirus expressing myc-tagged DispA-WT 
or not, were cocultured at the indicated dilution ratios with Hh-responsive Shh Light II cells. Twelve hours after 
plating, serum was washed off and the cells were incubated for 30 hr in serum-free media, followed by luciferase 
reporter assays. Luciferase measurements were normalized to Shh Light II cells grown alone (control). All 
experiments were performed in triplicate. Error bars represent SD of the mean. DispA expression increased the 
response of reporter cells to hShh but not to hShhN. 
(B) The cells used in (A) were analyzed by SDS-PAGE followed by immunblotting with anti-hShh and anti-myc 
antibodies. Shh Light II cells were used as negative control. HShhFL denotes the full-length hShh precursor. 




Supplemental Figure 3.S2 HShh Released by Serum or Heparin Is Inactive, in Contrast to hShh Released by 
Scube2, Related to Figure 3.3 
(A) 293T cells stably expressing hShh were incubated with heparin, fetal bovine serum (FBS), or HA-tagged Scube2 
added at the indicated concentrations in serum-free media (DMEM). Secreted hShh was collected for 3 hr and then 
analyzed by luciferase assay in Shh Light II reporter cells. As negative controls (!hShh), reporter cells were 
incubated with DMEM alone, DMEM with heparin (883 µM), DMEM with serum (5%), or DMEM with Scube2 
(1:20 dilution) 
(B) 293T cells stably expressing hShh were incubated with serum-free media, heparin, or FBS for 1.5 or 3 hr. 
Supernatants were precipitated with TCA, and were analyzed by SDS-PAGE and immunoblotting with anti-hShh 
antibodies. 
(C) Collection of supernatants and analysis by luciferase reporter assays was performed as in (A). Aliquots of the 






SUPPLEMENTARY MATERIAL (CHAPTER FOUR) 
 
Supplemental Figure 4.S1  Specificity of the novel polyclonal antibodies used for immunofluorescence 
staining in this study 
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Supplemental Figure 4.S1 (Continued) 
A) Specificity of the rabbit anti-mSmo antibody in immunofluorescence staining  
NIH-3T3 cells, wild-type mouse embryonic fibroblasts (MEFs) and Smo-/- MEFs were grown to confluence, 
starved and stimulated with Shh for 6 hours. The cells were stained with mouse anti-acetylated tubulin antibody (to 
reveal primary cilia) and affinity-purified rabbit anti-mSmo antibody. Strong staining of cilia is seen in NIH-3T3 
cells, wild-type MEFs but not in Smo-/- MEFs. Scale bar is 2 µm. 
B) Specificity of the rabbit anti-mSuFu antibody in immunofluorescence staining  
NIH-3T3 cells, SuFu+/- MEFs and SuFu-/- MEFs were treated as in A). The cells were stained with mouse anti-
acetylated tubulin antibody and affinity-purified rabbit anti-mSuFu antibody. Specific staining of cilia is seen in 
NIH-3T3 cells and SuFu+/- MEFs, while staining is absent in SuFu-/- MEFs. SuFu-/- MEFs respond to Hh 
stimulation as shown by Smo recruitment to cilia (bottom panels), demonstrating that the lack of SuFu staining is 
not due to a defect in signaling at the level of Smo. Scale bar is 2 µm. 
C) Specificity of the rabbit anti-GliC antibody in immunofluorescence staining 
NIH-3T3 cells, wild-type MEFs, Gli2-/- MEFs, Gli1-/- Gli2-/- MEFs, Gli3-/- MEFs and Gli2-/- Gli3-/- MEFs were 
treated as in A). The cells were stained with mouse anti-acetylated tubulin antibody and rabbit anti-Gli antibody 
affinity purified against a C-terminal fragment of human Gli3 (amino acids 1061-1599). Specific staining of cilia is 
seen in NIH-3T3 cells, wild-type MEFs, Gli2-/- MEFs, Gli1-/- Gli2-/- MEFs and Gli3-/- MEFs.  Gli staining is 
absent in Gli2-/- Gli3-/- MEFs, although Smo is recruited to cilia normally upon Shh stimulation of Gli2-/- Gli3-/- 
MEFs (bottom panels), demonstrating that the lack of Gli staining is not due to a defect in signaling at the level of 
Smo. Data in this figure demonstrate that the rabbit anti-GliC antibody recognizes both mouse Gli2 and Gli3 
proteins. Scale bar is 2 µm. 
D) Specificity of the rabbit anti-GliN antibody in immunofluorescence staining  
NIH-3T3 cells, wild-type MEFs, Gli2-/- MEFs, Gli1-/- Gli2-/- MEFs, Gli3-/- MEFs and Gli2-/- Gli3-/- MEFs were 
treated as in A). The cells were stained with mouse anti-acetylated tubulin antibody and rabbit anti-Gli antibody 
affinity purified against an N-terminal fragment of human Gli3 (amino acids 1-799). Strong specific staining of cilia 
is seen in NIH-3T3 cells, wild-type MEFs, Gli2-/- MEFs and Gli1-/- Gli2-/- MEFs. Weak but specific staining is 
seen in Gli3-/- MEFs.  The anti-GliN antibody does not stain Gli2-/- Gli3-/- MEFs, although Smo is recruited to cilia 
normally upon Hh stimulation of Gli2-/- Gli3-/- MEFs (bottom panels), demonstrating that the lack of Gli staining is 
not due to a defect in signaling at the level of Smo. These data demonstrate that the anti-GliN antibody recognizes 
endogenous mouse Gli2 only poorly and most of the signal corresponds to endogenous mouse Gli3 protein, 
consistent with the staining of overexpressed Gli proteins (not shown). Scale bar is 2 µm. 
E) Specificity of the goat anti-GliC antiserum in immunofluorescence staining 
NIH-3T3 cells, wild-type MEFs, and Gli2-/- Gli3-/- MEFs were treated as in A).  The cells were stained with mouse 
anti-acetylated tubulin, rabbit anti-Smo, and goat anti-human Gli3C antibodies.  Strong specific staining of cilia tips 
is seen in NIH-3T3 cells and wild-type MEFs, as well as a faint non-specific staining of the cilium shaft.  The goat 
anti-GliC antibody does not stain Gli2-/- Gli3-/- MEFs, although Smo is recruited to cilia normally upon Shh 






Supplemental Figure 4.S2  The effects of oxysterols, protein synthesis inhibition, and microtubule 
depolymerization 
 A) NIH-3T3 cells were treated with 10 microM of either 20-hydroxycholesterol or 25-hydroxycholesterol, for 3 
hours. Immunofluorescence micrographs show recruitment of SuFu and Gli to cilia. The oxysterol 7-
hydroxycholesterol, which does not activate the Hh pathway, does not recruit SuFu and Gli to cilia above basal 
levels (not shown). Scale bar is 2 µm. 
B) Inhibition of protein synthesis by cycloheximide (CHX) does not block recruitment of Smo, Gli and SuFu to 
cilia. NIH-3T3 cells were treated or not with Shh for 1 hour, in the presence or absence of CHX (50 
micrograms/mL). Scale bar is 2 µm. 
C) Inhibition of proteins synthesis by CHX in the experiment in B). NIH-3T3 cells were incubated with or without 
CHX (50 micrograms/mL), in the presence of 35S-methionine. Total cell lysates were separated by SDS-PAGE and 
either stained by Coomassie for total protein or autoradiographed to reveal new protein synthesis. 
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Supplemental Figure 4.S2 (Continued) 
D) Microtubule (MT) depolymerization does not affect recruitment of SuFu, Gli and Smo to cilia. NIH-3T3 cells 
were pre-treated or not with nocodazole (Noc, 2.5 microM) for 1 hour, then stimulated or not with Shh for 3 hours, 
in the continued presence or absence of Noc. Recruitment of Smo, SuFu and Gli is not affected by MT 
depolymerization. Scale bar is 2 µm. 
E) Cilia counts for the experiment in (D). 
F) MT depolymerization by Noc in the experiment in D). NIH-3T3 cells were treated with various concentrations of 
Noc for 4 hours, and were immunostained for !-tubulin. Even the highest concentration of Noc does not affect the 
stable MTs in cilia, which are visible against the diffuse cytoplasmic staining due to depolymerized tubulin. 
Disappearance of cytoplasmic MTs in the presence of increased Noc concentration correlates with the degree of 
inhibition of Hh signaling by Noc. Scale bar is 10 µm. 
G) MT depolymerization by Noc inhibits the transcriptional output of the Hh pathway in a dose-dependent manner. 
NIH-3T3 cells pre-incubated for 1 hour with the indicated Noc concentrations, were then treated for 3 hours with 
Shh, in the continued presence of Noc. Transcription of the Gli1 gene was measured by Q-PCR relative to the 





Supplemental Figure 4.S3  Experiments characterizing Smo-/- MEFs, SuFu-/- MEFs, and 3T3 cells expressing 
Gli1-SuFu fusion 
A) SuFu and Gli localize to the tips of cilia in Smo-/- MEFs. Cilia were stained with anti-acetylated tubulin and 
basal bodies were stained with anti-gamma tubulin. Percentages shown under the bottom panels indicate ciliary 
localization of Smo, SuFu and Gli, in untreated cells and in cells stimulated overnight with Shh. SuFu and Gli are 
not recruited to cilia above basal levels following Shh stimulation of Smo-/- MEFs. Scale bar is 2 µm. 
B) The effect of forskolin (FSK) on the levels of Gli1-SuFu fusion. NIH-3T3 cells stably expressing Gli1 directly 
fused to SuFu, were treated overnight with control vehicle, the proteasome inhibitor bortezomib (100 nM), or FSK 
(10 microM). Expression levels of Gli1-SuFu fusion, endogenous SuFu and GSK3 (loading control) were 
determined by immunoblotting. 
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Supplemental Figure 4.S3 (Continued) 
C) The effect of FSK on localization of Smo and Gli1-SuFu fusion to cilia is reversed by the small molecule PKA 
inhibitor, H-89. NIH-3T3 cells stably expressing Gli1-SuFu fusion were treated overnight with control vehicle, SAG 
(200 nM), FSK (5 microM), or FSK and H-89 (5 and 10 microM, respectively). Recruitment of endogenous Smo to 
cilia by FSK is reversed by H-89. Ciliary localization of Gli1-SuFu, which is abolished by FSK, is rescued by H-89. 
Percentages shown under the bottom panels show ciliary localization of the Gli1-SuFu fusion for the various 
treatments. Scale bar is 2 µm. 
D) No Gli signal is present at cilia in SuFu-/- MEFs, while recruitment of Smo to cilia by Shh is normal in SuFu-/- 
MEFs. The graph shows cilia counts for the experiment shown in figure 4C. 
E) Expression of FLAG-tagged SuFu in SuFu-/- MEFs rescues ciliary localization of Gli. SuFu-/- MEFs stably 
expressing mouse SuFu tagged with 3 FLAG epitopes were stimulated with 100 nM SAG for 6 hours. Endogenous 
Smo was detected with a rabbit antibody, SuFu-3FLAG was detected with a mouse anti-FLAG antibody and 
endogenous Gli was detected with a goat antibody. Scale bar is 2 µm. 
F) Gli3-FL levels are greatly decreased in SuFu-/- MEFs, compared to SuFu+/- MEFs and to NIH-3T3 cells. Gli3-
FL levels are partially rescued by inhibition of the proteasome with bortezomib. Cell cultures were incubated for 6 
hours in the absence or presence of bortezomib, and probed with antibodies against GliC, SuFu and GSK3. Lane 1: 
NIH-3T3 cells, lane 2: SuFu+/- MEFs, lanes 3-5:  SuFu-/- MEFs treated with 0, 50, or 250 nM bortezomib, 
respectively. 
G) Overexpressed Gli1 accumulates in the nucleus in SuFu-/- MEFs, but not in SuFu+/- MEFs. The cells shown are 
from the same experiment as the one in figure 4E. Gli1-HA was overexpressed in both SuFu+/- and SuFu-/- MEFs 












Supplemental Figure 4.S4 (Continued) 
A) Effect of Shh stimulation on SuFu and Gli3-FL levels in various cell lines used in this study. Starved, confluent 
cultures of wild-type MEFs, Gli2-/- MEFs, Gli3-/- MEFs, Gli2-/-Gli3-/- MEFs, Smo-/- MEFs, SuFu-/- MEFs, and 
NIH-3T3 cells were incubated overnight in the absence or presence of Shh. SuFu, Gli3-FL and the loading controls 
GSK3 and !-tubulin, were detected by immunoblotting. Two different exposures of the immunoblot for Gli3-FL are 
shown. Gli3-FL levels decrease during prolonged Shh stimulation in wild-type MEFs, Gli2-/- MEFs, and in 3T3 
cells. Gli3-FL levels are not affected by Shh stimulation in Smo-/- MEFs. Gli3-FL is not detectable in MEFs that 
lack Gli3, as well as in SuFu-/- MEFs, in which Gli proteins are very unstable. SuFu levels and its electrophoretic 
mobility are not affected by Shh stimulation in any of the cell lines in this panel. Blotting against GSK3 and !-
tubulin was used to control for loading. 
B) Endogenous Gli3-FL levels are decreased following stimulation of 3T3 cells with 100 nM SAG for 6 hours. Gli3-
FL was detected by immunoblotting with anti-GliC antibodies. The decrease in Gli3-FL levels can be reversed by 
incubation with 2 microM of the proteasome inhibitor bortezomib. 
C) The levels of both Gli3-FL and Gli3 repressor (Gli3-R) are decreased following prolonged Hh pathway 
stimulation. Serum-starved, confluent cultures of 3T3 cells were incubated for 12 hours in starvation media in the 
absence or presence of 100 nM SAG. Arrowhead indicates a non-specific band. 
D) Hh pathway stimulation does not change the half-life of endogenous SuFu but reduces the half-life of Gli3-FL. 
Confluent, starved 3T3 cells were pre-incubated for 10 minutes with CHX (100 micrograms/mL), followed by 
incubation with CHX in the absence or presence of Shh, for the indicated amount of time. Endogenous levels of 
SuFu and Gli3-FL were determined by immunoblotting. Immunoblotting against GSK3 and !-tubulin was used to 
control loading. 
E) Quantification of the experiment in D). The plot shows the percentage of endogenous SuFu and Gli3-FL 





Supplementary Table 4.S1 
 
Recruitment of Smo, SuFu, Gli2 and Gli3 to primary cilia in NIH-3T3 cells and in various mouse 
embryonic fibroblast lines 
 
 
 Smo SuFu Gli2 & 3 
Cell Line    
WT 3T3 -, I +, I +, I 
WT 3T3 + cyclopamine + -, N -, N 
WT 3T3 + SANT-1 -, N -, N -, N 
WT 3T3 + forskolin +, I -, N -, N 
WT MEFs -, I +, I +, I 
SuFu-/- -, I - -, N 
SuFu+/- -, I +, I +, I 
Smo-/- - +, N +, N 
Smo-/- + forskolin - -, N -, N 
Gli2-/- -, I +, I +, I 
Gli3-/- -, I +, I +, I 
Gli1-/- Gli2-/- -, I +, I +, I 
Gli2-/- Gli3-/- -, I -, N - 
 
- = not detectable at cilia without Shh treatment  
+ = detectable at cilia without Shh treatment 
N = not inducible by Shh 




Mass Spectrometry Results 
Peptides of endogenous Gli2 identified in Sufu pulldown 
In collaboration with Wilhelm Haas 
 
IPI:IPI00284476.2 Mus musculus (Mouse) PREDICTED: GLI-KRUPPEL FAMILY MEMBER 
GLI2 ISOFORM 1. [MASS=165031] 
METSAPAPAL EKKEAKSGLL EDSSFPDPGK KACPLAVAAA VAAHGVPQQL LPAFHAPLPI DMRHQEGRYH 
YDPHSVHSVH GPPTLSGSPV ISDISLIRLS PHPAGPGESP FSAHHPYVNP HMEHYLRSVH SSPTLSMISA 
ARGLSPADVA HEHLKERGLF SLAAPGTNPS DYYHQMTLMA SHPTPYGDLL MQSGGAASAP HLHDYLNPVD 
ASRFSSPRVT PRLSRKRALS ISPLSDASLD LQRMIRTSPN SLVAYINNSR SSSAASGSYG HLSAGALSPA 
FTFPHPINPV AYQQILSQQR GLGSAFGHTP PLIQPSPTFL AQQPMTLTSI STMPTQLSSS SSNCLNDANQ 
NKQNSESAVS STVNPITIHK RSKVKTEAEG LRPASPLGLT QEQLADLKED LDRDDCKQEA EVVIYETNCH 
WADCTKEYDT QEQLVHHINN EHIHGEKKEF VCRWQACTRE QKPFKAQYML VVHMRRHTGE KPHKCTFEGC 
SKAYSRLENL KTHLRSHTGE KPYVCEHEGC NKAFSNASDR AKHQNRTHSN EKPYICKIPG CTKRYTDPSS 
LRKHVKTVHG PDAHVTKKQR NDVHVRAPLL KENGDNEASA EPGGRGPEES VEASSTSHTV EDCLHIKAIK 
TESSGLCQSS PGAQSSCSSE PSPLGSAPNN DSGMEMPGTG PGSLGDLTAL ADTCPGADTS ALAAPSTGGL 
QLRKHMSTVH RFEQLKREKL KSLKDSCSWA GPAPHTRNTK LPPLPVNGSV LENFNNTGGG GPAGLLPSQR 
LPELTEVTML SQLQERRDSS TSTMSSAYTV SRRSSGISPY FSSRRSSEAS PLGGLRPHNA SSADSYDPIS 
TDASRRSSEA SQCSGGGPGL LNLTPAQQYN LRAKYAAATG GPPPTPLPGL DRVSLRTRLA LLDAPERALP 
GACPHPLGPR RGSDGPTYSH GHGHGYAGAA PAFPHEGPNS STRRASDPVR RPDPLILPRV QRFHSTHNMN 
PGSLPPCADR RGLHVQSHPS VDSNLTRNAY SPRPPSINEN VVMEAVAAGV DGPGLECDLG LVEDELVLPD 
DVVQYIKAHT GGTLDDGIRQ GYPTEGTGFP ENSKLPSPGL QGHRRLAAAD SNMGPSAPGL GGCQLSYSPS 
SNLNKSNMPV QWNEVSSGTV DALPTQVKPP PFPHSNLAVV QQKPAFGQYP GYNPQSVQSS SGGLDSTQPH 
LQLRGAPSAS RGSYTQQPRQ PAAGSQCLGM SAAMSPQASY SQAHPQLSPN IVSGSLNQFS PSCSNMAAKP 
SHLGLPQQME VVPNATIMNG HQREHGVPNS SLAAVSQPHP VLSYPQQDSY QQGSNLLSSH QPGFMESQQN 
AGFGLMQPRP PLEPNTASRH RGVRSGQQQL YARTTGQAMV TSANQETAEA MPKGPAGTMV SLAPQPSQDT 
GRAQDQNTLY YYGQIHMYEQ NGGCPAVQPQ PPQPQACSDS IQPEPLPSPG VNQVSSTVDS QLLEPPQIDF 
DAIMDDGDHS SLFSGALSPT LLHNLSQNSS RLTTPRNSLT LPSIPAGISN MAVGDMSSML TSLAEESKFL 
NMMT 
 
ScanF z   XCorr !Corr # Ions *Gene "  Redun  -  Peptide 
3732 2 3.102 0.298 13/26 IPI00284476 2 K.SGLLEDSSFPDPGK.K  
1497 2 2.257 0.373 15/28 IPI00284476 4 R.SVHSSPTLSM*ISAAR.G  
6226 2 3.680 0.485 18/30 IPI00284476 3 R.ALSISPLSDASLDLQR.M  
6153 2 3.504 0.457 17/30 IPI00284476 3 R.ALSISPLSDASLDLQR.M  
4121 2 2.635 0.377 13/26 IPI00284476 3 R.TSPNSLVAYINNSR.S  
6390 2 4.274 0.554 25/30 IPI00284476 4 R.LPELTEVTM*LSQLQER.R  
2520 2 2.201 0.154 16/20 IPI00284476 4 R.SSGISPYFSSR.R 
3260 2 4.237 0.424 21/34 IPI00284476 3 K.YAAATGGPPPTPLPGLDR.V  
1384 2 4.365 0.675 21/36 IPI00284476 2    K.GPAGTM*VSLAPQPSQDTGR.A 




Mass Spectrometry Results 
Peptides of endogenous Gli3 identified in Sufu pulldown 
In collaboration with Wilhelm Haas 
 
IPI:IPI00123429.1 Mus musculus (Mouse) ZINC FINGER PROTEIN GLI3. 
[MASS=173512] 
MEAQAHSSTA TERKKAENSI GKCPTRTDVS EKAVASSTTS NEDESPGQIY HRERRNAITM QPQSVQGLNK 
ISEEPSTSSD ERASLIKKEI HGSLPHLAEP SLPYRGTVFA MDPRNGYMEP HYHPPHLFPA FHPPVPIDAR 
HHEGRYHYDP SPIPPLHVPS ALSSSPTYPD LPFIRISPHR NPTAASESPF SPPHPYINPY MDYIRSLHCS 
PSLSMISAAR GLSPTDAPHA GVSPAEYYHQ MALLTGQRSP YADILPSAAT AGAGAIHMEY LHAMDSTRFP 
SPRLSARPSR KRTLSISPLS DHSFDLQTMI RTSPNSLVTI LNNSRSSSSA SGSYGHLSAS AISPALSFTY 
PSAPVSLHMH QQILSRQQSL GSAFGHSPPL IHPAPTFPTQ RPIPGIPTVL NPVQVSSGPS ESSQSKPTSE 
SAVSSTGGPM HNKRSKIKPD EDLPSPGSRG QQEQPEGTTL VKEEADKDES KQEPEVIYET NCHWEGCTRE 
FDTQDQLVHH INNDHIHGEK KEFVCRWLDC SREQKPFKAQ YMLVVHMRRH TGEKPHKCTF EGCTKAYSRL 
ENLKTHLRSH TGEKPYVCEH EGCNKAFSNA SDRAKHQNRT HSNEKPYVCK IPGCTKRYTD PSSLRKHVKT 
VHGPEAHVTK KQRGDMHPRP PPPRDSGSHS QSRSPGRPTQ GAFGEQKELS NTTSKREECL QVKTVKAEKP 
MTSQPSPGGQ SSCSSQQSPI SNYSNSGLEL PLTDGGSVAD LSAIDETPIM DSTISTATTA LALQARRNPA 
GTKWMEHIKL ERLKQVNGMF PRLNPILPSK APAVSPLIGN GTQSNNNYSS GGPGTLLPSR SDLSGVDFTV 
LNTLNRRDSN TSTISSAYLS SRRSSGISPC FSSRRSSEAS QAEGRPQNVS VADSYDPIST DASRRSSEAS 
QGDGLPSLLS LTPVQQYALK AKYAAPTGGP PPTPLPHMER LSLKTKMALL GEGRDSGVTL PPVHPPRRCS 
DGGGHTYRGR HLMPHDALAN SVRRDSDPVR TVSENMSLAR VQRFSSLNSF NPPNLPPSVE KRSLVLQNYT 
RQESSQPRYF QASPCPPSIT ENVALEALTM DADANLNDED LLPDDVVQYL NSQNQTGYGQ QLQSGISEDS 
KVAHEPEDLD LAGLPDSHVG QEYPALEQPC SEGSKTDLPI QWNEVSSGTS DLSSSKLKCG QQRPRQQPRG 
FGLYNNMVVH PHNLWKVGTG PAGGYQTLGE NSSTYNGPEH FAIHSGDGLG TNGNTFHEQP FKTQQYGSQL 
NRQPLTSSAL DHACGTGIQG SKLKGNSLQE NGGLLDFSLS VAPNELAGNT VNGMQTQDQM GQGYIAHQLL 
SGSMQHQGPS RPGQQVLGQV GATSHINIYQ GTESCLPGTQ DNSSQPSSMA AIRGYQPCAS YGGNRRQAMP 
RGNLTLQQGQ LSDMSQSSRV NSIKMEAQGQ SQQLCSTVQN YSGQFYDQTM GFSQQDRKAG SFSLSDANCL 
LQGTCTENSE LLSPGANQVT STVDSFESHD LEGVQIDFDA IIDDGDHTSL MSGALSPSII QNLSHSSSRL 
TTPRASLPFP IPIHGHHQHG YRGYEFFADL PCRRKQVPCS YAVGGRQGGP QTQRLK 
 
ScanF z   XCorr !Corr # Ions *Gene "  Redun  -  Peptide 
1057 3 2.764 0.480 25/76 Gli3 1 K.AVASSTTSNEDESPGQIYHR.E  
1449 2 4.600 0.486 21/28 Gli3 1 R.NAITM*QPQSVQGLNK.I  
470 2 1.812 0.154 11/22 Gli3 1 K.ISEEPSTSSDER.A 
4478 2 3.595 0.292 18/26 Gli3 1 R.TSPNSLVTILNNSR.S  
950 2 3.084 0.307 18/24 Gli3 1 R.GQQEQPEGTTLVK.E  
887 2 2.717 0.370 16/24 Gli3 1 R.GQQEQPEGTTLVK.E  
954 2 2.053 0.143 11/24 Gli3 1 R.GQQEQPEGTTLVK.E  
637 2 2.319 0.300 13/26 Gli3 0 R.SPGRPTQGAFGEQK.E  
7089 2 3.543 0.349 18/30 Gli3 0 R.SDLSGVDFTVLNTLNR.R  
6376 2 2.814 0.417 13/30 Gli3 0 R.SDLSGVDFTVLNTLNR.R 
1732 2 5.318 0.585 22/34 Gli3 0 R.GNLTLQQGQLSDM*SQSSR.V  
1570 2 4.664 0.626 22/34 Gli3 0 R.GNLTLQQGQLSDM*SQSSR.V  





Analysis of two mass spectrometry experiments from Nov 14 2007. 
Repeat hits for Ski interactors 
In collaboration with Wilhelm Haas 
Went through the two Ski datasets (Boiling after acid elution, and the newest dataset without acid elution) to identify 
proteins that show up in both. 
A list of proteins that appeared in both, had above-average Light to Heavy ratios, and were not obvious 
contaminants or FLAG-tag binders: 
Presented here in order of descending signal-to-noise ratio of the first Ski IP.  Only cDNA FLJ31747 had a light to 
heavy ratio (significantly higher than average). 
reference annotation 
IPI00032003 EMERIN. 
IPI00014400 DNAJ HOMOLOG SUBFAMILY B MEMBER 
IPI00024642 ISOFORM 1 OF COILED-COIL DOMAIN-CONTAINING PROTEIN 47 PRECURSOR. 
IPI00220739 MEMBRANE-ASSOCIATED PROGESTERONE RECEPTOR COMPONENT 1. 
IPI00166785 TRANSMEMBRANE PROTEIN 32 PRECURSOR.  
IPI00009320 ISOFORM 1 OF TRANSMEMBRANE PROTEIN 85 
IPI00107357 ISOFORM 2 OF CLEFT LIP AND PALATE TRANSMEMBRANE PROTEIN 1. 
IPI00025874 DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE--PROTEIN GLYCOSYLTRANSFERASE 67 
KDASUBUNIT PRECURSOR. 
IPI00180956 UNCHARACTERIZED PROTEIN ENSP00000308452. 
IPI00027547 DERMCIDIN PRECURSOR. 
IPI00010740 ISOFORM LONG OF SPLICING FACTOR, PROLINE- AND GLUTAMINE-RICH.  
IPI00009841 CDNA FLJ31747 FIS, CLONE NT2RI2007377, HIGHLY SIMILAR TO RNA-BINDING 
PROTEIN EWS. 
 
SuFu phosphorylation sites: S301, S346, S349 
 
 
In collaboration with Wilhelm Haas 
